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ABSTRACT 
The aim of this project was to employ phage-display libraries to investigate epitopes 
recognised by antibodies directed against the hepatitis B virus surface antigen 
(HBsAg). 
The experiments were based upon a library comprising a pool of filamentous phage 
(fusion-phage) which displayed random hexapeptides on the surface of the particles. 
Antibodies of monoclonal and polyclonal origin were used for selection of phage that 
bound the antibodies via their exposed peptides. 
In the case of the monoclonal antibody, the phage ligands selected showed highly 
related amino acid sequences with a few distinctively conserved residues. These 
residues could be aligned with the primary sequence of the PreS 1 domain of HBsAg 
thus precisely locating the epitope recognised by this monoclonal antibody. A 
quantitative assay, adapted specifically for use with fusion-phage particles, revealed 
binding constants in the nM range for the interaction of the fusion-phage with the 
antibody. Comparison of the binding constants of phage with divergent amino acid 
sequences and competition binding studies with synthetic peptides defined the 
epitope recognised by this antibody with high-resolution. 
A similar approach was applied to polyclonal serum IgG from a chimpanzee that had 
been vaccinated with HBsAg. The complex situation of the polyclonal background 
made interpretation of the isolated phage ligands more difficult. However, consensus 
motifs were found among the phage analysed which could be aligned with short 
stretches of the primary sequence of HBsAg. Investigation of these consensus motifs 
and a screening procedure that selected for phage preferentially recognising immune 
serum IgG led to two related families of fusion-phage that displayed a sequence 
motif that could be aligned with residues 117-122 of HBsAg. Competition 
experiments with peptides representing this motif provided, in association with the 
other results, support for the argument that this area is recognised by this polyclonal 
serum raised against HBsAg. 
It has been demonstrated that the phage-display approach can provide high-resolution 
epitope mapping for monoclonal antibodies. Quantitative values for the interaction in 
solution between fusion-phage representing this epitope and the antibodies have been 
V 
obtained readily by means of a simple assay based upon phage titre. Further, even 
within the complex context of a polyclonal serum individual epitopes or at least 
elements of them could be identified, thus indicating immunologically important 
areas of this antigen. 
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I. Introduction 
I.A) 	Fusion-Phage and Peptide Libraries: Tools for 
Exploring Molecular Interactions 
The filamentous phage fd 
Fd is a filamentous bacteriophage very similar to the well-studied M13 
bacteriophage. Their genomes consist of single-stranded DNA molecules and M13 in 
particular has been extensively used as a vector for molecular cloning since the late 
seventies (Messing et al., 1977). The reasons for its suitability are first, these 
bacteriophage do not kill their host cells after infection i.e. they are not lytic. Virions 
are exported from the host cells by extruding the circular plus strand, the one which 
is packaged into the virions, through the cell membrane where it associates with 
phage capsid proteins that were integral parts of the host membrane prior to 
assembly. Second, these phage allow the packaging of DNA molecules that are 
longer than the unit length of the phage genome (Messing, 1981) and third, phage 
DNA which has been subjected to in vitro manipulation can easily be reintroduced 
into Escherichia coli cells by standard transfection methods. 
The principal structural component of the phage particle is pVIII, the product of gene 
VIII which is present in almost 2700 copies per virion. pVIII has a molecular weight 
of 5.2 kD and consists of only 50 amino acids. Other minor coat proteins are the 
products of genes III, VI, VII and IX (pill, pVI, pVII and pIX, respectively), p111 and 
pVI and pVII are present in about five copies per phage and pIX in 10 (Lin et al., 
1980; Simons et al., 1981). The other gene products p1, p11, pIV and pV are non-
structural and provide functions for phage proliferation and assembly. 
The N-terminal domain of the coat protein pIll is exposed on the surface at one tip of 
the phage particle and is essential for the infection process. pill interacts with the F-
pili of susceptible E.coli cells to initiate infection (Armstrong et al., 1981). Its C-
terminal domain is buried in the capsid and necessary for correct assembly of normal 
phage particles (Crissman and Smith, 1984). 
Following uptake of the particle and unpacking, the single stranded DNA molecule 
present in the virion is converted into the double stranded RF (replicative form) DNA 
form by host cell polymerase activities. Replication of RE DNA serves two purposes. 
2 
I. Introduction 
First, it provides the sense strand for transcription of the viral gene products and 
second, as the name might imply, it generates templates for further synthesis of 
progeny DNA (plus strands). This synthesis is thereby performed in a continuos 
fashion around the circular minus strand template. The resulting multimeric copies 
are then cleaved by the gene II product in order to separate the unit length progeny 
DNA molecules from each other. 
RF DNA accumulates to 100-200 copies per host cell before a regulatory phage-
derived protein, the gene V product, reaches levels that prevent further accumulation 
of RF DNA and promotes export of progeny single strands by interacting with newly 
synthesised plus strand molecules. This ssDNA-protein complex then migrates to the 
membrane where it becomes engulfed with membrane associated coat proteins and is 
extruded into the periplasmic space. However, when phage morphogenesis is 
impaired but phage genome replication still continues, as it is for example in the case 
of mutants defective for correct assembly, the host cell is finally killed by the 
accumulation of phage DNA and phage gene products which cannot be packaged and 
exported. This phenomenon is known as cell killing (Pratt et al., 1966). 
RF DNA can easily be prepared from cultures of infected E. coli cells in a similar 
way to plasmid DNA, but usually with lower yields due to the relatively low copy 
number present per cell. For sequencing purposes it is also possible to prepare 
ssDNA from phage particles contained in the supernatant of cultures of infected cells. 
I.A.2) 	Fusion phage: Phage that display foreign peptides or protein 
domains 
The term "fusion phage" was first introduced by George Smith in 1985 for 
filamentous phage particles that had foreign proteins fused to their pill coat proteins 
and therefore displayed these moieties on the virion surface. In this pioneering work 
Smith constructed fusion-phage which displayed fragments of the EcoRi restriction 
endonuclease. Using petri dishes with adsorbed anti-EcoRl antibodies he was able to 
demonstrate the feasibility of an affinity purification that achieved the isolation of 
these fusion-phage from a large background of unspecific phage. 
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Since their introduction fusion-phage vectors have been modified in various ways to 
optimise the system or to tailor it according to specific applications. One important 
modification was the introduction of an antibiotic resistance gene against tetracycline 
(Parmley and Smith, 1988) as had been done earlier with the non-fusion phage 
vectors (Zacher et al., 1980). The propagation of these altered fusion-phage does not 
depend on continuous reinfection of new E. coil cells but can be propagated in 
selective medium in which the DNA genome is passed on like a plasmid. A single 
infection therefore leads to a visible clone even when infectivity of the phage is 
reduced, as is often the case for fusion-phage involving the infectivity-sensitive p111 
coat protein. Since the tetracycline gene was inserted into the origin of minus strand 
replication these phage were also partially defective for minus strand synthesis. This 
avoids the accumulation of progeny ssDNA in bacteria infected with virions which 
are impaired in assembly or export and as a consequence cell killing is prevented. 
It also became apparent that inserting sequences at the 5' end of gene III and 
consequently displaying the foreign peptide at the very N-terminus of pill was 
preferable to internal sites used previously (Parmley and Smith, 1988), probably 
because the p111-fusion was more surface-accessible and the negative effects on 
infectivity were reduced. 
After the idea of fusion phage was established, other groups picked up the principle 
and generated fusion-phage by linking the foreign peptide to pVIII, the major coat 
protein which is present in about three thousand copies per particle. This allows a 
higher degree of multivalency and also circumvents a potential infectivity problem 
since pVIII is not involved in the infection process (Felici et al., 1991; Kang et al., 
1991; Markland et al., 1991). Recently, fusions to pVI, another minor coat protein 
have been reported (Jesper et al., 1995). The main difference of this system is that, in 
contrast to pill, the C-terminus of pVI is exposed on the phage surface which allows 
foreign proteins to be fused with their N-termini leaving the C-termini of the fusions 
free to interact with specific ligands. Further, fusions with not naturally secreted 
proteins or domains seem to be more efficiently displayed than in the current systems 
which could be of particular importance for the display of eDNA libraries. 
At least in the case of pVIII fusions the inserts seem to be somewhat limited in size 
since larger inserts appear to interfere with assembly of the phage particle. This 
problem can be overcome by using so-called phagemid vectors where wild type 
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pVIII is provided by an external helper phage (Felici et al., 1991; Kang et al., 1991). 
Competition between the wild type pVIII and the manipulated pVIII (from the 
phagemid) during assembly of new phage particles in the cell will result in 
incorporation of a relatively low number of mutant pVIII molecules. This usually 
assures correct assembly of particles and increases the tolerance for larger fragments. 
This system can also be applied to the p111-fusion phage resulting in incorporation of 
fewer than five copies per virion. Since wild type p111 from the helper phage is in 
vast excess a near monovalency of the displayed peptide or domain can be achieved 
which may have advantages for certain applications (Bass et al., 1990; Lowman et 
al., 1991; Marks et al., 1991; Hoogenboom et al., 1991). This way a range of whole 
proteins or domains have been displayed on filamentous phage which would 
otherwise have caused serious problems with infectivity (p111-fusions) or assembly 
(pVIII-fusions). They include enzymes such as alkaline phosphatase (McCafferty et 
al., 1992), trypsin (Corey et al., 1993) and Staphylococcus nuclease (Chiswell and 
McCafferty, 1992), growth factors and cytokines such as human growth hormone 
hGH (Bass et al., 1990) and IL-3 (Gram et al., 1993), and receptors like the IgE-
binding extracellular domain of FcERlct (Robertson et al., 1993). The display of 
antibody fragments (Fab) or so called single chain Fv fragments (scFv) has been 
extremely successful since they show full binding activity and can be used essentially 
like free antibodies (McCafferty, 1990; Hoogenboom et al., 1991). 
Most of the displayed proteins and domains are extracellular proteins and naturally 
secreted and therefore do not cause problems when exported from the host cell for 
phage assembly. The export problem seems to be a more important factor than the 
size of the fused polypeptide which does not seem to be limiting per se. However, 
the cell internal DNA-binding trancriptional regulators Zif268 (Rebar and Pabo, 
1994; Wu et al., 1995) and Jun/Fos (Crameri et al., 1993) have also recently been 
displayed on phage. 
Some phagemid vectors contain amber stop codons between the foreign gene and 
gene III which allow the production of soluble fusion fragments in non-suppressor 
strains (Hoogenboom et al., 1991; Lowman et al., 1991; Robertson et al., 1993). This 
can be helpful if the fused domain is to be used in subsequent studies. 
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I.A.3) 	Phage-display libraries 
After it had been demonstrated that fusion-phage can be isolated from large 
backgrounds of unspecific phage on the basis of their displayed protein moiety the 
next breakthrough was to display random peptides and create large pools of such 
fusion-phage in order to search for any phage that bind specifically to molecules of 
interest. Since these libraries were initially used in connection with antibodies to 
perform epitope mapping studies the classical term "epitope library" was introduced 
(Scott and Smith, 1990) but strictly speaking this term does not apply if other 
interactions are studied. Therefore the more general term "phage-display library" is 
preferable and widely used now. 
The inspiration for creating libraries on a random basis came from earlier work by 
Geysen et al. (1986) who developed a synthetic peptide library on plastic pins to 
search for specific ligands to antibodies. They isolated peptides mimicking a 
discontinuous epitope and consequently called their library a "mimotope library". 
Despite this obvious success, however, biological libraries have distinct advantages 
over synthetic libraries. First, sequence analysis of the ligands is much easier since 
the selection for binding activity also means selecting for the gene encoding it 
because the coding information and the protein displayed are physically linked (in 
the phage particle). Second, biological libraries are cheaper to make and can be 
propagated indefinitely. Third, multiple rounds of selection followed by 
amplification enhance the chances of finding very rare ligands that might have 
existed only once in the original library. On the other hand synthetic libraries offer 
the advantage of not having a biological bias towards certain sequences since there is 
no in vivo selection pressure (Clackson and Wells, 1994). 
Random phage-display libraries can be based upon either pill- or pVIII fusions and 
usually display between 6 and 15 amino acids. For reasons explained above pVIII-
libraries are usually phagemid libraries and therefore require superinfection with 
helper phage (Felici et al., 1991). Both libraries offer distinct advantages depending 
on the application. pVIII-libraries have the point of a higher degree of multivalency 
for them which can be helpful if very weak interactions are studied that would 
otherwise be lost. In the same way the p111-library can have advantages if stronger 
interactions are pursued since too many interactions per virion could result in too 
tight binding and failure to recover the bound phage during the selection procedure. 
rei 
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Both fd and the close relative M13 have been used successfully for the construction 
of combinatorial display libraries. 
Ideally, a random library covers all possible amino acids sequences using all 20 
amino acids. For a random hexapeptide library this means that there have to be at 
least 206  or 6.4 x 107  different transformants to have every possible amino acid 
combination represented in theory. In reality this will of course not be precisely the 
case due to biological preference for some amino acid sequences and the abortive 
effects of others. Further, some amino acid sequences are likely to be 
thermodynamically less favourable than others and therefore less likely to be present. 
It is also probable that some sequences will occur more than once further reducing 
the overall complexity. Consequently, even higher numbers of transformants are 
required, in practice about 2.5 x 109 transformants if one would like to achieve 90% 
confidence for having all possible peptides represented (Hoess, 1993). However, the 
transformation efficiency of the E. coli host cells limits library sizes to 107-108  
transformants if still manageable amounts of competent cells are to be used. This 
means that libraries consisting of more than five random residues will be 
underrepresented to various extents (Hoess, 1993). Although a complete 
representation might be impossible in many cases it has been proposed to increase 
the number of possible short peptides by cloning larger random peptides. The idea is 
that, for example, a 38- residue random peptide offers 33 "windows" for unique 
hexapeptides thus significantly reducing the number of independent transformants 
required for a hexapeptide library (Kay et al., 1993; McLafferty et al., 1993). 
Several cloning strategies have been developed for the construction of phage-display 
libraries, but essentially all use chemically synthesised random oligonucleotides 
which are converted into double stranded fragments by annealing or polymerase 
chain reaction (PCR) and ligated into the linearised vector RF DNA while 
maintaining the reading frame for the phage fusion protein. Often the third base of 
the triplets coding for the random amino acids are restricted to G or T (Scott and 
Smith, 1990). This still provides all 20 amino acids but reduces the degeneracy of 
triplets used to code for a single amino acid since several amino acids are represented 
by more codons than others in the genetic code. Furthermore two of the three stop 
codons are avoided which would lead to non-functional nonsense fusions. After 
ligation E. coli cells are transformed with the ligation mixture, usually by 
electroporation. To increase library size several independent transformations are 
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performed and the transformants pooled. The library is then amplified by growing up 
the transformed host cells in large scale and then purified by precipitating the phage 
particles. Aliquots of the transformed cells are plated out prior to amplification to 
check transformation efficiency and provide colonies for sequence analysis which is 
an indicator of the quality of the library. For the integrity of the library it is important 
that there is no preference for certain amino acids or positions within the displayed 
peptide. 
I.A.4) 	The fuseS hexapeptide library 
The fuse5 library is an epitope library of the first generation of libraries and is 
probably one of the most commonly used libraries at present mainly attributable to 
the generous distribution policy of Prof. George Smith. 
The library consists of random hexapeptides fused to the N-terminus of the minor 
coat protein pill of a modified fd-tet (Zacher et al., 1980) based phage vector (fuse5; 
Scott and Smith, 1990). It is based on 2x10 8 independent transformants in the 
original primary library which represent around 69% of all possible hexapeptides 
(6.4x1 o ; Scott and Smith, 1990). However, in the amplified library, which is the one 
distributed, each original clone is represented by approximately 500 subclones. 
Amplification of this amplified stock further reduced the diversity of this library in a 
given volume due to expansion of subclones, but was obviously needed in order to 
have enough material to perform several screening experiments. 
Titration of the amplified culture showed that it contained 8x1 010  infected cells in 
total. In relation to the input phage (10 12 particles) the infectivity was around 8%. 
After purification of the phage particles the library had a titre of lx10 13   t.u./ml and 
1 .5x 1014  physical particles/ml. 
The original primary library was constructed by using PCR for the conversion of the 
single stranded degenerate oligonucleotide into a clonable double stranded fragment. 
The triplets coding for the random amino acids were NNK with K standing for either 
G or T which, as previously mentioned, excludes two of the three stop codons and 
reduces the number of codons leaving 32 possible triplets. The annealed PCR 
products were cut with the restriction endonuclease 13911 in order to generate sticky 
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ends. Through this method theoretically about 12000 of the 6.4x10 7 possible 
hexapeptides are lost due to internal Bgl I restriction sites created within the random 
sequence. Alternative cloning procedures for generating random phage libraries use 
universally compatible inosine nucleotides (Devlin et al., 1990) or a single stranded 
gap opposite the degenerate sequence (Cwirla et al., 1990) to avoid this problem of 
losing random sequences. 
The fragments were then ligated into compatible Sfi I restricted fuse5 vector DNA 
molecules. E.coli host cells were transformed with aliquots of the ligation product in 
64 independent electroporations in order to increase the number of total 
transformants generated. The transformed cells were pooled and amplified. Phage 
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wash off unbound phage 
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Figure 1.1: The general principle of "biopanning" 
I. Introduction 
I.A.5) 	"Biopanning" and factors that influence selection 
The general principle for screening a library, often referred to as "biopanning", is to 
attach the molecule of interest to a solid support and then present the immobilised 
molecules to the phage pool or, alternatively, to present the molecules first and then 
capture them on a solid support (Fig.I.l). Phage that display peptides that bind to the 
molecules presented will adhere to the solid support. Subsequent washing procedures 
remove all unbound phage. Phage that stay bound are then recovered by elution, 
usually with low pH buffers. These eluted phage will be enriched for phage that bind 
the molecule of interest and the whole eluate is then amplified creating many 
subclones of each phage in this selected population. Several rounds of binding-
washing-eluting-amplifying are performed to select for very rare sequences and 
obtain pools consisting to a large degree, if not exclusively, of phage that bind the 
molecule of interest. Methodical aspects have proven to be a crucial and often 
unpredictable factor in biopanning experiments and recent modifications of the 
method focus on the following parameters: 
Solid support 
The streptavidin-biotin link is often used to immobilise the substrate. This is 
largely due to the fact that proteins can be easily biotinylated and the bond is 
virtually irreversible. This way molecules can be linked to plastic dishes (Scott 
and Smith, 1990), microtiter wells (Barret et al., 1992; Blond-Elguindi et al., 
1993) and beads (Bass et al., 1990; Hawkins et al., 1992). The molecules are 
either first incubated with the library in solution and then captured on 
streptavidin-coated matrices or presented to the library after being immobilised. It 
is not even necessary to biotinylate the molecule of interest since the capturing 
can be achieved via biotinylated secondary antibodies (Scott and Smith, 1990). 
Even simpler is adsorption on columns (McCafferty et al., 1990; Dedman et al., 
1993) or unspecific adsorption on plastic (Jellis et al., 1993; Ames et al., 1994; 
Germaschewski and Murray, 1995) and nitrocellulose (Dyson and Murray, 1995) 
which all have been used for attachment. For some purposes it might be 
important to present the molecule in a directed fashion so that certain domains 
become better accessible. 
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• Incubation step 
Most incubations are performed for 4 h or overnight so that equilibrium is 
approached. Temperature has effects on binding and incubation at room 
temperature will probably select for tighter ligands. Some cases are reported 
where libraries were pre-incubated with other substrates prior to biopanning in 
order to deplete the library of certain phage. This can be important if the 
molecules of interest are present in a mixture or contain unwanted impurities 
(Dybwad et al., 1993; Ames et al., 1994). In any case the selection procedure will 
not distinguish between different molecules and potentially provides ligands to all 
molecules that are presented. Blocking of all unspecific binding sites therefore is 
essential, but despite this, problems can occur due to the enormous sensitivity of 
the combined selection and amplification procedure (Christian et al., 1992; G.P. 
Smith, personal communication; see also Results section, p.68). The 
concentration of the molecules presented to the library is also crucial and can be 
adjusted in order to promote competition between different phage resulting in 
selection for ligands with higher affinities (Scott and Smith, 1990). This can 
easily be achieved if the molecules are incubated with the library in solution but it 
has also been found to be valid for solid matrices in which case lower coating 
concentrations will to some degree eliminate interactions of one phage particle 
with several ligand molecules at the same time due to larger distances between 
binding sites (Barret et al., 1992). 
• Washing procedure 
The stringency of washing is crucial for the selection procedure and determines 
the affinity threshold of the ligands selected for (Barret et al., 1992; Hawkins et 
al., 1992). It also has to be considered that, although to different extents, pill- and 
pVIII libraries are both multivalent systems and that this may affect the avidity of 
a potential ligand. The avidity being the combination of the affinity of a ligand, 
specified by its chemical properties, and the number of sites involved in the 
interaction, even low affinity ligands may have high avidities due to multiple 
interactions of one phage with one or several molecules. Phage vectors that allow 
multiple interactions are therefore thought to bias towards the selection of low to 
moderate affinity phage with strong affinity phage being too tightly bound to be 
recovered. To increase stringency pH or salt concentrations can be varied. 
Sequential washes with increasing stringency or different specificity can be 
applied and phage contained in the different washes separately analysed (O'Neil 
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et al., 1992; Koivunen et al., 1993; Dyson and Murray, 1995). Temperature is 
also an important factor and washes with cold buffers in the cold are likely to be 
less stringent. 
Elution process 
Most commonly low pH buffers are used since phage are relatively stable and pH 
as low as pH 2 can be used. Natural ligands of the molecule used for biopanning 
have been used to specifically select for phage that are only released on binding 
of the ligand (O'Neil et al., 1992; Dedman et al., 1993; Blond-Elguindi et al., 
1993) or displace the phage from the same binding site (Koivunen et al., 1993). 
I.A.6) 	Applications for phage-display libraries 
As mentioned before phage-display libraries have, until recently, been used mainly 
for epitope mapping purposes. Many examples of this have been reported, but the 
number of completely newly defined epitopes that can be located precisely on the 
antigen remains low (Stephen and Lane, 1992; Yayon et al., 1993; Bottger and Lane, 
1994). Most of the successes are confined to continuous epitopes where the 
contributing amino acids follow each other in the same sequence as in the primary 
sequence of the antigen against which the antibodies were raised thereby making 
identification of the epitope straight forward (Scott and Smith, 1990; Felici et al., 
1991; Stephen and Lane, 1992; Jellis et al., 1993; Grosso et al., 1993; Yayon et al., 
1993; Bottger and Lane, 1994; Miceli et al., 1994; Bottger et al., 1995; 
Germaschewski and Murray, 1995). 
One of the key advantages of phage-display libraries is that no structural information 
about the protein of interest is required prior to biopanning. Since the random 
population will theoretically cover all possible binding sites it was assumed that 
phage might also mimic conformational epitopes or binding sites consisting of amino 
acids that are far apart in the primary sequence of the protein but in close proximity 
in the folded form. In many cases phage binding such antibodies could be isolated 
but it was difficult or impossible to identify the corresponding residues, i.e. the 
epitope, in the antigen unless the structure was known. As a result, numerous 
attempts with antibodies recognising discontinuous epitopes have been unsuccessful 
in terms of epitope mapping purposes. 
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One example where structural information was available, however, has been reported 
and here the authors isolated phage with a weak consensus motif that bound a 
monoclonal antibody to human ferritin. The conserved residues could be located in 
the structural model and point mutation of these residues abolished recognition of the 
antibody (Luzzago et al., 1993). Another similar experiment by the same group was 
less successful however, since no strong consensus sequence was found and 
structural information was not available, although the selected phage again 
recognised the specific antibody (Felici et al., 1993). 
In most cases it will be possible to isolate specific ligands with the biopanning 
procedure, but the sequences isolated will often bear little or no sequence similarity 
with the natural ligand (e.g. the antigen in the case of antibodies being used for 
screening). These so called mimotopes are not useful for epitope mapping purposes 
since for this application the exact identity of the amino acids is desired (Cwirla et 
al., 1990; Christian et al., 1992; Felici et al., 1993; Keller et al., 1993). In many other 
cases however, mimotopes proved extremely valuable due to their ability to 
specifically recognise a ligand about which very little prior information was 
available. These mimotopes can have importance if they recognise molecules of 
biological or medical interest and bear the potential of being lead compounds for the 
development of drugs (Ames et al., 1994; Christian et al., 1992; O'Neil et al., 1992; 
Balass et al., 1993; Keller et al., 1993; Koivunen et al., 1993; Dyson and Murray, 
1995). It is also possible to identify sequences with higher binding constants than the 
ones of naturally occurring ligands (Lowman and Wells, 1991; Barret et al., 1992; 
O'Neil et al., 1992) and the method is capable of distinguishing subtle single amino 
acids changes (O'Neil et al., 1992; Koivunen et al., 1993). In these cases binding 
affinity and specificity are of particular interest, and not necessarily the amino acid 
sequence. For example Balass et al. (1993) isolated phage that recognised a 
monoclonal antibody directed against the chicken acetylcholine receptor. Although 
there was no sequence similarity with any region of the receptor molecule free 
peptides of the same sequence inhibited the interaction of the antibody with the 
receptor in vivo. 
As these examples illustrate, applications for phage-display have recently moved 
away from classic epitope mapping and all kinds of interactions are studied involving 
many other protein-protein interactions and protein-nucleic acid interactions (Reba 
and Pabo, 1994; Wu et al., 1995). 
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Libraries themselves have also undergone changes and recently so called constrained 
libraries have been successfully used in some cases (O'Neil et al., 1992; McLafferty 
et al., 1993; Luzzago et al., 1993). It is assumed that in many cases peptides that are 
displayed in a constrained conformation may be recognised better by ligands since 
target sequences often also occur in a more or less constrained environment 
(Koivunen et al., 1993). However, the range of restricted conformations engineered 
during library construction might not include the conformation suitable for 
interaction with the molecule, in which case it may be impossible to select for a 
ligand with this specific library. Conformational constraints often result from 
cysteine residues that flank the random peptide so that the peptide forms a loop on 
the surface of the phage by intramolecular disulphide bridge formation. 
It is worthwhile mentioning alternative recombinant libraries which have been 
developed from the idea of the phage-display system and sometimes rely on different 
expression or display vehicles. Libraries of displayed antibody fragments [F ab or 
scF(single chain)], generated by cloning genes for the heavy and light chains of the 
v-region into bacteriophage vectors have been mentioned already and have gained 
considerable importance since they can be prepared from cells of unimmunised 
animals or humans and offer the prospect of selecting monoclonal antibodies specific 
for virtually any target molecule including, self-antigens (Griffith et al., 1993) or 
whole cell surfaces (Marks et al., 1993). Further, it has been demonstrated that the 
affinity maturation process that usually occurs during an immune response in vivo to 
generate high affinity ligands by somatic mutation can be mimicked in this in vitro 
system by introducing random mutations and subsequent screening. (Gram et al., 
1992; Hawkins et al., 1992). Also, by mixing different heavy and light chain 
libraries, chain combinations can be shuffled creating new specificities and greater 
affinities (Marks et al., 1992). 
Synthetic peptide libraries have also been mentioned earlier and remain important 
through their advantages already discussed and the possibility of including residues 
that do not occur in nature, but have in many instances been replaced by the cheaper 
biological libraries. In fact the identification of reactive peptides with these libraries 
is often a mass screen rather than a selection procedure (Geysen et al., 1984). 
Peptides have also been expressed as fusions to surface proteins of E. coli cells (Little 
et al., 1993; Lu et al., 1995) or even directly attached to the plasmids that encode 
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them (peptide-on-plasmid approach; Cull et al., 1992). Some of these techniques 
offer advantages in very specific situations and were often developed for these 
purposes and will probably not gain universal success like the bacteriophage 
approach or the synthetic libraries. An interesting variation of the p111-fusion phage 
has been described recently where the coat-anchored and the exposed infection-
mediating domain of pill are split into two independent molecules and infectivity is 
only restored in cases where the two domains interact via protein-protein 
interactions. If one component of the interface is kept constant while the other one is 




1.13) 	Antibody-Antigen Interactions 
I.B.1) 	Antibodies: Structure and general aspects 
Antibodies consist of two identical light (25 kD) and two identical heavy chains (55 
kD) forming the familiar Y-shaped bivalent structure by interchain disulphide 
crosslinking. The N-terminal domains of the heavy and light chains (V domains) 
each contain three hypervariable loops (CDRs, complementarity determining 
regions) which directly contact the antigen and therefore determine the specificity of 
the antibody. The six loops that form the antigen binding site (paratope) are in close 
proximity to each other in the folded V domains which provide a scaffold for correct 
presentation. The size and the shape of the antigen binding site can be very different 
depending on the amino acid sequence although the n-sheet framework in which the 
loops are presented is very conserved. At least four of the six loops, termed L1-3 and 
Hl-3, respectively, are involved in any given interaction (Wilson and Stanfield, 
1993) and heavy chains are believed to contribute slightly more to the interaction 
(Kabat and Wu, 1991). This is supported by a larger promiscuity of the heavy chains 
for many different light chains observed in chain shuffling experiments (Collet et al., 
1992; Zebedee et al., 1992). 
The C-terminal domains of the heavy chains (C domains) form a conserved 
framework and determine the subclass of the antibody molecule. This Fc region also 
mediates the biological effector functions on binding to various receptors of the 
immune system. For the IgG class there are three basic receptor types termed FcyRI-
III and two receptors of the complement system (CR1 and CR3) which are located on 
different cell types mediating different functions. 
The CDR loops are encoded by the v-genes (for variable) which provide a diversity 
of about 107  which is then greatly increased by somatic recombination and 
hypermutation of the CDR areas generating in excess of 1010  specificities. 
Hypermutation also accounts for an effect called affinity maturation which leads to 
mutants with improved affinity during secondary responses. 
Antibody fragments are often used for binding studies particularly the Fab  fragment 
(for antibody binding) consisting of the truncated heavy and light chain antigen 
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binding site, but lacking the conserved Pc region (for constant) of the heavy chains. 
Since each truncated Fab fragment only consists of one antigen binding site the 
fragments are monovalent in comparison to bivalent for the complete antibody. 
I.B.2) 	Antigen recognition: What are epitopes? 
The term "epitope" was established as early as 1960 by Niels Jerne describing an 
epitope as the area on the surface of a native antigen accessible to the immune 
system. Areas that were only recognised after denaturation or breakage were termed 
"cryptotopes" since they were cryptic in the native form. 
Epitopes are classically divided into continuous, or linear, and discontinuous, or 
conformational, epitopes. Linear epitopes are supposed to involve a contiguous 
stretch of amino acids of the primary sequence of the antigen. It is therefore likely 
that linear epitopes are recognised on the native and denatured form of the antigen. 
"Epitopes" recognised by antibodies raised against denatured antigens are mostly 
linear and so are T-cell "epitopes" recognised by T-cell receptors since they are 
located on short fragments of the proteolytic degraded antigen which are presented 
by cells of the immune system such as B-cells and antigen presenting cells. 
Discontinuous epitopes are not represented in the primary sequence as such but 
assembled from various parts of the amino acid sequence brought together in the 
folded structure of the native antigen. They are therefore dependent on the 
conformation of the antigen and usually disrupted on denaturation. 
Strictly speaking there are no linear epitopes since the original definition was 
restricted to native functional epitopes and there is experimental evidence that all 
epitopes of Ab-Ag complexes studied by X-ray diffraction analysis so far are 
conformational and involve several parts of the primary sequence (Amit et al., 1986; 
Sheriff et al., 1987; Padlam et al., 1989; Tulip et al., 1992). 
Comprehensive mutational analysis of the amino acid sequence of hGI-I (human 
growth hormone) and its effects on recognition by 21 monoclonal antibodies also 
revealed that all epitopes recognised on hGH were conformational involving at least 
two areas of the primary sequence and were, although overlapping, recognising 
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slightly different epitopes (Jin et al., 1992). However, the authors also argued that 
although many residues were involved in these "contact epitopes" (i.e. residues 
making contact at the interface), the functional epitope (i.e. the residues crucial for 
binding) maybe constituted of only a few of these residues and that certain amino 
acids dominated this role. In this case an average of three amino acids dominated the 
functional epitopes and eight residues contributed noticeably to binding with arginine 
(R) and proline (P) being the amino acids most commonly involved. 
Despite these findings it is assumed that linear components can be part of larger more 
complex conformational determinants. Linear target sequences of antigens have been 
shown in numerous examples to be sufficient for specific recognition by antibodies. 
There is also structural data supporting this, for example, a 1 5mer peptide of the 
capsid protein VP2 of human rhinovirus representing a linear epitope has been shown 
to assume a similar conformation to that of the native antigen on binding the 
antibody (Tormo et al., 1994). 
In contrast with more recent findings by X-ray diffraction of crystallised Ab-Ag 
complexes it was initially thought that the areas of interaction between antibodies 
and antigens involved only a few residues and were quite rigid binding pockets 
which gave rise to the lock-and-key theory of antibody interaction (Saul et al., 1978; 
Satow et al., 1986). Through detailed studies on more Ab-Ag and Ab-peptide 
complexes during the last few years it became evident though that i) conformational 
changes occur in the antibody on binding of the antigen (Herron et al., 1991; Rini et 
al., 1992; induced fit theory), ii) depending on the size of the antigen, the contact 
areas are quite flat and also larger than anticipated involving 10-25 amino acids 
(Amit etal., 1986; Sheriff et al., 1987; Padlam et al., 1989; Tulip etal., 1992), iii) 
numerous Van der Waa!s and salt bridges stabilise the binding (same references as 
ii)) and iv) water molecules can play an important role in mediating binding 
(Fischman etal., 1991; Bhat et al., 1994). 
Potentially the whole surface of an antigen is immunogenic, but in many cases 
immunodominant areas will exist which are highly accessible and often flexible 
allowing a perfect fit with a wide range of antibody paratopes especially in view of 
the induced fit theory (Davies and Padlam, 1992). Charged and hydrophobic residues 
also are more likely to be the target of antibody binding due to the nature of 
interactions occurring at antibody-antigen interfaces (Jin et al., 1992). 
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I.B.3) 	Epitope mapping 
Detailed pictures of the residues involved in antibody-antigen interactions and the 
precise structures of the molecular interfaces have been provided in the last few years 
by X-ray diffraction analysis of Ab-Ag crystals and defined epitopes as 
conformationally defined areas recognised on the surface of the folded protein in the 
classical sense of the term. However, obtaining useful crystals is not trivial and often 
elusive. Further, the native conformation of neither the antigen nor the antibody in 
the crystal can be guaranteed and is difficult to assess when no other structural 
determination in solution is available for comparison. Structural determination by 
NMR, which could achieve this goal, is currently restricted to molecules much 
smaller than antibodies (25kD or 200 amino acids, depending on labelling 
techniques and technical equipment) and far smaller than any complexes formed with 
them. 
The term "epitope mapping" is widely used for a range of techniques which all reveal 
various aspects of a particular interaction in question, but have, for example, very 
different degrees of resolution. Investigating whether two monoclonal antibodies 
have overlapping binding sites is also epitope mapping and can be very helpful in the 
individual case. In some cases the identification of the approximate site of interaction 
on the surface of the antigen, for example identifying a certain subdomain as the 
target, can be sufficient, in others the identification of the crucial amino acids 
involved in binding the antibody is the principal interest. 
The following list gives an overview of the most commonly used epitope mapping 
techniques and their degree of resolution. Other advantages or problems are 
indicated: 
• Cross-reactivity between monoclonal antibodies against the same antigen 
As already mentioned this technique is often used if the interest is solely whether 
two antibodies have overlapping binding sites or not, but when the binding sites 
are in close proximity steric hindrance can also lead to apparently overlapping 




• Cross-reactivity of anti-sera with fragments or peptides representing various 
portions of the antigen (antigenicity) 
Anti-sera are tested for reactivity with peptides representing various regions of 
the antigen. The regions are linear stretches of the primary sequence of the 
antigen and therefore a true conformational representation of the fragment is not 
guaranteed and conformational epitopes can be lost. Resolution depends on the 
size of the peptides used but although shorter pieces improve resolution, they 
jeopardise the conformational authenticity of the fragment. 
• Cross-reactivity of anti-peptide and anti-antigen fragment antibodies with the 
native antigen (immunogenicity) 
Although raising antibodies against peptides is not the major problem the 
outcome of these experiments cannot be predicted and even a high titre of anti-
peptide antibodies does not mean that the antibodies will recognise the native 
antigen. Conformational inegrity of the fragments is as questionable as with the 
previous method, but nevertheless some successes have been achieved (Geysen et 
al., 1987; Van Regenmortel et al., 1989). 
• Screening antibodies with overlapping synthetic peptides 
Methods such as PepScan have been quite successful since they only present 
peptides to the antibody that are based on the primary sequence of the antigen 
thus excluding the appearance of so-called mimotopes (Geysen et al., 1984; 
Hastings et al., 1990; Coursaget et al., 1991; Howard et al., 1991; Sallberg et al., 
1990, 1991). Linear target sequences are more likely to be detected since short 
peptides usually give poor representation of native conformations. Again shorter 
sequences improve resolution, but the technique does not define the contribution 
of individual residues within the peptide "window" (i.e. the length of the 
peptides) used for screening since shifting the window one position basically 
represents a N-terminal deletion and a C-terminal addition in comparison to the 
peptide of the position before. Deletion of just one crucial residue may thus 
abolish binding to a degree that makes it difficult or impossible to assess the 
contribution of the other neighbouring residues (Coursaget et al., 1991; Howard 
et al., 1991). 
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• Random peptide library screening 
These libraries often mimic conformational epitopes and peptides that bind to a 
wide range of antibodies can be isolated, but since mimotopes are often isolated 
(Geysen et al., 1986; Cwirla et al., 1990; Christian et al., 1992; Felici et al., 1993; 
Keller et al., 1993), the application for mapping purposes is limited. However, 
even if the amino acids that form the conformational epitope displayed on the 
phage are represented in the primary sequence of the antigen the antibodies were 
raised against, it is virtually impossible to identify them unless structural 
information about the antigen is available (Luzzago et al., 1993). Linear parts of 
antigen determinants are easier to identify and have been successfully determined 
in many cases revealing new epitopes and specificities. 
Libraries can be entirely synthetic (Geysen et al., 1986) or biological, for 
example presented on bacteriophage (Scott and Smith, 1990). 
Mutations of the antigen that affect antibody binding 
Deletions, insertions or point mutations can be introduced in the antigen and the 
effects on recognition by the antibody investigated. Although this method allows 
one to study the effects of subtle changes in the context of the whole protein it 
usually requires some prior information that highlights hot spots for mutational 
analysis. Further, it is difficult to establish whether the effects correlated with the 
mutation occur because the mutated residue is a contact residue with the paratope 
or whether the overall conformation of the antigen has been changed so 
dramatically that the epitope was also disrupted, possibly at a different site of the 
antigen. These problems may be reduced by alanine substitution studies where 
one by one the crucial residues are substituted by alanine which is expected to 
have neutral effects on the actual conformation of the antigen but may reveal 
essential side chains for antibody binding (Jin et al., 1992). Nevertheless, this 
approach provides high resolution and usually gives a good picture of the 
epitope. 
• Structural predictions based on sequence data 
These provide a highly hypothetical approach that can help to target certain 
residues for mutational analysis or highlight areas for peptide studies. Facts about 
the primary sequence of the antigen based on the chemical properties of the 
amino acids and other known protein sequences are gathered and structural 
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predictions for the antigen are made. However, the method is not directly suitable 
as a mapping technique and still requires experimental verification. Molecular 
modelling of antigen-antibody binding sites has also been used to suggest crucial 
residues, but this also requires prior information (Padlam and Kabat, 1991). 
• Protection assays 
Chemical derivatisation of amino acids or proteolytic digestion of the peptide 
chain can be prevented in areas where the antibody interacts with the antigen and 
thus leads to regions in the primary sequence that are participating in the 
interaction. This method assures correct conformation of the antigen during 
treatment and large fragments generated often retain the conformation of the 
native antigen, but identification of individual residues is difficult and 
microanalysis of digested fragments is required. 
Whether mapping techniques based on the use of linear peptide fragments truly 
represent epitopes or whether in most cases they just represent parts of larger overall 
conformational structures is a matter of debate. The fact is that in many cases 
mapping studies involving techniques based upon linear peptides have been 
extremely successful, but in others no region could be conclusively identified as the 
target. It should be kept in mind when using peptide based techniques however, that 
other residues (or areas) may also contribute to binding and that to some extent the 
residues identified may represent a somewhat artificial epitope. On the other hand 
linear target sequences have been demonstrated to be highly specific, antigenic and 
sometimes immunogenic. This has led to examples where immunisation with 
peptides representing parts of the pathogen gave rise to neutralising antibodies which 
could provide the basis for vaccines against a number of diseases (diphtheria: 
Audibert et al., 1982; cholera: Jacob et al., 1984; malaria: Patarroyo et at., 1988; 
common cold: Francis et at., 1987b; Hastings et at., 1990; influenza: Muller et at., 
1982; foot-and-mouth disease: Parry et al., 1989; Francis et al., 1987a; and AIDS: 
Javaherian et al., 1990; Rini et al., 1993). The idea of using only synthetic parts of an 
antigen as a vaccine is not new and already developed in the 1960s when antibodies 
against a peptide representing parts of the tobacco mosaic virus coat protein inhibited 
assembly of the virus and infectivity (Anderer, 1963) 
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I.C) 	Hepatitis B Virus: Studying the Immune 
Response to a Complex Antigen 
I.C.1) 	The morphology of hepatitis B virus (HBV) 
The hepatitis B virion, or Dane particle as it is sometimes called after its discoverer 
Dane (1970), is found in the blood and the liver of infected individuals as a spherical 
particle of 42 nm diameter. The outer envelope consists of three forms of the viral 
surface antigen (HBsAg) called S (short), M (middle) and L (long), embedded in a 
lipid bilayer membrane derived from the host cell since the virions leave the cells 
through a budding process (Ganem, 1991). The inner capsid, or core particle, is -P27 
nm diameter and occurs in two sizes assembled of 180 or 240 monomers of the core 
antigen (HBcAg), respectively (Crowther et al., 1994). A truncated form of HBcAg, 
named HBeAg exists as a non-particulate secreted antigen in the serum of infected 
individuals (Magnius and Espmark, 1972) and is correlated with the number of viral 
particles in the blood and relative infectivity, and its disappearance has therefore 
been used as an indicator for viral clearance at the end of an infection process. 
The partially double stranded viral DNA genome is packaged inside the capsid 
together with a viral DNA polymerase activity and a protein bound to the 5' end of 
the minus sense DNA-strand. 
In addition to complete infectious HBV virions two other particulate non-infectious 
structures can be found in the serum of infected individuals which are basically 
"empty" envelopes not containing any viral nucleic acids. They may contain empty 
nucleocapsids which is rare in the serum but can be found in infected liver tissue. 
The two forms occurring are either small spherical particles or long rod-shaped 
filaments of variable length which both are around 22 nm diameter. They consist 
almost exclusively of the S form of HBsAg and only very few molecules of M and L. 
Both these antigens are produced in large quantities in infected host cells which has 
the effect that the subviral particles are actually present in vast excess (10 3 -106-fold) 
over complete virions in the serum (Simonet al., 1988). The biological function, if 
there is any at all, may be to act as decoy molecules for neutralising antibodies 
generated by the immune response of the infected host (Ganem and Varmus, 1987). 
Subviral particles are non-infectious and highly immunogenic resulting in a 
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protective immune response which made them a successful vaccine against hepatitis 
B. Originally the particles were isolated from the sera of patients which made the 
vaccine expensive and also potentially risky due to other pathogens associated with a 
blood derived product. With the development of molecular cloning and genetic 
engineering in the 1970s and 80s the vaccine is now produced in large quantities and 
extremely pure by recombinant DNA methodology in microrganisms. 
I.C.2) 	Clinical aspects 
HBV infection is considered to be one of the most important virus infections in the 
world. Typically, an infection with HBV ranges from very mild, inapparent disease 
to fulminant hepatitis, severe chronic liver disease and liver cirrhosis (Ganem, 1982). 
At present it is estimated that there are more than 300 million people world-wide 
who are chronic HBV carriers, many of whom may suffer from liver failure or 
hepatocellular carcinoma (11CC) eventually. In this respect HBV has been shown to 
be associated with HCC and two possible mechanisms for tumour formation have 
been advanced. Integration of viral DNA into host chromosomal DNA may cause 
activation of cellular oncogenes (Hino et al., 1986; Fourel et al., 1990) or disruption 
of tumour suppressor functions (Zhou etal., 1988). Alternatively, the continuos event 
of cell death and regeneration in chronic liver inflammation could increase the 
probability of critical mutational events leading to subsequent tumour formation 
(Chisari et al., 1989). The latter theory is favoured by many scientists because 
patients with liver diseases that are not connected to HBV but also cause chronic 
liver inflammation also show high incidence of 11CC. 
The spread of HBV is linked to social and environmental circumstances. In 
developing countries, where there are high rates of HBV carriers, the virus spreads 
mainly maternal-neonatally, i.e. vertically from one generation to the next. In 
industrialised countries however, virus spread is mainly horizontally by sexual 
contact, drug abuse and direct contact with infected blood products or blood samples 
by people that work in the health sector or in science. Interestingly, the epidemiology 
of HBV and HIV, the virus which causes AIDS are very similar and both viruses 
affect the same high risk groups among the population, but it should be stressed that 
HBV is more contagious than HIV in terms of the likelihood of contracting the 
disease on exposure to the virus. 
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In many cases infection with HBV leads, after an incubation time of two to six 
months, to acute hepatitis with jaundice and other symptoms. HBV infection can then 
be detected by identifying 1-IBsAg in the serum. In the classical form of acute 
hepatitis patients recover completely with an immunity against reinfection for many 
years. In some cases, however, the disease remains permanently asymptomatic. In a 
minority of cases, infection' will develop into fulminant hepatitis, a form of the 
disease which is usually fatal. It is caused by a very strong immune response of the 
host which destroys large parts of the liver by killing all cells bearing HBV antigens 
as markers by cytotoxic T-cells. 
In chronic carriers no antibodies against HBsAg are ever detected and the viral 
antigens can be detected in the serum for a lifetime. The infection is therefore never 
cleared and the virus persists in the liver, causing various states of chronic disease 
patterns again ranging from more or less asymptomatic to liver cirrhosis and HCC. 
The risk of developing HCC among chronic carriers is at least 500-fold higher than 
normal, probably for the same reasons discussed above (Beasley et al., 1989). 
I.C.3) 	Replication and transcription of the HBV genome 
After the virion has successfully entered a host cell by binding to liver cell-specific 
receptor molecules in a process which is still poorly understood, the viral DNA 
migrates to the nucleus. The first step during a primary infection is the conversion of 
the asymmetric open circular (oc) DNA of the virion into a covalently closed circular 
(ccc) replicationally active form. This is the starting point for both viral replication, 
via reverse transcription of a pregenomic full length RNA transcript by the virally 
encoded DNA polymerase activity, and gene expression involving additional 
subgenomic mRNA transcripts. The various stages can be summarised as follows: 
Conversion of the ocDNA originating from the virion to cccDNA by enzymes of 
the host cell. 
Transcription of cccDNA by host cell RNA polymerase II generates a 3.5 kb full 
length pregenomic RNA which represents the plus strand and serves as template 
for the viral reverse transcriptase to create DNA minus strands and as mRNA for 
the core antigen (C gene product) and the viral polymerase (P gene product; Will 
25 
I. Introduction 
et al., 1986, 1987). Other transcripts of 2.4 kb and 2.1 kb length function as 
mRNAs for the remaining viral gene products. All transcripts are unspliced and 
capped. Since neither of the two shorter mRNAs cover the C and preC open 
reading frame (ORF) or the P ORF, the pregenomic RNA has to fulfil the mRNA 
function for the C and P gene. The 2.4 kb mRNA covers the ORFs for the surface 
antigen domains PreSi and PreS2 (S gene) and the viral transactivator HBx (X 
gene) but is believed to function mainly as template for the expression of the L 
form of HBsAg which includes PreSi and PreS2 (Will et al., 1987; Fig.I.2). The 
2.1 kb mRNA serves as template for the translation of the M and S form of 
HBsAg (Cattaneo et al., 1983, 1984). Although it is now clear that the P gene, 
like the C gene, is expressed from the pregenomic 3.5 kb RNA, no mRNAs that 
contain the message for the P or the X gene alone have been found in natural 
infections. However, several additional mRNA species have been identified in 
HBV-transfected human (Saito et al., 1986; 0.7 kb) and rat (Gough, 1983; 1.0 kb) 
hepatocytes and in WHV-transfected woodchuck hepatocytes (Kaneko and 
Miller, 1988). 
PreCI 	 C 	 I 	 A 
- 	 - full length 3.5kb 
- 	 - 3.5kb(PreC) 
- 	 - 3.5kb(C) 
- 	PreSi 	PreS2 	 S 	 I 	B 
----------------------------------------------- 2.4 kb (L) 
2.lkb(M) 
--------------_2.lkb(S) 
Figure 1.2: Transcripts of HBV genes: A) the full length genomic RNA serves as 
mRNA for the expression of PreC (HBeAg) and C (HBcAg) by starting at two 
different transcription sites (note: transcript also serves as mRNA for P gene but this 
ORF is not shown here); B) the 2.4 kb transcript serves as mRNA for the expression 
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of the. L form of HBsAg; heterogeneous 5' ends of the 2.1 kb transcript generate 
mRNAs for expression of the M and Sform ofHBsAg. 
The pregenomic RNA and the viral polymerase activity (P gene product) are 
packaged into capsids which readily assemble in the cytoplasm from core antigen 
monomers by largely unknown mechanisms, possibly involving high-molecular 
weight intermediates and cellular chaperones (Lingappa et al., 1994). During 
encapsidation the first minus strand DNA molecules are synthesised by the viral 
polymerase, or reverse transcriptase, using a protein as primer. Simultaneously 
with the DNA minus strand synthesis the pregenomic RNA is degraded. 
The complementary plus strand is synthesised within the capsid, during 
envelopment and export of the virion, and utilises an oligonucleotide from the 
degraded pregenomic RNA as primer. Pores in the capsid might allow small 
molecules including nucleoside triphosphates to enter the capsid for 
polymerisation of the extending plus strand (Crowther et al., 1994). Plus strand 
synthesis stops as soon as the virion buds off the host cell. As a result of this the 
length of the plus strands and hence the single stranded gap in the genome is 
variable among virions depending on the time elapsed until budding. Before 
release from the host cell the capsid harbouring the polymerase and the 
pregenomic RNA is enveloped by budding into the lumen of the ER where it then 
follows the secretory pathway to the surface of the cell. 
I.C.4) 	The genes of HBV and viral gene products 
The nucleotide sequence of HBV was determined by two groups in 1979, Galibert et 
al., and Pasek et al., which led to two different numbering systems which are both 
used today. Galibert et al., specified the unique EcoRI restriction site in the genome 
as nucleotide No.1 which bears the inconvenience that not all sequenced HBV 
genomes have an EcoRl restriction site and that nucleotide No.1 is within two coding 
sequences. Pasek et al. therefore chose the first coding nucleotide of the C gene as 
No. 1. Most of the four open reading frames C, 5, P and X overlap substantially and 
so about half of all nucleotides are part of more than one reading frame (Fig.I.3). 
Furthermore, some genes within the same reading frame possess multiple start 
codons which give rise to several gene product subspecies of the same gene. This is 
the case for both structural antigens HBsAg and HBcAg. 
27 
I. Introduction 
0 	0.5 	1.0 	1.5 	2.0 	2.5 	3.0 3.2 (kb) 
I I 	 I 	 I 	 I 	 I 	 77771 
N HBcAg 
PreC 
DNA polymerase-reverse transcriptase 
Figure 1.3: Organisation ofHBV genes: The four major genes are shown in relation 
to the total length of the HBVgenome (-3.2 kb); the S gene (HBsAg) consists of three 
sub genes coding for the PreSi, PreS2 and S domains; the C gene also has two 
transcription start sites giving rise to HBeAg (including PreC) and HBcAg. 
The four gene products of HBV are: 
The S gene gives rise to three related surface antigens (HBsAg) using three different 
in frame start codons. The functional parts of the gene can be divided into PreS 1, 
PreS2 and S and code accordingly for the PreS 1; the PreS2 and the S domain of 
HBsAg. The shortest transcript codes for the S (short) domain consisting 226 amino 
acids. The medium length transcript codes for the S and the PreS2 domains which 
form the M (middle) form of HBsAg and adds another 55 amino acids to the N-
terminus of the S domain. Both transcripts are driven by the same promotor. The 
longest gene product is L (long) which contains all three domains encoded by PreS 1, 
PreS2 and S. The PreSi domain adds another 108-119 amino acids, depending on the 
virus subtype, to the N-terminus of M (Fig.I.4). 
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Figure 1.4: The surface antigen HBsAg and its three subforms derived from internal 
start codons within the same open reading frame; the length of PreS] is variable 
depending on the virus subtype; filled circles mark glycosylation sites. 
The C gene codes for the core antigen (IUBcAg), a 21 kD protein with 184 amino 
acids which is the subunit of the nucleocapsid. It has two distinct domains with the 
N-terminal 144 amino acids being sufficient for self-assembly of capsids. The C-
terminus is extremely arginine rich due to multiple SPRRR(R) motif repeats and is 
probably involved in non-specific RNA binding during virion assembly. A short 
region named PreC proximal to the C gene encodes a signal sequence that directs 
translated transcripts bearing this signal region into the secretory pathway of the cell. 
During post-translational processing parts of the N-terminal PreC region and the C-
terminus are cleaved off leaving a 10 amino acid N-terminal extension to the 
truncated primary sequence that the gene product has in common with HBcAg. This 
resulting 1 7kD viral antigen, termed HBeAg, is secreted and only found in a soluble 
form in the serum (Fig. 1.5). 
Although HBcAg and HBeAg share in large part an identical amino acid sequence, 
they have a very different conformation resulting in different antigenicity, which 
results in little cross-reaction between anti-HBcAg and anti-HBeAg sera (Salfeld et 
al., 1989). HBe epitopes can be detected however, on denaturation of core antigen 
(i.e. particles; MacKay et al., 1981) which implies that HBe epitopes are cryptic on 
core antigen and only become exposed on denaturation. The conformational 
differences observed are related to the few amino acids which are different between 
the two antigens, including cysteine residues in particular which are responsible for 
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the folding framework of these antigens (Nassal and Rieger, 1993; Wasenauer et al., 
1993). In the case of HBeAg an additional cysteine residue is found in the short N-
terminal extension (C) whereas C 183 is deleted due to its truncation in comparison to 
I-IBcAg. 
I 	 I 
ATG ATG 
	
I 	HBcAg (184 aa) 	 I + + + + I 
preC 	precore polypeptide (212 an) 	+ + + + 
post-translational modification 
I J 	. HBeAg(159aa) 	 I 
Figure 1.5: HBcAg and HBeAg share large parts of the amino acid sequence but are 
translated from mRNAs with different transcription start points; + indicates 
positively charged arginine-rich C-terminus, triangles indicate proteolytic cleavage 
sites which are used to transform the precore polypeptide into HBeAg during post-
translational modifications (explanation see text). 
The P gene which codes for the DNA polymerase, or reverse transcriptase, activity 
is, considering the length of the entire genome, relatively long and overlaps with all 
other open reading frames. 
The X gene and its product HBxAg was the last to be discovered since detection of 
the gene product was hampered by the low expression levels of this protein which 
had, until recently, no known function. It was finally detected by antibodies raised 
against the recombinant protein in transfected cell cultures (Pugh et al., 1986) and 
infected liver tissue (Moriarty et at., 1985). Antibodies that cross-reacted with 
HBxAg were detected in the sera of infected individuals (Kay et al., 1985; Weber et 
al., 1988), providing evidence that the antigen was expressed at some stage during 
the viral cycle. It is clear now that HBxAg acts as a transcriptional activator for HBV 
gene expression (Colgrove et al., 1989; Rossner et al., 1990) but it can also serve as a 
transactivator for genes under control of foreign viral promotors such as SV40, Rous 
Sarcoma and HIV. It is also known that HBxAg induces maximal activation of genes 
under control of the transcriptional activator NF-KB in hepatocytes (Lucito and 
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Schneider, 1992). However, the precise mechanism for HBxAg transactivation is still 
unknown but is believed to be mediated through interaction with other 
transcriptionally active proteins (Rossner, 1992). 
I.C.5) 	The surface antigen of HBV (HBsAg) 
The three related products of the surface antigen gene which share identical protein 
domains (Fig.I.4), provide a good example of the extremely efficient use of the small 
HBV genome to generate several gene products from one open reading frame by 
using various translation start codons. HBsAg not only occurs in three differently 
sized forms but also in various glycosylation states and investigators became 
interested in the question whether the different forms of HBsAg fulfilled different 
functions. However, it was not until recently that details about the structure and also 
about the involvement of the various forms of HB5Ag in the biology of HBV began 
to emerge. Some of the reasons that made progress comparatively slow included: i) 
in vivo the three different forms occur in very different concentrations and always as 
a mixture, ii) they are conformationally sensitive transmembrane proteins with a 
complex structure that is essential for their functional integrity, iii) different HBV 
subtypes have variable amino acids in crucial positions of HBsAg affecting cross-
reactivity with anti-HBsAg sera which probably reflects differences in conformation, 
and iv) expression in E.coli gives only poor yields (MacKay et al., 1981) so that 
expression in yeast or animal cells in culture is preferable (Valenzuela et al., 1982; 
Miyanohara et al., 1983; Hitzeman et al., 1983). Recently, HBsAg has been 
successfully expressed in vitro (Ostapchuk et al., 1994; Prange and Streeck, 1995; 
Dyson and Murray, 1995). 
The shortest polypeptide S (226 an) is by far the most abundant form and constitutes 
the major fraction of the envelope of mature virions and subviral particles. M (226 an 
+ 55 an) can also be found in the viral envelope and, in small amounts, in subviral 
particles. The largest form L (226 an + 55 an + 109-119 an) is mainly present in 
complete virions and therefore gives it unique properties. Both PreS-containing 
forms M and L comprise only up to 10% of the total HBsAg. 
The surface antigens are co-translationally integrated in the ER membrane and L 
plays a crucial role in aggregating other S molecules into patches to interact with 
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core particles to form complete enveloped virions by budding into the ER lumen 
(Ganem, 1991). Several factors seem to influence this process and the expression 
levels of the three forms of HBsAg 5, M and L probably play a role in regulating the 
export of complete virions or subviral particles (Bruss and Ganem, 1991a). Subviral 
particles also bud off the ER membrane but independent of an interaction with core 
particles. Both complete virions and subviral particles then follow the secretory 
pathway to the cell surface where they are released. 
Domains pointing into the ER lumen after integration into the membrane are 
generally believed to become external on the released virion whereas regions located 
on the cytosolic side of the ER become buried inside the envelope i.e. not accessible 
from outside. Recent evidence, however, suggests that this simplistic view is not 
entirely true for HBsAg. 
Synthetic peptides representing parts of the PreS domains of L and M had been 
shown to be highly immunogenic, generating antibodies cross-reactive with native 
HBsAg and even neutralising antibodies in chimpanzees; they were also recognised 
by anti-I-IBsAg antibodies (Neurath et al., 1984, 1985, 1986; Okamoto et al., 1985). 
In order to be recognised by B-cells the identified sequences required an external 
location on the virion. It was also found that PreSi sequences were involved in cell 
attachment of HBV particles to HepG2 cells (a hepatoma cell line) in culture 
(Neurath et al., 1986) and liver cells (Pontisso et al., 1989; Budkowska et al., 1993) 
and that a MAb directed against a linear epitope at the N-terminus of PreS 1 inhibited 
attachment (Pontisso et al., 1989). This observation also implied an external 
orientation of the PreSi domain. Sensitivity of the PreS sequences to trypsin 
digestion further supported an external location (Heermann et al., 1987). 
In contrast with these observations, PreS 1 had also been linked with viral assembly, 
mainly for the following reasons: 
L is mainly present in complete virions and is essential for secretion of virions in 
transfected cell cultures (Bruss and Ganem, 1991b). L alone is not secreted as 
subviral particles (Persing et al., 1986), in contrast to M and S (Sheu and Lo, 1992), 
which points towards a crucial function for L during assembly. Furthermore, the 
glycosylation site within the PreS2 domain of L is not glycosylated in virions 
(Heermann et al., 1984) which could mean that the PreS sequences may initially not 
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be located in the lumen of the ER where they could undergo post-translational 
modifications. 
Work by Dyson and Murray (1995) recently showed that L but not S interacted with 
core particles in an in vitro system. This also suggested a crucial involvement of PreS 
sequences in the interaction between HBsAg and core particles. 
Collectively, these results indicate that at least PreS 1 maybe located on the 
cytoplasmic side of the ER after integration, but how could the same domain be 
orientated to the lumen of the ER (i.e. externally on the virion) at the same time to 
fulfil the functions outlined above ? Recent studies which compared the topology of 
newly synthesised L in the ER membrane with that of L in complete virions secreted 
from transfected cell cultures (Bruss et al., 1994) or studied the topology of L in in 
vitro expression systems (Ostapchuk et al., 1994; Prange and Streeck, 1995) 
indicated that HBsAg may undergo unique post-translational translocation events. 
According to this almost all PreS domains are initially orientated cytoplasmically 
allowing interaction with core particles and thus triggering off the budding process. 
During virion maturation the domains would then become translocated across the 
envelope membrane so that on mature virions about 50% of all L molecules would 
have their PreS domains exposed on the surface. This scheme satisfies the 
involvement of L on both sides of the envelope membrane and solves the apparent 
contradiction. 
Further analysis is required to identify the precise contact sites between the surface 
antigen and core particles which may depend on a specific conformation of L. N-
terminal deletion studies of L have indicated that residues 1-102 may be deleted 
without effects on virion secretion but that deletion beyond residue 102 abolished 
secretion (Bruss et al., 1994). However, it is difficult to draw conclusions from cell 
culture transfection studies which use the secretion of virions as an indicator for the 
interaction of HBsAg with core particles. Evidences of in vitro studies of the 
interaction between N-terminal deletion mutants of L and core particles indicate that 
deletion of up to position 60 of PreS 1 has no negative effect on the interaction but 
that further deletion results in reduction of binding and is completely abolished when 
the whole PreS domains are deleted (Wen Siang Tan, unpublished observations). The 
S domain may also contribute to the interaction of L with core particles since in vitro 
studies on the topology of HBsAg in the membrane recently suggested a cytosolic 
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orientation of the predicted first transmembrane region of S (Prange and Streeck, 
1995) and studies with C-terminal deletions of L show a requirement of parts of the S 
sequence for this interaction (Michael R. Dyson, unpublished observations). 
I.C.6) 	The immune response to IIBV 
General aspects 
After infection with HBV an individual usually mounts an immune response against 
the virus which in most cases leads to viral clearance and full recovery from 
hepatitis. The wide range of symptoms observed for I-IBV infections however, are a 
result of the varying types and intensities of responses in different individuals. 
During a normal immune response a balanced interplay of the humoral, i.e. antibody 
based, and cellular, i.e. lymphocyte-mediated, immune responses is observed. 
Antibodies are produced by B-cells which recognise epitopes on the surface of 
antigens circulating in the body fluids. Most B-cells require helper functions from 
activated T-helper cells (Th) to undergo clonal expansion and produce antibodies. 
The Th cells in turn become activated by interacting specifically with antigen 
presenting cells (APC). B-cells usually encounter antigens in their native 
conformation as they occur in the blood and the lymph fluids, in this case complete 
virions and subviral particles. Consequently, the antibodies produced by these 13- 
cells, or plasma cells once they are activated, are directed against the outside of the 
virion i.e. the parts of the surface antigen which are exposed on the surface. In 
contrast, cytotoxic (T c) and helper T-cells recognise parts of antigens which result 
from degradation of the antigen and subsequent display of viral peptides on the 
surface of infected host cells, APCs and B-cells. T-cell epitopes are therefore short 
linear peptide segments of the primary sequence of the viral antigen whereas the 
majority of B-cell epitopes are conformational since they bind to native structures on 
the surface of the complete particle. T-cell epitopes are only recognised in connection 
with proteins encoded by the major histocompatibility complex (MHC) on the cell 
surface of infected host cells (MHC class I) or antigen presenting cells (MHC class 
II). 
Internal antigens of HBV, such as the core antigen, can also confer protection since 
vaccination with recombinant core antigen resulted in partial protection of 
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chimpanzees (Murray et al., 1984). It was thought that activated Th-cells  could 
provide helper functions to B-cells producing virus neutralising antibodies directed 
against HBsAg which was later confirmed by studies by Milich et al. (1987b). It was 
shown that it is crucial that HBcAg T-cell epitopes and HBsAg epitopes are 
physically linked, as for example in an HBV virion. B-cells specific for HBsAg 
epitopes take up whole virions and process the antigens displaying many HBcAg T-
cell epitopes that can be recognised by primed Th-cells which then induce production 
of the HBsAg-specific antibodies. It was also demonstrated that immunisation with a 
synthetic peptide carrying a Th-cell epitope from HBcAg and a B-cell epitope from 
PreS2 induced antibodies which cross-reacted with native HBsAg (Milich et al., 
1988). 
Neutralising antibodies aggregate and mark virions for uptake and degradation by 
APCs and lymphocytes, or prevent binding of the virions to receptors on the surface 
of target hepatocytes. Despite the fact that potentially the whole surface of an antigen 
is antigenic most antibodies will be directed against a few so called immunodominant 
areas of the antigen which are readily accessible to the immune system and elicit 
neutralising antibodies. 
HBsAg is the prime target for the immune system 
Early serological studies revealed a major immunodominant area on HBsAg which 
was common to all HBV subtypes and consisted of more than one epitope. This area, 
termed the a determinant, is located in a hydrophilic region between residues 122-
147, which conforms with an external positioning of this determinant (Bhatnager et 
al., 1982; Prince et al., 1982). Other determinants, not related to the a determinant, 
were also identified which led to the classification of the subtypes we know today. In 
an attempt to further elucidate the elements of these determinants, and maybe draw 
conclusions for the design of synthetic vaccines, numerous studies were carried out 
with fragments of HBsAg or, more often, synthetic peptides representing the a 
determinant and various other parts of HBsAg, covering almost the whole primary 
sequence (Bhatnager et al., 1982; Brown et al., 1984; Dreesman et al., 1982; Gerin et 
al., 1983; Howard et al., 1988; Lerner et al., 1981; MacKay et al., 1981; Prince et al., 
1982; Neurath et al., 1982). Many of these peptides elicited antibodies in rabbits or 
mice which recognised native HBsAg (immunogenicity) or the peptides cross-reacted 
with antibodies (mono- or polyclonal) specific for native HBsAg (antigenicity). In 
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some instances the latter was not investigated, but in others peptides were both 
immunogenic and antigenic. 
Taken as a whole the results obtained from these experiments were of great value and 
demonstrated well the complexity of the immunological properties of HBsAg. In 
some cases they led to the identification of virus neutralising epitopes which even 
conferred partial protection when injected into chimpanzees (Gerin et al., 1983; 
Purcell et al., 1985), but generally they did not contribute in a large degree to our 
understanding of the folding and the three-dimensional orientation of HBsAg in the 
envelope. This lies mainly in the nature of using short linear peptides for studying 
folded antigen structures and their possible failure to reproduce correct 
conformations. However, peptide studies were very successful in identifying T-cell 
epitopes within surface and core antigen since they occur naturally as short linear 
sequences (Milich et al., 1985, 1986, 1987a). 
Point mutational analysis identified residues which contributed to the correct folding 
of HBsAg and which had profound effects on the conformation if changed or deleted 
(Ashton-Rickard and Murray, 1989a,b; Antonini and Peterson, 1981). Most of these 
residues were cysteines which could form disulphide bridges with other cysteines 
thus creating a secondary structure framework. This is the reason why some peptides 
were more effective in inducing HBsAg-specific antibodies or being recognised by 
anti-HBsAg antibodies when they were presented in a cyclic form which was 
achieved by oxidising internal cysteine residues (Brown et al., 1984; Dreesman et al., 
1982; Howard et al., 1988). 
Fig. 11.8 (p.71) gives an overview of most of the peptides used in various studies of 
the immunogenicity and antigenicity of HBsAg (S). Residues 1-160 are well covered 
by a range of peptides, but C-terminal areas have been relatively poorly investigated 
and peptides 212-226 and 221-226 (not shown) failed to induce antibodies at all 
(Lemer et al., 1981). Peptides covering residues 140-160 depended strongly on the 
inclusion of crucial cysteine residues which probably forced the peptides to adopt a 
conformation similar to possible loop structures which have been suggested to create 
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Figure 1.6: Possible loop structures predicted for the "a determinant" of S (after 
Carman, 1994), individual amino acids are shown between residues 116 and 149, 
square boxes indicate positions of naturally occurring point mutations; possible 
disulphide bridges are indicated. 
According to this model C 124 and C, 37 and C 139 and C, 47 or C, 49 form disulphide 
bridges which create two loops (Carman, 1994; Fig.I.6). Accordingly, peptide 140-
148 (not shown) which excluded C, 39 was not immunogenic whereas cyclic peptides 
representing loop 1 (124-137) or loop 2 (139-147) where able to induce anti-S 
antibodies and were more potent than their linear counterparts in doing so. However, 
other structural arrangements are equally possible. 
The region near the N-terminus seemed to be very immunogenic and not dependent 
on complex secondary structure because linear peptides induced antibodies that 
recognised native S (Fig.II.8, p.71). Some peptides not only induced antibodies 
(Lerner et al., 1981; Gerin et al., 1983) but also cross-reacted with anti-S antibodies 
(Howard et al., 1988). Three peptides between residues 31 and 52 (not shown) failed 
to induce antibodies against themselves (31-52) or failed to induce antibodies 
reactive with HBsAg (38-52 and 47-52) (Lerner et al., 1981). Although some of the 
failures may be attributed to the use of extremely short peptides which are usually 
not considered good immunogens since they are not very effective in reproducing a 
given conformation, it may however indicate that some areas, such as 31-52 or 212-
226 cannot induce antibodies which recognise native HBsAg because these 
sequences may not be exposed (i.e. recognisable) on the surface of the virus particle 
in vivo. 
Area 110-140 has been investigated intensively, mainly because of interest in the a 
determinant, the interesting cysteine residues in the region, and the subtype specific 
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amino acids exchanges which are located mostly in this region. Various peptides, all 
including C, 37 but with variable N-termini, starting at residues 110, 117, 122, 124 and 
125 respectively were all able to induce antibodies that reacted with HBsAg, or were 
recognised by anti-S antibodies (124-137; Howard et al., 1988), indicating that the 
variable N-termini did not have a great effect on immunogenicity (Fig.II.8, p.71). 
Cyclic peptides were more potent than their linearised counterparts. Surprisingly, 
peptide 125-139 (Gerin et al., 1983) was immunological active despite the deletion of 
C 124 thought to be involved in formation of the postulated loop 1 structure (Fig.I.6, 
p. 37). 
Point mutational analysis of S was mentioned earlier in connection with cysteine 
residues, but other residues which are either exchanged in different subtypes or occur 
in natural escape mutants have also been investigated. Mutant polypeptides were 
expressed and effects on the reactivity with polyclonal subtype-specific sera or 
monoclonal subtype-specific antibodies tested. Mutation of P 142 had negative effects 
on recognition by y-specific sera but change of R 122 and Y 134 had no such effect 
(Ashton-Rickard and Murray, 1989a). However, double amino acid replacement of 
S, 13 and R122 or S 3 and Y, 34 resulted in HBsAg being recognised by both anti-y and 
anti-d-specific sera (original subtype yd) and induced antibodies reactive with both 
d and y subtype HB5Ag. Triple mutants of S1,3, R122 and Y 134 were also recognised by 
both anti-sera but more importantly, induced antibodies that reacted with only the d 
subtype, i.e. completely switching the subtype from y to d in terms of 
immunogenicity (Ashton-Rickard and Murray, 1989b). Recent studies by Bruce and 
Murray (1995) showed that mutation of the central cysteine residue of the three 
cysteine stretch 137-139, C 138 , had no effect whereas changing the two others were 
deleterious, consistent with their involvement in the predicted two loop structure. 
Changes of C, 49 to serine also affected cross-reaction with anti-HBsAg sera which 
offers several possibilities for disulphide bridges between these residues (Fig. 1.6). 
These studies show that subtype specificities are also complex and probably 
determined by several amino acids which all contribute to the overall conformation 
and therefore cause changes in antigenicity when mutated. Escape mutants like G 145 
to R (Carman et al., 1990; Bruce and Murray, 1995) probably have similar effects, so 
that neutralising antibodies can no longer recognise the altered antigen and thus 
escape the immune response (Waters et al., 1992). 
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I.C.7) 	The monoclonal antibody MA18/7 
The monoclonal antibody MA 18/7 is widely used in research on hepatitis B virus 
(HBV) mainly because of its well characterised properties and its interesting effects 
on HBV biology. It interferes with attachment of HBV to liver cells (Pontisso et al., 
1989) and is specific for the PreSi domain of the surface antigen (Heermann et al., 
1984). This domain has been connected with cell attachment and therefore binding of 
MA 18/7 to PreSi interferes with this process. This observation prompted numerous 
investigations into the precise target site of MA1 8/7 on PreS 1. By using the PepScan 
method linear amino acids 18-25 of PreS 1 (QLDPAFRA; Coursaget et al., 199 1) and 
17-20 (HQLD; Howard et al., 1991) were reported as binding sites for MA18/7. 
Studies involving the screening of deletion mutants of the coding sequence of PreS 1 
cloned into fr bacteriophage expression vectors (Sominskaya et al., 1992) identified 
four amino acids consisting of residues 20-23 (DPAF). 
This monoclonal antibody was chosen as a model system to investigate the potentials 
of phage-display technology for high-resolution epitope mapping, and to compare the 
results obtained with the results of the mapping techniques applied previously, which 
had led to somewhat incompatible views on the target sequence for MA1 8/7 (e.g. 
compare residues identified by Howard et al., 1991 and Sominskaya et al., 1992). 
It was particularly important to distinguish between internal residues in respect of 
their contribution towards binding of this antibody. None of the methods previously 
applied was able to address this question satisfactory. The approach chosen here was 
to immobilise the MAb on microtiter wells of an ELISA plate and then screen the 
pool of phage contained in the random phage-display library by multiple rounds of 
selection and amplification (biopanning). 
I.C.8) 	The polyclonal serum sample of a vaccinated chimpanzee 
The animal lanthe was one of six chimpanzees inoculated with a recombinant HBV 
antigen in an immunisation evaluation (Murray et al., 1984). lanthe and Dolf 
received at least two injections of hepatitis B virus surface antigen (HBsAg) 
produced by recombinant DNA methods in yeast (adyw subtype, coding sequence 
derived from pHBV130, Gough and Murray, 1982) and Gwen and Rinka received 
core antigen particles (HBcAg) that had been produced similarly in Escherichia coli 
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(Stahl et al., 1982). Two animals served as controls and were not vaccinated. After 
challenge with HBV (ayw subtype) the two controls developed hepatitis four weeks 
after infection with a normal disease pattern. Gwen and Rinka were partially 
protected and suffered very mild infections. The protections were believed to be due 
in part to anti-HBe specificities contained in the HBcAg preparation, but possibly 
also to anti-HBc to some extent. It has been demonstrated in the meantime that 
immunisation with these internal antigens of HBV leads to protection against HBV 
infection via cell-mediated immunity by priming T-cells to provide helper function 
for proliferating B-cells including those producing virus-neutralising anti-HBs 
antibodies (see also I.C.6, p.35). 
Table 1.1: Chimpanzee vaccination experiment by Murray et al. (1984) 
name I  sex I vaccinated with: I  injections  I  status after infection with HBV: 
Dolf m HBsAg 4 	protected 
lanthe f HBsAg 2 	protected 
Gwen f HBcAg 2 	partially protected 
Rinka f HBcAg 3 	partially protected 
Peter m - - 	 developed hepatitis 
Fraukje f - - 	 developed hepatitis 
lanthe and Doif were both protected against the challenge as expected since both 
animals showed high anti-HBs titres before the time of infection. Protection of lanthe 
and Doif was not surprising per se since inoculation with HBsAg was known to 
protect against the disease and had been used previously as a vaccine in the form of 
inactivated serum-derived subviral particles purified from patients. However, the use 
of recombinant surface antigen acting as an efficient vaccine was demonstrated by 
this experiment. The reason for protection is obviously the primed status of the 
immune system of an vaccinated individual leading to an efficient and quick 
secondary response on exposure to the surface antigens of virus particles. lanthe was 
chosen for the investigation of the antibody repertoire, primarily for the high anti-
HBsAg titre she developed on challenge with HBV. The serum samples were from 
day 301 which was 117 days post-infection (day 184) and 196 days after the first 
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inoculation, and from day 105, one day before the first inoculation (pre-immune 
serum). 
After viral challenge the vaccinated animals showed a typical secondary response 
with immunoglobulins of the G class being the major fraction in the blood. IgG 
molecules of this stage (day 301) and the pre-immune stage (day 105) were prepared 
from lanthe serum by two ammonium sulphate precipitations followed by an ion-
exchange column. The antibody preparations were then biotinylated to provide linker 
groups for immobilising the antibodies on solid supports via biotin-streptavidin 
interactions. 
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CHAPTER H: RESULTS AND CONCLUSIONS 
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II.A.) 	Epitope Mapping of the Monoclonal Antibody 
MA 18/7 
II.A.1) 	Amplification of the phage-display library and verification of the 
random composition of the displayed peptides 
Before the library could be used in biopanning experiments it was important to verify 
that the hexapeptides displayed on the phage were truly random. 15 phage clones 
were picked at random and the DNA inserts analysed by sequencing. Peptide 
sequences of the p111-fusions were derived by translating the DNA sequence by using 
the genetic code (Table 11.1). All analysed phage displayed different hexapeptides 
and —50% of them consisted of six different amino acids. 
Table Iii: Amino acid sequences of the p111-fusions analysed 
clone no. hexapeptide displayed number of different an 
1 GMSYYS 4 
2 HAERYL 6 
3 LFATCG 6 
4 HLAATG 5 
5 GTQIFS 6 
6 SRNDYL 6 
7 AQLSGF 6 
8 LETALN 5 
9 VKRITG 6 
10 YGGFML 5 
11 LSHHRD 5 
12 KLSSLA 4 
13 FVSSHV 4 
14 MNPQGF 6 
15 FVTARG 6 
Table 11.2 demonstrates two important fmdings: First, all six positions showed a 
similar diversity although position 2 was somewhat above and position 6 somewhat 
below the average. Second, the amino acids occurred in frequencies roughly 
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according to the number of possible triplets that coded for them (bearing in mind that 
the library was constructed in a way that excluded 50% of all triplets). For example, 
leucine was the most abundant amino acid in accord with three triplets that could be 
used to code for a Leu residue. However, two exceptions could be mentioned which 
occurred either above (F) or under (P) their expected codon representation but this 
could be attributed to the relatively small number of phage analysed. 
Table Ii 2. Frequency and distribution of amino acids between positions 1-6 and 
codon usage 
aa frequency 1. 2 	a 4 5 6 codons possible 
L 11 3 2 1 	- 2 3 3 
S 11 1 1 	3 3 - 3 2 
G 9 211 -23 2 
A 8 1123 - 1 2 
F 7 21-1 1 2 1 
T 6 -1212 - 2 
R 5 -1112 - 2 
H 5 2-1 1 1 - 1 
Y 5 1 --13 - 1 
M 4 1 11 	- 1 - 1 





I 2 ---2- - 1 
K 2 
C 1 
P 1 --1 - - - 2 
W - - - 	 - 	 - - - 1 
stop - - - 	 - 	 - - - 1 
Total number of different 
aalposition: 
Total number of aalposition: 
10 13 11 10 9 8 
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II.A.2) 	Defining the epitope recognised by MA18/7 
The intention here was to apply the phage-display library to a well studied antibody, 
presumably recognising a linear epitope and compare the results obtained with other 
mapping techniques. The approach chosen here was to immobilise the MAb on 
microtiter wells of an ELISA plate and then screen the pool of phage contained in the 
phage-display library by multiple rounds of selection and amplification (biopanning). 
Table 11.3 shows the yields (ratio of input to output phage) obtained from the four 
rounds of biopanning. From round 1 to 2 there was a 5-fold increase in yield 
followed by a 16-fold increase in round 3. Round 4 showed the smallest increase in 
yield. It has to be noted however that the amounts of input phage were not identical 
due to variations in titre for the amplified eluates. In this case the yields from each 
round do not truly reflect the increase in phage recovered from the wells. If the 
absolute number of phage recovered from each well is considered, it becomes evident 
that, with the coating conditions being identical for each round, the number of phage 
recovered rose from 2.5x104 t.u. in round 1 to 1.1x10 8 t.u. in round 4, equal to a 
4,000-fold increase. 
Table 11.3: Inputs and outputs of the biopanning experiment with MA 1817 
Round Input phage Output phage Yield (%) 
1 1.9x 10 10 2.4x 101 1.2x 104  
2 3.2x10" 2.0x106 6.3x10- 
3 1.2x 1010 2.4x 107 l.Ox 10-2 
4 4.Ox10" l.lx 108 3.0x10-2 
From rounds 1, 2 and 4 about a dozen phage were chosen at random and analysed by 
sequencing the gill-insert of the phage genome. The nucleotide sequences were 
translated into the peptide sequences displayed on the individual phage. The colonies 
for template preparation were derived from the titration of the output titres. Fig.II. 1 
shows the alignment of all hexapeptides displayed on the analysed phage. After only 
one round of biopanning almost 50% of the phage analysed displayed peptides 
corresponding with three or four residues with the amino acid sequence of PreS 1 
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Degree of conservation 
in % (29 matches total): 7 48 100 100 45 93 3 0 
PreSiresidues: 1181191201211221231241251 
Q L D P A F R A 	Epitopeas identified by 
__ Coursaget et al.(1991) 
Round! 	3/6 T V B P S E1-6 
3/6 I B I 	P 	I A Y K El-b 
4/6 i.: D P G '1 L El-4 
4/6 T F B P A T1 Ei-3 
4/6 H 5—  A F Y E1-2 
n. m. H L R Y F R El-I 
P V L V L T E1-8 
L S S W P N El-S 
H Y S R S S El-7 
G W F F H T El-11 
Y P K R 0 V E1-12 
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Figure ILl: Amino acid sequences ofpill fusion phage isolated from selection rounds 1, 2 
and 4; residues 18-25 of PreSl, defined as the binding site for M41817 by Coursaget et al. 
(1991), are shown in bold; percentages shown at the top indicate the degree to which these 
residues were conserved among the phage matching in this area (29 in total), matching 
amino acids are shown in bold in grey boxes, figures to the left indicate how many amino 
acids of the hexapeptide were conserved for each individual phage clone (clone numbers to 
the right); n. m. = "no matches" and refers to hexapeptides from round 1 which display no 
obvious consensus motif with the PreSl region shown here. 
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between position 19 and 23. All matching phage displayed the dipeptide DP (20, 21). 
Other phage from round 1 showed no obvious consensus with this or any other 
region of PreS 1. From round 2 onwards all phage analysed matched in the region 18-
24 of PreS 1 and all phage displayed the dipeptide DP. No non-matching sequences 
were found. The phenylalanine (F) at position 23 was also conserved to a high degree 
and replaced by tyrosine (Y) in only two of the phage analysed. Position 22 which is 
sandwiched between the highly conserved residues P 21 (100%) and F23 (93%) allowed 
substitutions from its native residue alanine to a high degree (55%) and indeed from 
round 2 onwards the core region DPQF seemed the most common one isolated. 
However, the amino acids substituting alanine at this position all had small side 
chains such as glycine (G), serine (S) and valine (V). 
Fig.II. 1 also shows the alignment of all p111-fusion hexapeptides with the residues 
defined as the binding site for MA 18/7 by Coursaget et al. (1991; bold box). 
Residues outside the core region DPAF, namely Q18 (7%), R24 (3%) and A25 (0%) 
were only very poorly or not at all conserved in the phage analysed. Further, the 
frequency of phage showing five out of six amino acids corresponding to PreS 1 did 
not greatly increase after round 2 for the numbers analysed here, and no phage were 
found which had all six amino acids corresponding to PreS 1. 
The biopanning with MA1 8/7 clearly led to the identification of a consensus motif 
within the PreS 1 sequence that consisted of three amino acids that were highly 
conserved. For residues D 20 and P21 no substitutions were found whereas two of the 
phage had residue F 23 substituted by another aromatic amino acid. Neighbouring 
residues were conserved to variable degrees but allowed considerable replacement, 
which did apparently not reduce binding affinity significantly. Interestingly, A 22 
which is located between the highly conserved residues P 21 and F23 also allowed 
substitutions and therefore interrupts the strict linear sequence of residues that seem 
to be essential for binding. 
Although the range of exchanges observed at this position is somewhat limited to 
amino acids with small side chains the properties of the actual side chain itself did 
not seem to matter. This is an example of a linear epitope where at least five linear 
residues do probably contribute to various degrees to the binding but where the three 
crucial residues sufficient for effective binding do not show a similar linear array. 
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II.A.3) 	Three non-linear core residues, D, P and F, are sufficient for 
specific interaction of phage and antibody MA18/7 
The biopanning experiment with MA1 8/7 defined three highly conserved core 
residues (D20, P21 and F23) that are crucial for efficient binding of the antibody. 
Although this core motif was almost unchanged, neighbouring residues were 
exchanged to various degrees and also internal residues like A 22 allowed 
substitutions. However, the results of the biopanning alone did not allow precise 
conclusions about the affinities of these different phage clones for the antibody. It 
was of interest therefore to quantitatively compare the binding affinities of phage 
displaying different hexapeptides, for this could reveal the effects of specific amino 
acid substitutions on binding affinity. Preferably, the interaction should be in solution 
since conformational changes can occur when proteins are bound to solid supports 
(Friguet et al., 1984). 
The assay employed here was developed from one used for studying antibody-
antigen interactions by ELISA (Friguet et al., 1985). In contrast the modified assay 
used here relied on phage titre as the signal readout of the experiment. However, to 
allow dissociation constants (KD) to be determined from the data obtained, some 
theoretical conditions had to be fulfilled. As shown below phage E44 was chosen as 
a representative to prove that these criteria were met. Table 11.4 is a summary of the 
phage chosen for the KDreIdetermination and the hexapeptides they display. Phage 
E2-12 represented the two phage where the highly conserved F 23 was replaced by 
another aromatic residue, tyrosine (Y). E4-2 has only the three highly conserved 
residues D 20, P21 and F23 corresponding with the primary sequence of PreS 1 and 
therefore represents the essential core motif identified by biopanning. E2-14, E2-16 
and E44 show an additional one or two residues corresponding with PreS 1 and were 
chosen to identify the effects of the flanking residues on binding. E2-17 displays the 
core motif but additionally contains the frequently replaced internal A 22 residue. 
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Table 114: Phage chosen for binding studies 
Phage No. I pill fusion peptidea I 	aa conserved 	I  reason for selectionb: 	I 
E2-12 ALD PAY 4 of 6 F23 replaced by tyrosine 
E2-14 SLDPGF 4 of 6 core motif +L19 
E2-16 LDPVFR 5 of 6 core motif+ L19 and R24 
E2-17 DPAFND 4 of 6 core motif + internal A22 
E4-2 PDPGFN 3 of 6 core motif only 
E4-4 QLDPGF 5 of 6 core motif+ L!9  and Q lS 
a bold writing indicates residues matching with PreSi amino acid sequence 
b "core motif =  D20, P21 and F23 
The method developed for the determination of KD  for the interaction of phage with 
substrate molecules in solution can be divided into two steps: 
Step I involves the incubation of a constant concentration of phage with variable 
amounts of antibody molecules in solution until equilibrium is reached. The purpose 
of step II is to determine the concentration of unbound phage present in this mixture 
by transferring the phage and antibody mixture to wells coated with the antibody for 
a short time period, after which all unbound phage are washed away and the bound 
phage eluted and titred as p.fu.. The concentration of phage eluted from these wells 
is proportional to the amount of unbound phage present in the mixture for the 
particular antibody concentration used. 
That this proportional relation is valid was demonstrated by incubating various 
concentrations of phage (input) with wells coated with the antibody for 1 h. The 
wells were washed, bound phage eluted (output) and the titres of the eluates 
determined. Fig.II.2 shows that the output p.f.u. was directly proportional to the input 
p.f.u. over two log ranges. With this relationship established the concentration of free 
phage remaining in solution p could be determined since the total concentration of 
phage Pt  incubated with the antibody was known: 
	
P Pt = p.f.u. / p.f.u. 0 	 (1) 
with p = p * p.f.u./p.f.u. 0 (2) 
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Figure 11.2: Linear relationship between input and output p.fu. from wells coated with MA 18/7; 
varying concentrations of phage E4-4 (input) were incubated for 1 It on polystyrene wells coated 
with MA1817 and the number of bound phage (output) after extensive washing determined by titering 
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Figure 113: Time course experiment of phage binding to wells coated with MA 18/7; phage E4-4 
(108 p.fu.) were incubated on wells coated with MA 18/7 for different periods of time and the amount 
of bound phage determined by titering the eluate; points represent the average of three assays. 
50 
II. Results and Conclusions 
p.f.u.0 is the titre obtained in the absence of antibody in step I (i.e. 100% of phage 
remain unbound in solution). The incubation time of 1 h was determined by a time 
course experiment in which a constant concentration of phage was incubated on 
antibody-coated wells for various time periods (Fig.II.3). The amount of phage 
bound to the wells coated with MA 18/7 reached a plateau after 5 h with about 14 % 
of the input phage bound. However, it was important that the percentage of free 
phage binding to the wells during step II was low since any large scale binding to the 
wells would have shifted the equilibrium towards the release of free phage from the 
phage-antibody complexes in solution: 
[phage] + [antibody] 	[phage/antibody] (equilibrium in solution) (3) 
Fig.II.3 shows that it was unlikely that the equilibrium was disturbed since after 1 h 
the fraction of phage bound to the wells was under 5%. A further experiment was set 
up shown in Fig.II.4 to demonstrate this. Various concentrations of phage were 
incubated for 1 h on wells coated with MA1 8/7 and the unbound phage transferred to 
a second set of identically coated wells and again incubated for 1 h. The titres of 
phage eluted from the two sets of wells were identical within 95% of standard error 
limits indicating that the total number of phage in the solution was basically 
unchanged. 
For determination of the KD'  values of the phage shown in Table 11.4, MA1 8/7 
concentrations in step I were varied from 10 - to 108  M and measured at 4 0C. All 
concentrations including one sample where no antibody was added (OM value) were 
assayed in triplicate and the mean calculated. For most phage more than one 
experiment was performed in which case the overall mean was taken. Table 11.5 
representatively shows the free phage remaining in solution for phage E4-2 expressed 
as percentage of the OM value. 
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Figure 11.4: Consistency of output titre for phage E4-4 binding to wells coated with 
MA 18/7 over 1 h incubation time; plate 1 was incubated with various concentrations 
ofphage E4-4 for 1 h (input plate 1), unbound phage then transferred to plate 2 and 
again incubated for 1 h (input plate 2); bound phage eluted from both plates are 
shown as p.fu. (output plate 1 • and plate 2 0); titres were determined in triplicate 
(plate 1) or duplicate (plate2). 
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Table 115. Data obtained from binding experiments of vhae E4-2 with MA 1817 
Concentration percentage of phage remaining in fraction of phage engaged in 
of MA 18/7 in solution during step I phage-antibody complexes 
step 1(M): [(,.f.u./p.f.u.o) * 100]: (= x/pt): 
0 	 100 (set value) 	 0 
	
10-9.5 	 35.6 ± 11.3 	 0.64 
10-9 	 15.8± 1.9 	 0.84 
10-8.5 	 5.8±3.3 	 0.94 
10-8 	 2.9 ± 0.6 	 0.97 
From these data the K DreI can be determined in two different ways: 
by plotting the percentage of free phage remaining in solution (i.e. the proportional 
percentage of phage bound to the solid phase during step II) at equilibrium versus the 
various antibody concentrations used during step I. As will be explained below the 
antibody concentration at which 50% of the phage remain unbound in solution during 
step I equals IT rel 
by applying the Scatchard equation which provides Scatchard plots. The actual 
values for KDreI can then be derived from the slope of these plots. 
a) 	Plotting the percentage offreephage against antibody concentration 
The titre obtained for the sample in the absence of MAb is set at 100% (p.f.u0). The 
concentrations of the reactants at equilibrium, with x being the concentration of the 
phage-antibody complex and a the concentration of free antibody can be calculated 
with the known total concentrations of Pt  and at , the total antibody concentration: 
x=p-p (4) 
a=at - x (5) 
The association constant KA  is defined as: 
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KA=x/p*a (6) 
The reciprocal of KA  is  KD the dissociation constant, and one can replace p after (4) 
to give: 
l/KK—a*(p-x)/x (7) 
which can be transformed into: 
x/pt=a/a+KD (8) 
For the plots the fraction of free phage remaining in solution can be expressed as 
(1-x/pt) 	(9) 
which is plotted versus a so that: 
(l - x/pt) =y = a/a+KD (10) 
y equals 1 (or 100%) when x = 0, i.e. when all phage remain free which is the case in 
the absence of antibodies (a = 0). At the concentration at which 50% of the total 
phage are engaged in a phage-antibody complex (i.e. y = '/2 because x = V2  * pt) a 
equals KD . 
Fig.II.5 shows these plots for all six phage of Table 11.4. The curves were fitted to the 
points using the least square curve fitting option to a hyperbolic function of the 
graphic package used for plotting the graphs (SigmaPlot, Jandel). From this 
operation the program delivers the value for the at at which 50% of the phage would 
remain in solution (i.e. the KD). 
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- 	 E2-12 (ALDPAY) E2-14 (SLDPGF) 
- 	 E2-16 (LDPVFR) E2-17 (DPAFND) 	- 
- 	 E4-2 (PDPGFN) E4-4 (QLDPGF) 
o 2 4 6 8 100 2 4 6 8 10 
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Figure 11.5: Percentage of free phage remaining in solution after incubation of phage (108 p.f.u.) 
with various concentrations of MA 18/7 in solution at 6°C; percentage offree phage at equilibrium is 
plotted against the concentration of MAb in solution (free phage in the absence of MAb = 100 01o); 
curves were fitted to the points using the hyperbolic least square curve fitting option (Mar quardt-
Levenberg algorithm, Marquardt (1963)) of SigmaPlot (Jandel Scientific GmbH) and the K0 ' 
values were derived from this process; plots shown represent data of at least two experiments 
performed for each phage. 
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b) 	Applying the Scatchard equation: 
	
x/a= (pt -x)/K 	(11) 
As shown above the concentrations of the reactants needed for the Scatchard 
equation can be calculated after (4) and (5). For Scatchard-plots the equation is 
rearranged to give: 
x/pt*a=1/KD -x/KD pt 	(12) 
X 'Pt * a is then plotted against X / Pt with the slope equal to - 1 / Kn . Fig.II.6 shows 
Scatchard plots for four phage from Table 11.4. The values for - 1 / KD  were derived 
from a regression line put through the points by using the regression curve option of 
SigmaPlot. 
Table 11.6 shows a summary of the KDreI values obtained for the various phage by the 
two methods described above. All constants were in the nM range and showed only 
small differences for the various phage studied. The differences between the two 
methods of calculating the KDreI values a) or b), were neglectable. The minor 
differences observed can probably be attributed to the fact that in the case of the 
curve fitting determination an additional point at 100% (for a = 0) was created which 
might have constrained the curve fitting operation. 
Table Ii 6: KD& values ofphage specific for M41817 
Phage No. I pill fusion peptide' I K' 1 valuesb (pJvI) I 	KDreI vaiuesc (nM) 
E2-12 	ALDPAY 	 0.79* 	 n.d. 
E2-14 	SLDPGF 	 0.26* 	 n.d. 
E2-16 	 LDPVFR 	0.11±0.08 	 0.10±0.01 
E2-17 	 DPAFN]D 	0.20±0.07 	 0.22±0.01 
E4-2 	 PDPGFN 	0.18±0.06 	 0.17±0.02 
E4-4 	 QLDPGF 	 0.18* 	 0.25±0.02 
a bold indicates residues matching with the PreSi sequence 
b determined by curve-fitting to a hyperbolic function 
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Figure 11.6: Scatchard plots for the interaction of four phage (Table 11.4) with 
MA 18/7 at equilibrium at 6°C; x is the concentration of pha ge-antibody complexes, 
pt the total phage concentration (for further details see text); points represent the 
average of two experiments. 
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C determined by Scatchard plots 
* no standard deviation given since curve fitting operation could not fir the curve to 
all points (see Figure 115) 
n. d. = not determined, note: these data were published together with other results by 
Dyson et al., (1995). 
It is important to note that the values determined here should be regarded as relative 
values (KD' ) since several factors have to be considered. First, the presence of 
several copies of p111-fusion hexapeptides per phage particle could mean that one 
phage is able to interact with one antibody molecule in solution and one antibody 
molecule on the solid support at the same time. The binding to solid phase-bound or 
solution-born antibodies was therefore probably not completely excluding each other. 
Second, the presence of multiple copies of p111-fusion proteins per phage could also 
lead to one phage particle binding via multiple interactions to the antibodies on the 
solid support thus enhancing the apparent affinity of this phage. The affinities 
determined here are hence the result of a complex interplay of such effects and are 
therefore not to be confused with the KD  for an "ideal" interaction. The aim of these 
studies was to compare the affinities of phage displaying different hexapeptides and 
thus allowing conclusions about the contribution of individual amino acids to the 
interaction. Since the effects discussed above should affect all phage to a similar 
degree a relative comparison should therefore be valid. 
The most dramatic effect on the affinity was observed when F 23 was replaced by 
tyrosine (E2-12) with a three-fold reduced K DreI in comparison to the weakest 
interaction for a phage displaying phenylalanine in this position (E2-14). Phage E2-
14 and E44 displayed additional PreSi residues (L 19 or Q js and L 19, respectively) to 
the core motif, but did not have significantly enhanced binding affinities no matter 
whether one or two additional residues were involved. Interestingly, phage E2-16 had 
a lower KD rel although A22 was replaced by an amino acid with a slightly bulkier side 
chain (valine). 
It is possible that the valine residue had positive effects on the binding affinity for 
MA1 8/7 but it cannot be excluded that residues L 19 and R24 also contributed to the 
binding. However, since R occurred only twice at this position among the 35 phage 
analysed this effect is probably rather small. 
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If the two phage representing the core region are compared (E2-17 and E4-2) it is 
interesting to note that the replacement of A 22 by a glycine is effectively neutral in 
respect of binding to MA 18/7 which supports the hypothesis of A 22 not being crucial 
for binding the antibody and therefore also would explain the high rate of 
replacement observed for A 22 . 
The comparison of E2-14 with E4-2 shows that the contribution of L 19 to binding of 
the antibody is at best very small since the phage with this residue replaced by a 
rather different proline residue had an even lower K DreI value. 
II.A.4) 	Synthetic peptides compete with selected phage for the interaction 
with MA18/7 
The comparison of the dissociation constants of individual phage isolated from the 
biopanning experiment revealed that the three residues D 201 P21 and F23 are crucial and 
also sufficient for effective binding of phage to the monoclonal antibody. Based on 
these results, it was of interest to see whether free synthetic peptides, representing to 
various degrees residues of the epitope were able to compete for binding of a phage 
carrying five out of six residues (E4-4, Table 11.4) to the monoclonal antibody. If 
peptides competed with the phage it would be additional proof for the fact that the 
nature and the spacing of the residues were crucial for efficient interaction and not 
necessarily the way they were presented in the context of the phage particle. In 
particular, a peptide only containing the three core residues could demonstrate that 
these amino acids are sufficient for a specific interaction. Three peptides of variable 
lengths were synthesised: 
Table 11.7: Synthetic peptides used for competition assays 
Peptide amino acid sequencea 	 comment: 
P1 	LDPAFR 	All six an correspond to the PreSi sequence (18-24) 
P2 	DPGF 	Core residues only; A 22 replaced by glycine 
P7 	ALLTRILG 	Negative control peptide with no relationb 
a bold residues indicate residues that match the PreSi sequence, b  Note: Flanking A and G residues 
are present in all phage displayed sequences 
59 








0 	0.001 	0.01 	0.1 	1 	10 	100 	1000 10000 
peptide concentration x 10-8  M 
Figure 11.7: Competition between phage E4-4 (108  p.fu.) and various 
concentrations of peptides P1 (0), P2 (S) and P7 (A) for binding to wells coated 
with MA 18/7; percentage of phage eluted from the wells is plotted against the 
concentration of peptide added as competitor (p.fu. eluted in the absence of peptide 
= 100%);points represent the average of two experiments; note: concentration of P2 
was slightly lower than other peptides since aa analysis of the hydrolised peptide 
revealed a slightly lower concentration. 
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P1 had six out of six residues matching with the PreS 1 sequence, a situation not 
encountered amongst the 35 phage analysed in II.A.2; Fig.II. 1, p.46). P2 could be 
referred to as the minimal possible epitope containing the three crucial residues as 
discussed above. It should be noted that A 22 was replaced by glycine to restrict the 
matching residues to D, P and F only. It was shown in II.A.3) that the effect on 
binding of replacing A 22 was relatively small. 
For the competition assays constant concentrations of phage E4-4 were mixed with 
serial dilutions of peptides ranging from 10-6  to 10 -11 M for P1 and 104  to 10-9 M for 
P2 and P7. The mixtures were then incubated on wells coated with the antibody. 
After washing the amount of phage eluted from each well was then plotted against 
the concentration of peptide added to that well (Fig.II.7). P1 shows strong inhibition 
effects on binding of phage E4-4 to MA 18/7 at concentrations above 10 nM and 
completely prevents binding of the phage at 1 pM. P2 required concentrations above 
1 tM to show an effect on phage binding, however, at 0.1 mM phage binding was 
also significantly reduced to 8% of the value with no peptide present. P2 is therefore 
about 300-fold less effective as a competitor for the binding of E4-4 to NIA 1 8/7 than 
P1. Control peptide P7 showed no effects on binding of E4-4 even at the highest 
concentration. The results shown are the summary of two experiments. It should be 
mentioned that P2 was very hygroscopic which made it difficult to achieve precise 
input concentrations. The concentration was therefore determined by amino acid 
analysis of the hydrolysed peptide which resulted in a slightly lower than expected 
concentration. Fig.II.7 shows the corrected values for P2. 
Although peptide P1 had only one amino acid more corresponding with the PreS 1 
primary sequence than the peptide sequence of E4-4 it required concentrations 10-
fold higher than expected from the KD  value determined for E4-4 to achieve 50% 
inhibition. This might be related to stereo chemical factors of unknown character and 
has been observed by other workers in similar experiments (Smith et al., 1993; 
Yayon et al., 1993). The fact that phage display multiple copies of the hexapeptides 
might explain the apparently higher affinity constant determined for the phage 
whereas the synthetic peptides are more likely to interact in a monovalent fashion 
and therefore have a higher KD.  Further, the conformational freedom of a free peptide 
in comparison to the same peptide displayed in a phage context is most likely to be 
considerably greater thus lowering the effective concentration of a particular 
functional conformation (Sachs et al., 1972). These effects might well explain the 
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reduced efficiency of the even shorter peptide P2 to compete for binding, but could 
also reflect weak contributions of the additional residues present in P1. Additionally, 
the close proximity of charged residues at the two termini to the binding site might 
have had destabilising effects (Smith et al., 1993) for P2. Contribution of 
neighbouring residues present in the phage context have also been reported (Felici et 
al., 1993; Yayon et al., 1993) and cannot be excluded either. 
Nevertheless, the three residues highlighted as being crucial for binding antibody 
MA18/7 in ILA.2) and II.A.3) were effective as a free peptide to act as specific 
competitor for the interaction of phage and antibody and therefore emphasise the 
essential character of these residues within the epitope recognised by MA1 8/7. 
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113) 	Investigating Antibody Specificities in the 
Serum of a Chimpanzee Vaccinated with 
Recombinant Surface Antigen 
II.13.1) 	Biopanning polyclonal IgG antibodies with the random phage- 
display library 
As described in the introduction (I.A.5, p.10) many different systems can be used to 
provide a matrix for immobilising antibodies for the biopanning procedure. Two 
approaches were chosen here, 1) streptavidin-coated petri dishes (3.6 cm diameter; 
BPIII), and 2) streptavidin-coated magnetic beads (2.8 m diameter; DBXII). The 
amount of beads coated with the biotinylated antibody preparation was chosen on the 
basis to provide a similar surface area to the petri dish. The effects of the two 
different systems on the selection procedure or the nature of the selected phage could 
hardly be predicted before the biopanning experiments were carried out and therefore 
the two parallel routes were envisaged. It could be that the magnetic beads allowed a 
better presentation of the antibodies to the surrounding solution due to less steric 
hindrance on the surface of one bead. Consequently, the accessibility of the antibody 
molecules could be very different in the two systems possibly eliminating a number 
of Fab  domains from being properly exposed to the phage in the case of the petri 
dishes. 
a) Affinity selection (biopanning) 
Table 11.8 provides an overview of the two experiments performed to select phage 
from the phage-display library on the basis of their affinity for polyclonal IgG 
preparations from lanthe. The experiments differed not only in the solid support 
system used to immobilise the antibodies but also in the way the final round of 
biopanning was performed. In the case of BPIII, round 3 favoured the selection of 
higher affinity binders since amplified phage were in competition for binding sites 
(see Materials and Methods, p.11  3). There was no such pressure on the selection of 
phage using the magnetic beads which might reflect the fact that the yield actually 
decreased in round 3 for the immune serum IgG. Both outputs increased similarly in 
round 2 but only the biopanning with neutral serum also increased in round 3. 
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Generally however, yields are not a reliable indicator for a successful selection and 
even rounds with identical yields or yields close to background level (usually around 
10-5 %) can contain an enriched population of phage (Smith and Scott, 1993). 
Table 118. Biopanning experiments involving polyclonal serum IgG from lanthe 
1) Experiment using petri dishes coated with immune serum IgG (BPIII): 	I 
Round input (A0 11 ) output (x105) yield (%x10 4) coating (gig) wash. amplif. (%) 
1 0.4 0.77 1.8 10 8x 100 
2 1.5 5.7 0.4 10 8x 21 
3a 	2.5 	73 	29 	1.8 	8x 	21 
2) Experiment using Dynabeads® coated with immune and [pre-immune] serum IgG 
(DBXII) 
Round 	input (x101 1) output (x105) yield (%x10 4) coating (tg) 	wash. 	amplif. (%) 
1 	0.36 0.04 [0.02] 0.1 [0.06] 5 [5] 	6 x 	100 
2 	0.26 [0.29] 1.8 [2.7] 6.9 [9.3] 5 [5] 	6 x 	100 
3 	1.6 [6.8] 0.3 [3.3] 1.2 [11.0] 5 [5] 	3 x 	100 
Table legend: 
I = Input p.f u.; amplfiedphage-display library for round] 
2 = Output p.fu. (total number of recovered phage prior to amplification) 
3 = Output expressed in percent of input phage 
4 = Concentration of IgG used to coat the dishes or beads 
5 = Washing conditions before elution of bound phage (TBS/Tween 20 0.05%) 
6 = Percentage of eluate taken for amplification; note that for round 1 of BPIII the 
eluate was reduced to 100 jil by spinning on microsept filters, for following 
rounds only 100 p1 equal to 21% were amplified 
a (round 3for BPJII was performed after the "PL+S method", i.e. the amount of IgG indicated refers 
to the amount incubated in solution with the amplified eluate from round 2) 
[]= values for experiment DBXII with pre-immune serum IgG 
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Table 11.9: p111-fusion peptides of 75 phage analysedfrom round 3 of BPIIJ (immune serum lgG, A) 
and DBXII (immune (B) and pre-immune (C) serum lgG); a (b) sequence occured twice (four times) 
Group 1 	Group 2 	Group 3 	Group 4 Fno group 
FA 	TRVPRRa MSYLEG RWFHRHa none 	TGTLLL 
SRLPLRb LIYLVN 	YLRWMY 	 FGRRAE 
SRLPKR 	YGYLVN PMWMIG FVYIILL 
RWSDMA 	 CIPTFF 
B SRVPLT 	ARYLMY 	ARWPMLa 	ARLYNY 
SRFPWS SYLFSN ARFVNS 
TRMPFFa 	 ARLLKF 
TRMFER ARYLMY 
TILPKR 	 S 	ARWPMLa 
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b) sequence analysis ofp111-fusions of isolated phage from round 3 
The most obvious way of analysing phage recovered from the biopanning procedure 
was to sequence the phage genome of various isolated phage in the region of the 
random DNA insert and translate the nucleotide sequence into the p111-fusion peptide 
displayed on the phage. The colonies chosen for template preparation were picked at 
random thereby giving an unbiased overview over the population of phage present 
after three rounds of selection. Table 11.9 shows 75 phage analysed for BPIII and 
DBXII. 
Some of the peptide sequences obtained from BPIII share sequence motifs which 
could be divided into three groups with: 
Group 1) Spanning 6 an featuring serine or threonine at position 1, arginine at 
position 2, proline at position 4 and arginine at position 6 [S/TR-P-R]. 
Group 2) Featuring tyrosine followed by a leucine [YL]. 
Group 3) A motif with RW, WM or RWM pattern [RWM]. 
Four phage occurred more than once with two of them being from group 1. 
Representatives of groups 1)-3) were also present in DBXII: 
Group 1) Four out of six phage (67%) had threonine instead of serine at position 1 
(compared with only 29% for BPIII) and position 6 (R) was only conserved in 33% 
of these phage (compared to 100% in B Pill). 
Groups 2) and 3) were also not as well represented as in BPIII with only one 
sequence fitting the pattern involving tryptophane (group 3) and two fitting the YL 
motif (group 2). 
Group 4) A new rather abundant group could be created with the general pattern A 
followed by R and in four out of six cases (67%) followed by an aromatic residue. 
Two of the three sequences that appeared several times could be arranged in group 1) 
and 4) indicating an enrichment of certain sequence motifs. 
If the short linear motifs of groups 1-4) represented crucial residues for recognition 
by antibodies directed against HBsAg some of them could probably be aligned with 
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the primary sequence of this polypeptide. The results of this alignment were as 
follows: 
Table IL 10. Alignment of identified group motifs with amino acid sequence ofHBsAg 
Group of p111-fusions I motif can be aligned with: 	non-identical matchesa 
SR-P-R, no alignment 	7R-P-R 
S--P-R, position 117 	T--P-R 
YL, no alignment 	 - 
RWM, position 73 	 - 
ARF, position 168 	 ARY, ARW 
a sequences from the same group with related but non-identical amino acid 
substitutions (italic) 
Interestingly, the two most abundant groups 1) and 4) matched well with short linear 
regions of HBsAg. The 3 amino acid match of the RWM motif of group 3) was also 
interesting since both experiments had overlapping p111-fusions with either RW or 
WM in this area (see also Fig.II.8, p.  71). 
Did sequences obtained from DBXII using pre-immune serum IgG also fall into 
groups 1-4)? 
No group 1) or group 3) motifs were found and AR of group 4) and YL of group 2) 
were each found once among the 13 phage analysed. The probability of a given 
dipeptide occuring by chance is 1 in 400. Since each hexapeptide can represent five 
adjacent dipeptides the 13 analysed phage clones represent 65 dipeptides. This 
corresponds to about a one in six chance to find one of the dipeptides amongst even 
this low number of analysed phage. 
Some sequence motifs were shared by a number of phage in both experiments and 
could be aligned with identical or similar amino acids which could indicate a 
directed selection for phage that required a certain motif for binding. Three of the 
four group motifs could be aligned with the primary sequence of HBsAg and may 
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therefore represent short linear parts of epitopes on HBsAg which were recognised 
by antibodies specific for surface antigen. 
Since there are potentially many different antibodies in a polyclonal serum it seemed 
surprising that there should be only a few of such group motifs i.e. putative epitopes, 
but this could mean that many of the antibodies in the serum were "ignored" by the 
selection procedure maybe for conformational reasons. It is possible that the 
displayed hexapeptides were too short to span all residues crucial for binding or 
reproduce the conformational situation encountered in the native environment for 
many of the antibodies present in the mixture. In other words the selection procedure 
could have been biased towards phage that bound antibodies that recognised epitopes 
with short linear core sequences and possibly, but not necessarily, were abundant in 
the serum. The multiple occurrence of some sequences was interesting in this respect 
although it could not be excluded that at this stage of the biopanning procedure they 
were clonal siblings and not necessarily the result of specific selection. 
The nature of polyclonal IgG molecules used for selection of phage here means that 
not only specificities against HBsAg but also against other immunogens, present in 
the chimpanzee before vaccination, were exposed to the phage pool. However, the 
experiment using pre-immune serum demonstrated that there was no significant 
selection for phage displaying distinct motifs as in the case of immune serum. 
Nevertheless, it should be noted that when immune serum was being used for 
biopanning the selection for phage recognising HBsAg-specific antibodies would 
always occur alongside the selection for phage recognising non-HBsAg-specific 
antibodies. It was therefore impossible to distinguish by sequence analysis and 
alignment between phage recognising anti-HBsAg antibodies, other antibodies or in 
fact sites on other proteins or reagents present in the IgG preparation. 
In this respect it is interesting to note that in other experiments performed on petri 
dishes (data not shown) the selection procedures led to highly related sequences of 
the type xRHRHIH, always consisting of several histidines (H) and arginines (R) and 
often lysines (K). It was not clear to what these sequences bound and why they were 
so effectively enriched, but they were typified as background since they also 
occurred in experiments where different chimpanzee sera were used (F. Gray, 
personal communication) and never occurred in experiments using magnetic beads, 
implying a specific problem occurring in connection with the petri dishes. Isolation 
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of sequences like these when using streptavidin-coated petri dishes was also observed 
by others who argued the phage recognised streptavidin sites different from the biotin 
binding site or unspecific sites on the plastic support (G.P. Smith, personal 
communication). Although this could be true the fact that this problem did not occur 
with the streptavidin-coated beads almost eliminates streptavidin as the source of the 
problem. In most cases the occurrence of these sequences completely obscured the 
results of the biopanning experiment so that they had to be abandoned. For reasons 
unknown, the problem was not observed in the case of experiment BPIII although 
some sequences of the type discussed were still isolated (Table 11.9, p.65). 
II.13.2) 	Sequence comparison and alignment of p111-fusion peptides with 
the primary sequence of HBsAg 
Instead of aligning the hexapeptides first with each other and then search for 
matches of the conserved group motifs with the primary sequence of the antigen, 
each hexapeptide was also aligned separately with the HBsAg sequence. This search 
has two main consequences: i) it includes all residues in the search and not just the 
ones that matched with a group motif and ii) it also included hexapeptides that did 
not fit in any group (Table 11.9, p.65; labelled 'no group'). The analysis was also 
based on the assumption that phage binding an antibody directed against HB5Ag 
could resemble parts of the epitope recognised by the same antibody on the native 
antigen. It was further assumed that even in the case of assembled epitopes, where 
parts of the epitope originate from different regions of the primary sequence, short 
stretches of the epitope, like two or three amino acids, may be linear. Unless a phage 
wholly mimicked an epitope and therefore was completely unrelated to the sequence 
of HBsAg, i.e. a mimotope, short linear stretches of epitopes may be identified. 
There also was the possibility of functionally pre-screening the phage for their ability 
to preferentially bind immune serum in comparison to pre-immune serum which 
could distinguish specific from non-specific phage. This approach will be described 
in section II.B.3). 
Sequence comparisons were performed using the "Findpattems" application of the 
GCG7 package of the University of Wisconsin. This program aligns sequences, here 
the p111-fusion hexapeptides derived from analysing phage genomes, with other 
sequences, here HBsAg from residue 1-226 of the subtype adyw (Pugh et al., 1986). 
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The programme thereby looks for identity of amino acids and by default only looks 
for absolute matches i.e. in this case six out of six residues matching with the 
primary sequence of HBsAg. For the reasons mentioned above it was of interest to 
allow a certain number of mismatches in this case three, for three amino acid matches 
and four, for two amino acid matches. Obviously, the total number of matches 
greatly increased with the number of allowed mismatches and the program did not 
distinguish whether matching amino acids were adjacent or interrupted by non-
matching residues. Table 11.11 shows the results of the computer alignments with all 
different p111-fusion sequences from BPIII and DBXII. 
Table Iii]: Computer alignment ofpIII-fusion peptides with the aa sequence of 
HBsAg using "Findvatterns"of GCG7 
Experiment pIIIfusionsa 4aa matches 3aa matches 2aa matches total 
BPIII 27 1(0.3%) 35 (10.5%) 297(89.2%) 333(100%) 
DBXII (immune) 35 5 (l.2%) 33 (7.8%) 385(91.0%) 423(100%) 
DBXII 
(pre- immune) 
13 - 12 	(6.6%) 169(93.4%) 181(100%) 
a number of total p111-fusion peptides including multiple aa sequences 
As expected, the large majority of matches were 2 an matches, around 10% 3 an 
matches and only up to —P1% 4 an matches. The results of this computer search can be 
divided into three main categories: 
1. Linear matches involving 3 and 4 amino acids: 
These matches were either interrupted by non-matching amino acids or 
uninterrupted. Fig.II.8 shows in detail the alignment of all 3 and 4 amino acid 
matches with the primary sequence of HBsAg. At the termini of the polypeptide and 
in an area around residues 80-100 both experiments matched with higher frequencies, 
but other areas where matches accumulated were different. BPIII showed a 
concentration of matches around residues 110-120 an area not well represented in 
DBXII. DBXII sequences on the other hand accumulated mainly around residues 
150-170 not represented in BPIII at all (for comparison also see Fig.II.9, p.75). 
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Figure 118: 
Alignment of p111-fusion hexapeptides from BPIII (blue) and DBXII (dark green) 
(Table 119, p.  65) with the primary sequence of HBsAg (adyw, Pugh et al., 1986) 
which match with at least 3 aa; group motifs shown in Table 119 which could be 
aligned with the HBsAg sequence are shown in red (see also Table 1110, p.  67); 
kQId residues in the HBsAg sequence (purple) indicate residues which were part of a 
motif found in a p111-fusion peptide; underlined HBsAg residues indicate point 
mutations investigated by various workers (see also IC. 6, pp.35-38); 
bold upper case residues in the hexapeptides indicate residues that could be matched 
with residues in the HBsAg primary sequence, lower case are non-matching 
residues; asterisks mark 4 aa matches; 
black lines represent peptides that have been used by various workers to investigate 
the immunogenicity and antigenicity of HBsAg (see also IC. 6, pp.35-38), number 
references according to code shown in legend table (p.  73). 
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1 1-10 yes(e) n.d 
2 1-121 n.d. yes (g) 
3 2-16 n.d. yes (d,J) 
4 22-35 n. d. yes (O no (d) 
5 48-81 n. d. yes (f), no (d) 
6 95-109 n.d. yes (d, J 
7 110-137 n.d. yes (d) 
n.s. 110-139 yes (d) yes (d) 
8 117-137(c) n.d. yes(c) 
9 121-226 n.d. yes (g) 
10 122-137(c) n.d. yes (c) 
11 124-137 yes(e) n.d. 
124-137(c) yes(e) n.d. 
12 125-139 n.d yes (d) 
13 135-155 yes (h) yes (Ii) 
14 138-149 yes weak (i) yes (z) 
15 139-147 yes (a, b, e) yes (a), n.d.(e) 
139-147(c) yes (b, e) n.d. 
16 139-158 yes (a) 	1 yes (a) 
17 	1 140-158 yes (a) yes (a) 
a (c) stands for "cyclic" and indicates that the peptide was used in cyclic form; n. s. = 
"not shown" and refers to Fig.]; n. d. = " not determined",- reference letter codes: (a) 
Bhatnager et al., 1982; (b) Brown et al., 1984; (c) Dreesman et al., 1982; (d) Germ 
et al., 1983; (e) Howard et al., 1988; (f)  Lerner et al., 1981; (g) MacKay et al., 1981; 
(h) Prince et al., 1982; (i) Neurath et al., 1982. 
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Interestingly, two uninterrupted 4 aa matches occurred, one at position 11 (DBXII) 
and one at position 112 (BPIII). 
Short linear matches of two adjacent amino acids: 
2 aa matches also accumulated within certain areas of the surface antigen (Fig.II. 10). 
However, some of the dipeptides like FL and LL occur several times in the primary 
sequence of HBs. They not only account for a larger proportion of the total matches 
(e.g. each FL occurring in a p111-fusion scores 7 matches) but areas of accumulated 2 
aa matches coincided with the areas where these dipeptides occured in HBs (not 
shown). Dipeptides of interest were therefore the ones that occurred in several phage 
but only occurred once in the sequence of HBs. Of these, TR (position 23) occurred 
in five p111-fusions, LR (position 77) in four and RR (position 78) in three. However, 
these dipeptide-motifs not only occurred in BPIII and DBXII but also in the fewer 
p111-fusions analysed from the biopanning experiment with pre-immune serum IgG 
(Table 11.9, p.65  and Fig.II.10). 
Non-adjacent 2 amino acid matches: 
Matches of this category were the majority of 2 aa matches. There was a good 
correlation between the two experiments but also with the experiment with pre-
immune serum IgG (Fig.II. 10). However, in many cases the alignment of a 2 an 
match allowed a further third residue to be identified which was maybe not identical 
but related with amino acids involved in a previously identified three amino acid 
match covering the same area. For example, the group of 3 an matches at position 
117-122 of the S--P-R type (Fig.II.8, p.71) were related to a number of sequences in 
BPIII and DBXII which occurred as 2 an matches since they only matched with P-R 
in this region but they possessed a threonine instead of a serine at position 117 which 
can be considered a conservative substitution (see also phage 6, 9 and 14 Fig.II.l 1, 
p.81). 
These results generated with the "Findpatterns" application can be divided in two 
respects: 
1.) 
The identification of high quality matches which in this case meant that at least three 
out of six linear amino acids were identical, could indicate the representation of 
linear stretches of HBsAg sequence on phage isolated by affinity selection with 
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Figure 11.9: Percent of 3 and 4 amino acid matches of p111-fusion peptides isolated 
from experiment BPJJJ and DBXII with the primary sequence of HBsAg at 10 aa 
resolution; figures shown on x-axis mark the last residue of the relevant decapeptide, 
i.e. "10" means residues 1-10. 
aa position of HBsAg (10 aa increments) 
Figure 11.10: Percent of 2 aa matches ofpIll-fusion peptides isolated from BPIII and 
DBXJI (including pre-immune serum) with the primary sequence of HBsAg at 10 aa 
resolution; figures shown on x-axis mark the last residue of the relevant decapeptide, 
i.e. "10" means residues 1-10. 
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the p111-fusion sequences of this category could have functioned as target sequences 
for antibodies that in vivo would recognise an similar linear region of the surface 
antigen by imitating or mimicking parts of this native epitope. In the case of 
mimickry the sequence could be entirely different from the native epitope recognised 
on HBsAg and a linear alignment could not identify such mimotopes. It cannot be 
excluded that some hexapeptides with different amino acid sequences that could not 
be aligned at all or only in different sequence areas, in fact mimicked the same 
epitope. Binding of phage like this would occur on the basis of structural similarity 
rather than sequence identity. 
Interestingly, both experiments selected for phage that matched with three or four 
amino acids and sometimes overlapped with the same matching amino acids, as for 
example at position 73-75 where two hexapeptides from DBXII matched with 
xWMCxR and xRWxxL and one from BPIII matched with xxRWMx, overlapping 
with both other matches (Fig.II.8, p.71). These residues were not always in a 
continuous arrangement but residues that are crucial for binding antibodies do not 
necessarily occur in a continuous array as the findings for the linear epitope 
recognised by MAb 18/7 clearly showed (chapter ILA). 
There were differences between the areas of higher frequency matches between the 
two experimental approaches as already mentioned. BPIII showed concentration in 
the area 110-120 whereas the most striking concentration in the case of DBXII was 
in the area 160-170 with six different p111-fusions matching within three amino acids 
(168-170; see Fig.II.8, p.71). 
2.) 
The object of analysing 2 an matches was that they might provide a way to identify 
areas within the antigen which contribute short linear parts to conformational 
epitopes. Apart from the assumptions outlined in the introduction of this chapter it 
was also believed that despite these matches being extremely short, the phage could 
still efficiently bind the antibody during the biopanning experiment. The latter could 
perhaps be justified in the light of the results obtained for MAb 18/7 (chapter ILA) 
where as few as three conserved residues were sufficient for specific and high-
affinity binding of the MAb, but binding efficiency also depends on the environment 
of the conserved dipeptide in the displayed hexapeptide since the neighbouring 
amino acids could to some extent support the binding without being necessarily 
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identical to the native environment in the epitope. Further, the stringency conditions 
during the biopanning experiment would also influence this class of interaction and 
in this respect DBXII could have been favouring the identification of weaker ligands 
since there was less competition for binding sites, although there was little evidence 
for that. 
The experiment with pre-immune serum IgG (DBXII) showed a similar pattern thus 
making conclusions about the distribution itself and the meaning of 2 an matches 
very difficult. As already mentioned, the 2 an matches were valuable in areas where 
there were already higher quality matches and where additional p111-fusion could be 
aligned which included the two matching amino acids and another related residue 
thereby supporting the conserved motif in this area. This was mainly the case in area 
117-122 (STGPCR) which was identified previously by aligning the consensus motif 
of group 1) p111-fusions with the HB5Ag sequence (Table 11. 10, p.6'7). 
II.13.3) 	Phage that preferentially recognise immune serum IgG share 
common sequence motifs and match in the same area of HBsAg 
Analysis of the p111-fusion peptides of phage picked at random from round 3 of the 
biopanning experiments gave a representation of the population of phage present 
after affinity selection against polyclonal serum IgG (II.B.1). The peptides could be 
aligned with each other or with the sequence of the antigen the antibodies were raised 
against (HBsAg) and matches with the primary sequence could indicate potential 
binding sites for antibodies (II.B.2). However, the situation encountered when using 
polyclonal serum IgG as substrate was very complex and analysis and alignment of 
sequences alone was not sufficient to predict areas of potential epitopes with great 
confidence. Although the sequence comparisons in II.B.2) gave an indication of 
where some of these areas might be located within HBsAg it did not prove that the 
phage identified were mimicks of these particular areas or indeed any other region of 
HBsAg. It should be stressed that the complete standard repertoire of the chimpanzee 
was present throughout the whole selection procedure and phage could therefore also 
mimick epitopes recognised by non-HBsAg specific antibodies. 
In this respect it was important to identify phage in the pool of affinity selected 
phage that preferentially bound specificities contained in the IgG repertoire of the 
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immunised animal used for selection and not with the repertoire of the same animal 
before immunisation. If most of the phage would have been selected against 
specificities also present in the serum before immunisation, one would not expect 
such differential binding behaviour since both sera would probably contain a similar 
representation of non-HBsAg specific antibodies. 
Table 1112: Selection procedure for 40 individual phage based on preferential 
binding to wells coated with immune serum IgG 
BPIII  DBXII 
phage numbers  phage numbers 
1-20 (20) 21-40 (20) 
1, 2, 4, 5, 6, 7, 9, 14, 19 (9) 21, 26, 27, 31, 36, 37, 38 (7) 
2, 4,5, 6, 7, 9, 14,19 (9) 21,26,27,31,36,37,38 (7) 
4, 5, 6, 7, 9, 14 (7) 26, 31, 37, 38 (4) 
2, 4,5,6, 7,9,14 (7) 26,31,37,38 (4) 
(13) F  (16) 
Experiment: 
Micropanning: 





sequence analysis on: 
number eliminated: 
-figures shown in bold indicate phage finally selected for sequence analysis, figures 
in parenthesis in second columns indicate the relevant total number ofphage 
Twenty new colonies, not previously analysed, were taken at random from round 
three eluates of biopanning experiments BPIII and DBXII and amplified in overnight 
cultures. Two consecutive elimination procedures were employed using different 
methods for detecting bound phage. The first assay was adapted from the 
micropanning procedure of Smith and Scott (1993). Phage supernatants of the 
overnight cultures were diluted 25-fold serving directly as input. After incubation on 
wells coated with IgG molecules of preparations from immune or pre-immune serum, 
wells were washed and bound phage eluted and spot titred on agar plates. 
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Phage were considered positive if they showed fewer than half the number of 
colonies in the eluate from the pre-immune IgG-coated well in comparison to the 
eluate from the immune IgG-coated well. 
Phage clones selected by this method were subjected to a second selection procedure 
featuring a different detection system. Bound phage were not eluted after washing 
but detected by ELISA using anti-fd phage rabbit serum ("Indirect Phage Sandwich 
ELISA"). This second selection step led to exclusion of further phage from the 
initally 20 clones. Selection criterion for the ELISA was the same as for 
micropaiining i.e. an at least twice as strong signal for phage binding to wells coated 
with immune IgG in comparison to wells coated with pre-immune IgG. Table 11.12 
illustrates the entire selection procedure for the 40 phage clones. Phage regarded as 
positive after the micropanning and ELISA selection procedure were analysed by 
sequencing and the p111-fusions they display compared: 
Table 1113: p111-fusion peptides ofphage identified by selective binding procedure 
from clones derivedfrom round 3 of BPIII and DBXII 
BPIII 
a the symbols indicate whether the same sequence had been found before when phage 
clones from round 3 were chosen at random for sequence analysis (Table 119, p.6.5) 
The seven phage analysed from BPIII consisted of only three different phage species 
with six of the phage displaying either SRLPKR or TRVPRR peptide fusions (Table 
11.13). All seven had a common motif with serine (S) or related threonine (T) 
phage no. Experiment:  p111-fusion found previously?a 
2 SRLPKR / 
4 SRRPSV * 
5 SRLPKR / 
6 TRVPRR / 
7 SRLPKR / 
9 TRVPRR / 
14 TRVPRR / 
26 VLLRST * 
31 SKPPTI x 
37 PYNLDV * 
38 GRMPTR * 
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residues at position 1, pro line (P) at position 4 and, in six out of seven phage, 
arginine (R) at position 6 (S--P-R motif). 
In contrast the phage isolated by the same procedure from DBXII were completely 
new peptide sequences and did not show a comparable conservation of residues or 
positions, although phage 31 and 38 showed some similarity with S--P or P-R motifs, 
respectively. 
How do these sequences isolated by selection procedure align with the amino acid 
sequence of HBsAg ? Equivalents of the dominating phage species from BPIII 
(phage clones 2, 5, 6, 7, 9 and 14) were also found previously when clones were 
selected at random from round 3 eluate (Table 11.9, p.65). Accordingly, SRLPKR 
could be aligned with three amino acids involving S 1171 P120 and R122 (Fig.II.1 1). 
Although TRVPRR did not match with three amino acids anywhere over the entire 
HB5Ag sequence it could also be aligned with the same region as SRLPKR involving 
P 120 and R122 but a related threonine instead of serine at position 117 (see also "non-
adjacent 2 an matches" II.B.2, p.74). The third phage, SRRPSV, shared the S--P 
motif and could therefore also be aligned in this area matching with S 117 and P 120 . In 
this case however, the arginine was not conserved and replaced by a valine 
(Fig.II.1 1). 
Of the more diverse sequences obtained from DBXII, SKPPTI (31) and GRMPTR 
(38) could also be aligned in the area 117-122 since these hexapeptides showed S--P 
or P-R motifs, respectively (Fig.II.11). Additionally, SKPPTI matched with four 
amino acids at residues 64-68, and VLLRST and PYNLDV matched with three 
amino acids in other areas of HBsAg (positions 96 and 29, respectively; not shown). 
The pool of affinity selected phage was screened functionally by a combination of 
different binding assays to identify phage that preferentially bound to immune serum 
IgG. It was assumed that phage that recognised both repertoires equally well were 
probably not specific for anti-HBs antibodies. However, it cannot be excluded that 
these phage were mimicking extremely rare epitopes and that the frequency of these 
epitopes, even in a serum with high anti-HBs titres, was so low that the signals 
obtained with the binding assays employed were close to background. Nevertheless, 
the selection procedure led to the exclusion of the majority of phage and the 
remaining phage were analysed by sequencing. Strikingly, in the case of BPIII, the 
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selected phage showed predominantly two hexapeptide sequences with a common 
consensus motif (Table 11.13, p.79). When aligned with the HBsAg primary sequence 
the hexapeptides matched in the same region and, more importantly, with the same 
amino acids (Fig.II. 11). Both sequences were also detected when the eluate was 
examined at random (II.B.1) but did not occur at the same frequency (Fig.II.9, p.65). 
111 	 117 	 120 	122 	 127 	 130 
PGSSTTSTGPCRTCTTPAQG 
S r 1 P k R phage 2/5/7 
S r r P S V phage 4 
T r v P r R phage 916114 
S k p P t i phage 31 
g r m P t R phage 38 
S G S S T P phage 10 
S T G P C R T C m T a 
C r T C a h P g e h a b 
TsnThacrTCsnpsrc 
Figure 11.11: Amino acid sequence of HBsAg (bold; adyw subtype) within the 
borders indicated aligned with p111-fusion peptides of phage isolated by selective 
binding experiments (Table H. 13, p. 79); upper case bold indicates residues identical 
to HBsAg (adyw) sequence, upper case related aa and lower case different  aa; 
underlined residue C124 was shown to be crucial for recognition by subtype-specific 
polyclonal serum (Ashton-Rickard and Murray, 1989a); phage numbers relate to 
Table 1114, a  linear epitope for HBs-specific MAb A15A 7 identified using 
overlapping hexapeptides (PepScan; Coursaget et al., 1991); b  phage clone isolated 
from phage display-library recognised by specificities contained in sera of hepatitis 
B patients (Folgori et al., 1994). C  phage clone isolated from phage-display library 
which mimic/cs the epitope recognised by MAb RFHBs6 (Motti et al., 1994); note: 
R 122 of b  and C  is shown as a non-matching residue here since it was not matching 
with the antigen sequence of the subtype used in the quoted references. 
The selected phage resembled a linear stretch of amino acids of the HBsAg sequence 
and could therefore represent a linear part of an epitope recognised by antibodies 
present in the serum of the immunised chimpanzee. The fact that the same residues 
were conserved in both phage families could indicate their crucial function in binding 
these antibodies. 
Among the four phage analysed from DBXII two phage shared parts of the S--P-R 
motif (Table 11.13, p.79). This could indicate that phage representing the same 
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epitope were also selected in DBXII but were perhaps more "diluted" by the 
occurrence of other, possibly lower affinity ligands. 
In addition to the synthetic peptide studies mentioned in the Introduction (p.34) and 
shown in Fig.II.8 (p.71), the area around residues 110-130 of HBsAg has recently 
been in the focus of other workers in connection with possible linear parts of 
immunogenic determinants. Coursaget et al. (199 1) and Motti et al. (1994) identified 
regions recognised by monoclonal antibodies specific for the short (S) surface 
antigen, using overlapping hexapeptides (PepScan) or phage-display techniques, 
respectively. The peptides binding to MAb A15A7 (Couroucé et al., 1983) 
encompassed residues 117-126 whereas the phage that mimicked the epitope for 
MAb RFHBs6 (Waters et al., 1992) could be aligned with residues 115-127 
(Fig.II.11). In the latter study the matching residues could indicate amino acids 
crucial for binding the antibody. In an approach similar to the one chosen for this 
project, Folgori et al. (1994) screened a nonapeptide phage-display library with 
human sera from hepatitis B patients and found four phage clones that were only 
recognised by sera from patients but not from healthy individuals. One of the pVIII-
fusion phage isolated matched with four amino acids within a linear stretch of 
HBsAg in the region 121-127 (Fig.II.1 1). The three other phage clones had no 
significant matches with HBsAg and were probably mimicking a different 
discontinous epitope (Meola et al., 1995). 
The idea of a linear epitope in this region is also interesting in the light of a number 
of models proposed for the structure of this region of HBsAg in which the cysteine 
immediately following the identified motif (C 124) forms a disulphide bridge with one 
of the two possible cysteines further downstream (137 or 139) generating a loop 
exposing conformationally sensitive epitopes (Carman, 1994; see Fig.I.6, p.37). P 1205 
the central amino acid in the S--P-R motif, could be the site of a proline-induced turn 
of the peptide chain and would therefore make the area an accessible epitope with 
linear features (Ogata, 1994). This could explain why this epitope was preferentially 
isolated from the diverse mixture of specificities present in the polyclonal serum. 
Proline restricts the range of possible conformations of a peptide due to the rigid 
cyclic structure of its side chain. The limitation to fewer possible conformations 
could have biased the selection not only for linear rather than discontinuous epitopes, 
but also for phage (i.e. epitopes) mimicking proline-containing epitopes. 
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Interestingly, an amino acid change from P 120  to Q was reported in a subpopulation of 
viruses in a chimpanzee inoculated with serum from a mutant virus strain infection 
(Ogata, 1994). It was thought that the mutation had arisen anew in the chimpanzee, 
but the biological effects of this mutation were not further investigated. 
II.B.4) 	Binding studies with individual phage that preferentially 
recognise immune serum IgG 
Phage identified by micropanning and Indirect Phage Sandwich ELISA from 
experiments BPIII (Table 11.13, p.79) were very similar and matched with positions 
117-122 of the amino acid sequence of HBsAg. This region thus represented a 
potential candidate for a linear part of possibly larger conformational epitope 
recognised by antibodies present in the polyclonal immune serum of lanthe and it 
was the aim of these binding experiments to focus in more detail on this particular 
region. 
Table 1114: Phage chosen for Indirect Phage Sandwich ELISA binding experiments 
6 	 TRVPRR 	 ELISA 	3aa, 117-122 
7 	 SRLPKR 	 ELISA 	3aa, 117-122 
10 	 SGSSTP 	not pre-selected 	4aa, 112-115 
E1-8 PVLVLT - negative control 
note: bold marks residues that match with the HBsAg primary sequence with 
identical or related amino acids 
The phage chosen for the binding experiments are shown in Table 11.14. Phage 6 and 
7 were representatives of the two groups of phage identified after the selection 
procedure described in II.13.3. Phage 10 was also derived from experiment BPIII but 
not identified by functional analysis i.e. not on the basis of its selective binding 
ability for immune serum IgG, but was chosen at random from the colonies derived 
from round 3 of biopanning and turned out to match with four adjacent amino acids 
in a region just upstream of the potential epitope area (112-115; Fig.II.l1, p.81). The 
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object of including this phage was to examine whether the mere occurrence of such a 
high degree of identity with a linear stretch of HBsAg sequence was reflected in an 
increased affinity for immune serum IgG. If this was not the case it would further 
support the argument that functional analysis is preferable for selecting specific 
phage and that sequence homology alone does not identify specific phage. 
The experiment was set up as an Indirect Phage Sandwich ELISA (IPS-ELISA) as in 
II.B.3 with either purified (by CsC1-gradient centrifugation) or partly purified (by 
PEG precipitation) phage particles. Experiments with a reversed set-up i.e. the wells 
of the ELISA plates coated with phage particles and the IgG molecules added and 
subsequently detected by anti-human alkaline phosphatase-conjugated antibodies 
(Motti et al., 1994) were not successful, giving extremely low signals and not 
showing differences between various phage and various sera (data not shown). This 
was probably due to the fact that the ligands used here were polyclonal antibodies 
and the concentration of available specific binding sites possibly quite low. Since the 
pill-fusions, in contrast to the pVIII-fusions used by Motti et al. (1994), only occur 
on one tip of the phage particle, orientation is also an important aspect and given that 
the binding to the wells was through unspecific adsorption to plastic the number of 
accessible copies of p111-fusions could have been even lower. 
Phage (10 10 t.u.) were incubated overnight at 4 0C on wells coated with purified 
immune or pre-immune serum IgG, the wells washed and bound phage detected by 
ELISA as described. Four independent experiments were performed with each 
sample in duplicate. Fig.II.12A shows the signals derived from wells coated with 
immune serum IgG in comparison to the signals of the same phage derived from 
wells coated with pre-immune serum IgG. The average signal obtained for the 
control phage on wells coated with immune serum IgG was just under 2-fold higher 
than the signal derived for the wells coated with pre-immune serum IgG. Phage 10 
showed even smaller differences than El-8 and was hardly elevated over the signal 
form wells coated with pre-immune serum. The two phage isolated previously on the 








































6 (TRVPRR) 	7 (SRLPKR) 	10 (SGSSTP) 	E1-8 (PVLVLT) 
Figure 11.12 A: Binding experiment involving phage 6, 7, 10 and control phage E1-8 
and wells coated with immune serum and pre-immune serum IgG; columns indicate 
how many fold the signal on the immune IgG-coated wells was elevated over the 
signal obtained for the same phage on wells coated with pre-immune serum JgG; x-
axis crosses at the value obtained for the control phage (E1-81.92-fold increase) to 
show the true variations obtained for the other phage; values shown are the mean of 
three experiments. 
U511  
6 (TRVPRR) 	 \H'LVL1) 
Figure 11.12 B: Diagram shows the same binding experiment as 1112 A, however, 
columns show the percentage of the ELISA signal obtained on immune and pre-
immune serum-coated wells in relation to the signal obtained for phage 6 on wells 
coated with immune serum IgG (value set at 100%). 
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were 3.5 and 4.7-fold increased over the signals obtained from wells coated with pre-
immune serum IgG. If the signal obtained for El -8 was taken as a reference, as the 
base line in Fig.II.12A indicates, phage 6 and 7 had 2.7 and 1.5-fold increased signals 
on the wells coated with immune serum IgG, respectively. In Fig.II.1213 all ELISA 
signals were related to that obtained for phage 6 on wells coated with immune serum 
IgG. This not only shows the relative differences, but also the absolute signals 
obtained for the phage. All signals from wells coated with pre-immune serum IgG 
were around 25-30% of the signal obtained for phage 6 on immune serum IgG-coated 
wells but signals for the wells coated with immune serum IgG differed considerably. 
Phage 6 and 7 both bound immune serum IgG with similar efficiency but the control 
phage and also phage 10 only reached about half of this level (61% and 45%, 
respectively). The difference of the ELISA signals between pre-immune and immune 
serum coated wells was therefore smaller for the control and phage 10 (46% and 31% 
difference, respectively). 
Given that phage 6 and 7 were identified according to their ability to preferably 
recognise immune serum IgG the results obtained here were reassuring, for they 
confirmed that the phage that had been the major species isolated by the two step 
selection procedure (I1.B.3) were indeed recognising the immune serum significantly 
more efficiently than the same phage recognised pre-immune serum of the same 
animal or an unrelated control phage. This demonstrated that these phage were 
specific for antibodies contained in the serum only after vaccination and challenge. 
Further, this experiment emphasised that a functional selection of phage on the basis 
of selective binding is important when complex populations are obtained from 
bioparming which may contain many ligands to unrelated specificities. The actual 
concentration of certain specificities within the polyclonal serum was of course 
unknown but since both sera were used as purified IgG preparations at least the 
amount of IgG molecules used for coating the wells was similar since otherwise there 
would be a difference in the concentration of IgG molecules between a neutral and a 
boosted serum. 
It is possible that the control phage coincidentally mimicked epitopes recognised by 
antibodies present in the immune sera and therefore bound more tightly than 
expected, which might explain why E1-8 recognised immune serum IgG almost 
twice as efficiently as pre-immune serum. Phage 10 matched the primary sequence of 
HBsAg with high homology and thus was a good candidate for a linear epitope, but 
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did not preferentially recognise components in the immune serum and therefore did 
probably not represent a putative epitope or even parts of it. It could not be excluded 
however that phage 10 did recognise antibodies specific for HBsAg but then this 
reactivity could not be demonstrated with this assay. 
Interestingly, although only phage 7 features the native serine residue (S 117 ) in 
comparison to a related threonine for phage 6 there was not much difference between 
the efficiencies of the interaction with immune serum IgG. This might support the 
argument already advanced that this exchange of amino acids does not effect binding 
and is a conservative substitution. 
II.B.5) 	Competing for binding of phage 6 and 7 to immune serum IgG 
with synthetic peptides 
Although the two dominating phage sequence motifs isolated from BPIII (II.B.3) 
could be aligned with area 117-122 of HBsAg they still showed considerable amino 
acid exchanges with the native sequence in the non-matching positions (Fig.II.11, 
p.81). To test whether it was this particular linear region of HBsAg which was 
mimicked by the phage, the effects of a free hexapeptide representing this region on 
the interaction of phage 6 and 7 with immune serum IgG was examined. This would 
demonstrate that, if competition occurred, the interaction was specific for this 
particular target sequence and not unspecific, in which case adding the peptide would 
not necessarily affect binding. A peptide with an unrelated sequence served as a 
negative control and comparison with a peptide representing one of the phage 
displayed motifs was helpful for assessing effects observed with the "native" 
hexapeptide (P3). 
The assay was performed as a competition ELISA and for each phage examined two 
sets of wells were coated with immune serum IgG and incubated with fixed amounts 
of purified fusion phage in the presence or absence of synthetic peptides. 
Experiments with peptide concentrations lower than 1 mM proved unsuccessful and 
had no effects on binding of the phage (data not shown). Wells were washed and 
bound phage detected by anti-fd serum and secondary alkaline phosphatase 
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P1 (LDPAFR) 	 P3 (STGPCR) 	 P5 (TRVPRR) 
Peptide competitor (1mM) 
Figure 11.13: Competition of the interaction of phage 6, 7 and E1-8 with wells 
coated with immune serum IgG by adding synthetic peptides P1, P3 or P5; results 
shown are the average of three experiments with the exception of P5 competition of 
phage 7 and E1-8; the ELISA signal obtained in the absence of peptides is set at 
100% in each case and represented by the thick line. 
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conjugated anti-rabbit antibodies as before. Fig.I1. 13 displays the average of results 
obtained from three experiments. 
Control peptide PI slightly reduced binding for all three phage but to very similar 
degrees (91-95% compared to the absence of peptide). P3, the linear HBsAg 
sequence 117-122, had inhibitory effects on phage 6 and 7 reducing binding by 13% 
and 14%, respectively. Interaction of the control phage was not reduced by adding 
P3. P5, representing the hexapeptide displayed by phage 6 had a weak effect on 
phage 6 but not on phage 7 or E1-8. Competition experiments with a peptide (P6) 
representing another frequently isolated phage sequence motif which was almost 
identical to the p111-fusion of phage 7 except for one amino acid exchange (SRLPLR 
instead of SRLPKR), showed inversed effects on binding i.e. interfered only with 
phage 7 but not with phage 6 or El -8 (data not shown). 
The effects of various peptides on phage binding were quite weak and required high 
peptide concentrations, but since this assay was complex and required manifold 
amplification of the signal possibly due to very low concentrations of available 
binding sites it probably did not allow for larger effects. A further reason could be 
that the free peptides bound less strongly than the same peptide in a p111-fusion 
environment, possibly reflecting contributing effects from neighbouring residues 
(Felici et al., 1993; Yayon et al., 1993). In this respect recent work by Meola et al. 
(1995) emphasises the importance of the phage context for correct presentation of 
mimotopes and raises doubts about looking at mimotopes as isolated peptide 
sequences outside their, in this case, phage context. 
Several experimental aspects remain speculative, for example, how many antibodies 
that recognised the epitope postulated here were actually available for binding on the 
solid matrix? 
It could not be excluded that adding synthetic peptides at such high concentrations 
interfered with the interactions in a sequence-independent way but since control 
phage and control peptide were included findings could be related to each other and 
led to the following conclusions: 
• The control peptide did have a slight competitive effect but it affected all phage 
including the control phage and was comparetively small (5-9%) despite the high 
concentrations. 
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• Inhibitory effects of the peptide representing the native HBsAg sequence (P3, 
STGPCR) were only observed for phage 6 and 7 but not for the control phage. 
• The peptide representing the peptide motif of phage 6 (P5, TRVPRR) had a weak 
effect on phage 6 but non on phage 7 or the control phage. 
Although the results obtained here varied considerably between different experiments 
and maybe regarded as trends rather than definite results, they support phage 6 and 7 
representing linear target sequences for HBsAg-specific antibodies that cross-react 
with the phage and the related native sequence as a free peptide. In comparison with 
the corresponding area of HBsAg the phage displayed sequence motifs had several 
amino acid exchanges (Fig.II.11, p.81) which could mean that the interaction was 
relatively weak. 
Free peptides representing the phage-displayed sequences competed only with their 
p111-fusion counterpart (e.g. P5 with phage 6) but not with phage of the other 
dominant sequence family (e.g. PS with phage 7). Perhaps peptides PS (TRVPRR) 
and P6 (SRLPLR, not shown) were both equally well mimicking the native epitope 
but not very efficiently each other, particularly when one partner was a free peptide 
and the other a phage fusion as it was the case in this assay and could explain why 
there was no competition between the two sequence families (SRLPKR or TRVPRR) 
in this assay. 
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Phage-display libraries have become a widely used tool and found their way into 
many areas of investigation of macromolecular interactions. Besides the advantage of 
being easy to use and requiring minimal expenditure, the key factor for the success of 
the phage-display technology is the possibility that it offers to probe for peptide 
ligands to almost any molecule, be it a whole protein, a protein domain or even 
nucleic acids, without requiring any information about the molecule used for 
screening. More complex targets such as organelles, viruses or nucleoprotein 
complexes may also be probed in a similar way. Many ligands for a whole range of 
molecules have been successfully isolated, many of them being specific for 
antibodies (see Introduction I.A.6, p.12). 
As mentioned in the Introduction, screening with antibodies allowed in many cases 
identification of the epitopes recognised by these particular antibodies since the 
isolated peptide ligands showed amino acid sequences similar to the primary 
sequence of the antigen against which the antibodies were raised. 
• Epitope mapping studies on MA 18/7 
In this project a relatively well characterised monoclonal antibody (MA1 8/7) which 
specifically recognises the PreS 1 domain of the HBV surface antigen was used to 
screen a random hexapeptide phage-display library. The epitope recognised by 
MA18/7 had been identified previously by means of other epitope mapping 
techniques which relied on overlapping synthetic peptides (Coursaget et al., 1991; 
Howard et al., 1991) or analysis of deletion mutants expressed on bacteriophage 
(Sominskaya et al., 1992). By mapping the epitope recognised by MA18/7 with a 
random phage-display library one could directly compare the results achieved with 
these different strategies. Based on the results of the previously applied mapping 
techniques it was expected that MA 18/7 would recognise a linear sequence of amino 
acids between 17-25 of PreS 1 and probably would not require complex 
conformational structures for efficient binding (Fig.II.1, p.46). 
• Three non-contiguous residues were highly conserved amongst isolated phage 
Phage isolated from biopanriing rounds 1. 2 and 4 carried peptide sequences that 
matched within area 18-24 of PreS 1, but only a few residues within this area were 
conserved, in some cases as few as three. In particular, the motif D, 0, P21 and F23 was 
conserved in almost all of the phage analysed whereas neighbouring residues of the 
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PreSi sequence were found only between 3% and 48% of all phage analysed 
(Fig.II.1, p.46). 
Although the epitope would have been located clearly after round 1 of biopanning 
since about 50% of the phage analysed from this round showed a striking similarity 
to the PreS I sequence, it was of interest to proceed with further rounds of selection in 
order to ascertain whether the pattern of conserved residues displayed by the isolated 
phage would change. For example, would further neighbouring residues be found 
increasingly frequently amongst the phage population derived from later selection 
rounds? 
After round 2 the population of phage did change in the respect that all phage 
analysed now matched with this motif from PreS 1 indicating a strong selection for 
these residues. Although the pattern of the conserved residues did not change 
significantly, residue L 9, neighbouring the core motif DP-F, was found more 
frequently than after round I indicating some selection for this residue. Other 
neighbouring residues of the core motif were found in only two cases in total 
(Fig.II.l, p.46). 
Interestingly, the three most conserved core residues D 20, P21 and F23 were not 
contiguous and amino acid exchanges of the intervening residue were tolerated 
although only amino acids with small side chains were found. Position 22 may 
therefore itself not be involved in the interaction with the paratope of MA 18/7, but 
the steric situation may require a small amino acid at this position for the interaction 
to be strong enough to persist under the experimental conditions used here. 
• Relative dissociation constants of the interaction between phage and MA 1817 
were in the nM range 
The above findings were supported by quantitative examination of the interaction of 
individual phage with MA18/7 using an assay that was developed on the basis of an 
immunoassay procedure described by Friguet et al. (1985) and which yielded relative 
dissociation constants for this interaction. The assay developed here was based on 
phage titre and allowed the individual phage that bound to MA18/7 to be ranked 
according to their relative dissociation constant K DreI. Comparison of the values 
obtained provided evidence that, i) the three core residues D 201 P71 and F-,-, were 
sufficient for an efficient interaction between phage and MA1 8/7 with a K DreI in the 
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nM range, ii) the exchange of the conserved F 23  residue by another aromatic residue 
(Y) had only a small effect on affinity and iii) exchange of the intervening A,, and 
neighbouring residues had practically no effect on the strength of the interaction 
(Table 11.6, p.56). 
• Synthetic peptides competed effectively with ph age ligands specific for MA 18/7 
To prove the specificity of the isolated phage for MA 18/7, synthetic peptides were 
used for competition studies which were also based on phage titre as the signal read-
out. The result demonstrated that the peptide sequences identified did not require the 
context of the phage particle to interact efficiently with MA 18/7 and that even an 
extremely short peptide (P2, 4 aa) representing only the three non-contiguous core 
residues with the correct spacing was recognised by MAI8/7 (Fig.I1.7, p.flO). Further, 
complex conformational structures were apparently not required for interaction with 
MA 18/7 since short peptides were efficiently bound. 
• Characterising the epitope recognised by MA 18/7 
Collectively, the results demonstrated that the core of the epitope recognised by 
MA! 8/7 consisted of only three amino acids which were sufficient for a strong and 
specific interaction and which were arranged in a linear, but non-contiguous array. 
They probably make direct contact with the paratope of the antibody and therefore 
contribute significantly to the binding energy of this particular interaction. In this 
respect it is interesting to speculate that the reported cross-reactivity of MA1 8/7 with 
peptides spanning 131-137 of PreS2 (Howard et al., 1991) may be due solely to the 
presence of the DP dipeptide which contributes most efficiently towards the binding 
of this antibody. In addition to DP, the multiple sequence alignment of PreS2 
subtypes presented by Howard et al. (1991) also contains a leucine (L 132) with the 
same spacing as L 19 in PreSi. Based on the results described above, a peptide 
carrying this leucine residue in association with the DP motif would be efficiently 
recognised and hence explain the observed cross-reactivity. In fact it could be argued 
that MAI 8/7 may recognise many other antigens and peptides that feature a DP 
dipeptide and one of the other neighbouring residues within a linear stretch of amino 
acids. 
• How do the mapping strategies compare? 
By using a random phage-display library a high-resolution epitope mapping could be 
achieved since internal residues were readily accessible for investigation and 
94 
III. Discussion 
revealed the discontinuous pattern of the crucial residues. If similar resolution was to 
be achieved with for instance the PepScan method, complex substitution analysis and 
synthesis of many peptides would be required. Further, the ease with which 
individual fusion phage carrying different peptide sequences could be amplified and 
examined in a non-radioactive quantitative binding assay highlights the value of this 
biological method in comparison to approaches with synthetic peptides. 
• Screening polyclonal anti-HBsAg IgG revealed consensus motifs amongst the 
phage ligands isolated 
The second major objective in this project was to apply the phage-display approach 
in a polyclonal context to provide an overview of the target sequences recognised by 
a mixture of antibodies directed against a complex antigen, in this case the HBV 
surface antigen. As explained earlier (Introduction I.A.5) there are many 
experimental variations for applying phage-display libraries and here two 
approaches, using different solid support matrices and different final rounds of 
selection, were pursued in parallel to examine possible influences on selection. The 
two methods led to two quite diverse populations of phage, but with some highly 
related p111-fusion peptides from both experiments (Table 11.9, p.65). 
Closer analysis of the fusion peptide sequences of the phage isolated showed a few 
consensus motifs that were of four basic types and, with the exception of one, 
occurred in both experiments, although at different frequencies. The group motifs 
were represented by two amino acids or by three amino acids and could represent 
short linear elements, possibly within larger conformational structures, which were 
sufficient for recognition by antibodies directed against HBsAg under the 
experimental conditions used for the selection (Table 11.9, p.65). It could not be 
excluded at this stage though, that the antibodies to which these motifs bound were 
not necessarily HBsAg-specific, but part of the standard repertoire. 
Considering the potential complexity of a polyclonal serum, it seemed surprising that 
only four sequence consensus motifs were found but this could be explained either if 
the majority of antibodies in the serum were directed against similar target sequences 
or, alternatively, if there was a bias during the selection towards certain types of 
sequences that were selected preferentially. One reason for such a preference could 
be that, although it is considered as one of the assets of the phage-display technique 
that conformational epitopes can to some extent be reproduced, in practise, the short 
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hexapeptides only poorly represent secondary conformations, and that therefore the 
selection was biased towards phage that were recognised by antibodies that did not 
require a specific conformation for efficient interaction (as for example linear type 
epitopes). Difficulties connected with conformational epitopes have also been 
experienced by others and the few successful examples of conformational 
determinants being revealed by screening of phage libraries underline this problem 
(see also Introduction I.A.6, p.12). 
• Evidence for the consensus motifs being parts of epitopes recognised on native 
HBsAg 
Three of the group motifs were represented within the sequence of HBsAg and may 
represent cases in which short linear elements contributed efficiently towards the 
binding of an antibody and were therefore selected on this basis. Group motif 1) (S--
P-R) was particularly interesting since it involved three amino acids covering six 
residues and matched within an immunological important region, the a determinant. 
The relevance of this motif was further emphasised by several other results and also 
by independent work by other research groups: 
Sequence comparison of pIll-fusion peptides isolated from round 3 with HBsAg 
revealed several 2 aa matches within the sequence 117-122 which could be aligned 
with an additional non-identical, but related third residue, and because of this 
degeneracy these sequences were not placed previously in group 1) (Table 11. 10, 
p.67). 
The motif S--P-R or T--P-R was present in six out of seven phage selected from 
round 3 of experiment BPIII (using streptavidin-coated petri dishes) on the basis of 
preferential recognition of immune serum IgG in comparison to pre-immune serum 
IgG in a two step selection procedure (Table 11.12, p.78), and the motifs selected 
were almost identical to group motif 1) (Table 11.9, p.65). 
Phage representatives displaying these two motifs recognised immune serum 3.5-
fold (phage 7, SRLPKR) or almost 5-fold (phage 6, TRVPRR) better than pre-
immune serum IgG (Fig. II.12A, p.85). 
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A synthetic hexapeptide representing the sequence 117-122 of HBsAg was able to 
compete weakly for binding with phage 6 and 7 to immune serum IgG although high 
peptide concentrations were required; effects varied considerably between 
experiments, but control phage and control peptide were included in the experiment 
and allowed a trend to be established (Fig.II.13, p.88). 
The epitopes recognised by two monoclonal antibodies specific for HBsAg were 
mapped to an area overlapping substantially with region 117-122 (Coursaget et al., 
1991: Motti et al., 1994; see Fig.II.1 1, p.81). 
Screening of several sera of HBV infected patients with a pVIII phage-display 
library produced one phage clone that matched with four residues between 121 and 
127 of HBsAg (Folgori etal., 1993; see Fig.1I.1 1, p.81). 
• The putative linear epitope did not induce antibodies cross-reactive with native 
HBsAg when injected into rabbits 
In order to provide a more extensive picture of the investigations into this putative 
epitope the immunogenicity of the isolated phage particles was also tested by 
injecting rabbits with phages 6 and 7 (data not shown). It was hoped that this would 
generate antibodies that would recognise native HBsAg, but the immunisation did 
not generate detectable levels of such antibodies, although phage particles per se are 
very immunogenic carriers (Meola et al., 1995). Similar immunisation experiments 
recently carried out with the pVIII phagotopes isolated by Folgori et al. (1994) 
showed however, that the phage clone matching with 121-127 of HBsAg, and those 
phage carrying mimotopes with no sequence similarity were able to induce 
antibodies that recognised HBsAg (Meola et al., 1995). It was also argued that 
although pVIII fusions probably display 10-100 times more fusion peptides per 
phage particle than do pill fusions, the doses of the administered peptide did not 
account for the observed differences in titre between the immunisation with pVIII- or 
p111-fused mimotopes. 
Interestingly, the two best conserved residues. P 120 and R 122 , among the phage 
isolated in this work were not conserved in the phagotopes (i.e. "disease related 
mimotopes displayed on fusion phage"; Folgori et al., 1994) isolated by Folgori et al. 
(1994), and C 171 was not found amongst any of the phage analysed from BPIJI (see 
Fig.II.11, p.81). Whether these differences account for the crucial difference 
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observed in terms of immunogenicity is difficult to assess and the immunisation with 
mimotopes by Folgori et al., (1994) remains the only successful case described to 
date. However, the presence of the two cysteine residues in the phagotope isolated by 
Folgori et al. (1994) could restrict the conformation of the displayed peptide in a way 
that may more closely resemble this area of the antigen, and therefore be more 
efficient in inducing cross-reactive antibodies. Clearly, detection of residues 
spanning more than the six residues carried by the phage was not possible with the 
hexapeptide library used here. 
• Distribution patterns oJshort amino acid matches with HBsAg; what do they 
mean ? 
Many of the isolated and analysed sequences could not be aligned with any of the 
groups of sequence motifs but nevertheless matched with sequences of three or even 
four amino acids within the sequence of HBsAg (Fig.II.8, p.71). This individual 
comparison of all the hexapeptides with the sequence of HBsAg generated a 
distribution pattern of matches which accumulated in some areas. These 
accumulations could point towards the involvement of these areas in immunogenic 
regions including conformational determinants. 
Both experiments, using either streptavidin-coated petri dishes (BPIII) or 
streptavidin-coated magnetic beads (DBXII), showed accumulation of three amino 
acid matches in the N- and C-terminal sequences, but otherwise accumulation was 
found in different areas for BPIII and DBXII (Fig.II.8, p.71). The differences 
observed between the two experiments are difficult to explain, but it cannot be 
excluded that individual hexapeptides, or indeed whole sequence groups, mimicked 
the same binding site although they were not related at the amino acid sequence 
level. The alignment with HBsAg alone could not answer this question and only 
provide a basis for speculations on the immunogenicity of certain areas and their 
involvement in larger epitopes. Analysis of pre-immune serum (as in DBXII) could 
in principle offer a way of resolving this problem, but would appear to require the 
analysis of many more phage clones to provide statistical relevant data. 
Conclusions drawn from the analysis of two amino acid matches have to be 
considered even more carefully in this respect, particularly since the experiment 
involving pre-immune serum provided a similar pattern of 2 amino acid matches to 
that of the other two experiments using immune serum (Fig.II.lO, p75). Further, the 
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odds for a certain dipeptide to occur by chance are relatively high (1 in 80 within a 
hexapeptide, approximately). 
The functional assay for selection of phage that preferentially interacted with specific 
components of the immune serum IgG pool in comparison to the pre-immune pool 
excluded phage that were recognised equally well by both sera and therefore were 
probably recognised by antibodies of the standard repertoire. Problems were 
encountered in setting up this assay, probably for the following reasons: i) the 
number, or concentration, of available binding sites for one particular phage in the 
polyclonal serum was potentially relatively low, thus requiring high sensitivity, 
which in turn resulted in high background levels; ii) the pill fusion-phage system 
displays at the most five copies of the fused peptide on one tip of the phage, which is 
disadvantageous in two respects; first, the absolute concentration of the displayed 
peptides is low and, second, the correct orientation is essential to enable efficient 
interaction. Fusion systems using pVIII do not have these disadvantages and 
therefore detection assays are more sensitive and appear to deliver clearer results 
(Motti et al., 1994; Folgori et al., 1994; Meola et al., 1995). 
• Detection of bound phage required signal amplification 
For these reasons a selection assay was developed based upon the detection of phage 
particles by anti-phage antibodies, thereby offering the whole surface of the phage as 
a target for interaction independent of orientation and with a high degree of 
amplification. These antibodies could then be detected by a second antibody 
conjugated with the enzyme used in the subsequent ELISA procedure to provide 
another level of amplification. In order to provide an additional level of selection a 
related selection procedure was carried out prior to the ELISA which relied on phage 
litre and not on enzyme-linked colorimetric detection (Chapter II.B.3, p.77; Table 
11.12., p.78). 
The problems just outlined can be encountered equally in the ELISA-based 
competition assay with synthetic peptides and although alternative experimental 
procedures were also investigated, the assay presented here was the only successful 
one in distinguishing between different phage and different peptides. High peptide 
concentrations were required to achieve inhibitory effects; this could reflect the fact 
that the free peptide may not be recognised as efficiently by the antibodies as the 
same sequence in the context of HBsAg or even the phage. However, in a study that 
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also used polyclonal serum and phage-display technology to detect antibodies 
specifically recognising antigens connected with rheumatoid arthritis, it was also 
found that peptide concentrations in the mM range were required to compete for 
binding of serum IgG to the phage, although the arguably more favourable reversed 
ELISA assay could be employed here because a pVIII fusion phage library had been 
used (Dybwad et al., 1993). 
• Overall conclusions 
A random hexapeptide phage-display library was used to study epitopes recognised 
by monoclonal and polyclonal antibodies directed against HBV surface antigen. 
Various strategies were employed for presenting the antibodies to the library 
including unspecific binding to plastic microwells and streptavidin-coated plastic 
dishes and magnetic beads. In the case of the monoclonal antibody simple unspecific 
coating of microwells was successful for presenting the antibodies efficiently. 
Presentation of the polyclonal antibodies on plastic dishes or magnetic beads in two 
independent experiments selected for similar phage pools but with different 
frequencies of the individual phage clones. 
Screening with the monoclonal antibody MA1 8/7 demonstrated the power of the 
biopanning procedure and that phage specific for the paratope of an antibody can be 
isolated from a random pool of hexapeptides. Even by just comparing the amino acid 
sequences of the hexapeptides isolated it was possible to evaluate residues which 
were preferentially selected and therefore highly conserved. The importance of these 
residues which matched with a linear stretch of PreS 1, was supported by quantitative 
binding experiments which allowed the comparison of individual phage clones in 
terms of binding avidity expressed by their relative dissociation constants. These 
values were determined by a simple assay based on phage titres which does not 
involve radioactive labelling, can be performed without the purchase of any special 
equipment and is comparatively quick. 
The phage-display library was also applied to polyclonal serum which revealed some 
problems connected with the complexity of a polyclonal situation and the potentially 
low concentration of specific binding sites in such a mixture. However, the results 
demonstrated that sera can be successfully analysed with phage-display libraries and 
that interesting consensus motifs can be identified which may represent 
immunologically relevant areas of the antigen. Although the identified areas were of 
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a linear nature in this case, due in part to possible restrictions of the phage library to 
mimic conformational binding sites, the results generated could provide insight into 
the immunological properties of any antigen. This approach could be valuable in 
cases where the immunological areas of an antigen are of interest but where only the 
amino acid sequence of the antigen is known. In a complex case like the surface 
antigen of HBV where some areas are buried in the envelope and others are exposed 
to the surrounding environment, the results may contribute towards the 
understanding of the topology of HBsAg in the membrane. Despite failing to induce 
antibodies that recognised HBsAg the results obtained imply that the sequence 
between residues 117-122 was recognised by antibodies generated on vaccination of 
a chimpanzee with HBsAg and this sequence is therefore likely to be exposed on the 
surface. Further, since the putative binding site was identified as a short linear 
sequence it is possible that parts of this area are not involved in predicted complex 
three-dimensional structures that are part of the a determinant and which start 
immediately downstream of this region (see Fig.I.6, p.37). 
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IV.A) 	Materials and Equipment 
IV.A.1) 	Suppliers of reagents and laboratory equipment 
(in alphabetical order) 
acrylarnide gel stock solutions Scotlab, UK 
bacterial culture plates Philip Harris, UK 
BCIP Boehringer. Mannheim 
biotin Boehringer, Mannheim 
biotinylation Kit Amersham, UK 
BSA Sigma, USA 
Coomassie blue G-250 BioRad, USA 
CsCl Boehringer, Mannheim 
DE52 column matrix Pharmacia, Uppsala 
Dynabeads® (M-280, streptavidin coated) Dynal, Oslo 
ELISA 96-well microplates Corning, USA 
HBsAg Green Cross, Japan 
kanamycin Gibco, UK 
Kienow DNA polymerase fragment NBL Gene Sciences, UK 
Microsept spin filters Filtron, USA 
milk powder Marvel 
Mini-Protean II gel apparatus BioRad, USA 
NBT Sigma, USA 
PEG BDH,UK 
petri dishes Falcon, USA 
polyacrylarnide stock solutions NBL Gene Sciences, UK 
pNPP Boehringer, Mannheim 
SDS Sigma, USA 
Sephatex G25 gel matrix columns BioRad. USA 
sequencing apparatuses BRL, USA; Hybaid, UK 
sequencing Primer Oswel, Dept. of 
Chemistry, University of 
Edinburgh 
Sigma Plot graph plotting program Jandel GmbH, Germany 
streptavidin Gibco, UK 
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TEMED 	 Sigma, USA 
tetracycline Sigma, USA 
Tween 20 	 Sigma, USA 
X-ray films Cronex 
IV.A.2) 	Bacteriological material and solutions 
L(Luria)-broth: 
Bacto-tryptone (lOg), bacto-yeast extract (5g), NaCl (5g) were dissolved in water (1 
I), adjusted to pH 7.2 and autoclaved. 
TB (Terrific Broth): 
Bacto-tryptone (12g), bacto-yeast extract (24g). glycerol (4 ml) were dissolved in 
water (900 ml) and autoclaved in aliquots (90 ml). Before use, autoclaved potassium 
phosphate buffer (2.31g KH,PO 4 (anhydrous), 12.54g K2HPO4 (anhydrous) per 100 
ml water; 10 ml) was added. 
L (Luria)-agar: 
As LB but with containing agar (lOg /1). 
Top layer agar: 
Trypticase (lOg), NaCl (5g), bacto-agar (lOg) were dissolved in water (1 1) and 
autoclaved. 
Antibiotics: 
Tetracycline was used as a 20 mg/ml stock solution (dissolved in water and filter 
sterilised), kanamycin was used as a 100 mg/ml stock solution (dissolved in water 
and filter sterilised) 
Bacteria strains (all from G. Smith. University of Missouri. USA): 
K91: (derived from N.D. Zinder, Lyons and Zinder, 1972); male Escherichia coli 
strain for propagation of filamentous phage and therefore has an elevated number 
(-5) of  pili. 
104 
IV. Materials and Methods 
K91 Kan: same as K91 except that a kanamycin mini element was inserted into the 
lacZ gene by using a transposon vector (Way et al., 1984). K91Kan cells are 
therefore kanamycin resistant. 
Bacteriophage library: 
The library was given to us by G. Smith, University of Missouri, USA and is based 
on the fuse5 fd phage vector (for details see I.A.4, p.8). 
IV.A.3) 	Standard solutions and buffers 
PBS (phosphate buffered salinJ - 
137
: 
mM NaCl, 2.7mM KC1, 4.3 mM Na2HP041  1.4mM K}I2PO4 adjusted to pH 7.4. 
TBS (Iris buffered saline: 
50 m Tris-HC1, pH 7.5 (25 ml of a IM stock solution), 150 mM NaCl (15 ml of a 
5M stock solution) ad 500 ml and autoclaved. 
TBE (Tris buffered EDTA solution). 1 Ox stock solution: 
90 mM Tris (109g), 90 mM boric acid (55.6g), 2 mM EDTA (9.3g of disodium salt) 
ad 11 and autoclaved. 
PEG/NaC1 solution: 
16.7% w/v PEG 6000 (1 00g), 3.3 M NaCl (1 17g) ad 475 ml water (600 ml final 
volume), stirred until PEG has dissolved completely (heated if necessary) and stored 
at 4°C. 
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IV.A.4) 	Antibodies and anti-sera 
Antibody/serum type specificity provided by 
MA1 8/7 monoclonal HBsAg W.H. Gerlich, University 
(PreS 1) of Gottingen 
Rabbit anti-fd phage serum polyclonal fd phage University of Edinburgh, 
virions Dept. of Med. Microbiol. 
Alkaline phosphatase - polyclonal rabbit IgG Sigma, USA 
conjugated goat anti-rabbit 
antibodies 
Chimpanzee anti-HBsAg polyclonal recomb. Murray etal.. (1984) 
serum (lanthe)  HBsAg  
	
IV.A.5) 	Synthetic peptides 
All synthetic peptides were synthesised by the Department of Chemistry, University 
of Edinburgh: 
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IV.B) 	Methods 
IV.13.1) 	Protein purification and analysis 
Purification of antibodies (IgG) from sera 
Serum samples were thawed and pasteurised at 56 0 C for 30 mm. A 2 ml aliquot was 
removed from the stock and cleared by spinning briefly in a benchtop centrifuge. The 
total volume was adjusted to 4 ml with PBS and the IgG molecules precipitated by 
two consecutive ammonium sulphate precipitations as follows: The solution was 
constantly stirred in the cold and 1.04g (NH 4)7 SO4 added in small portions over 30 
mm. The then slightly turbid solution was stirred for another 30 min and centrifuged 
(Sorvall SS34; 10000 rpm; 10 mm) and the pellet dissolved in 2 ml PBS. After 
clearing the solution by spinning briefly, the second precipitation was performed as 
described above by adding 0.54g (NH4),SO4 over 30 mm. The then heavy precipitate 
was centrifuged as above and resuspended in 2 ml PBS. The solution was dialysed 
overnight against 2 1 PBS at 4°C with gentle stirring, changing buffer twice. The 
dialysed solution was passed over an ion-exchange column (DE52, 10 ml volume) 
using (Na) 7HPO4 buffer (20mM, pH 8.0) and 0.5 ml fractions collected. Aliquots (10 
tl) of the fractions were analysed by SDS-polyacrylamide gel electrophoresis, 
PAGE) and fractions containing the IgG pooled. Overall protein concentration was 
determined by Bradford assays 
Bradford assay for the determination ofprotein concentrations 
Bradford dye was prepared as a 5x solution (400 ml) by dissolving 200 mg 
Coomassie blue G-250 in 10 ml 95% ethanol and adding 200ml 85% phosphoric 
acid. The volume was adjusted to 400 ml with water and the solution filtered to 
remove undissolved dye. 
For the standard curve 5, 10, 15 and 20 tl of a BSA solution (lmg/ml) were 
transferred to a plastic cuvette (total volume 100 p1 adjusted with PBS). I ml of the 
dye solution was added and the 0D 595 measured instantly. Samples were measured 
the same way using various amounts of protein solution (5-10 p1) instead of BSA 
solution. Concentrations were determined graphically from the standard curve. IgG 
solutions purified by ammonium sulphate precipitation from crude sera as described 
above usually had concentrations of around I mg/ml. 
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Biolinylation of antibody molecules 
Antibodies were biotinylated using an Amersham Biotinylation Kit according to the 
manufacturers instructions. The protein was diluted with borate buffer (50 mM; 
pH8.6; final concentration 1 mg/ml) and 40 p1 biotinylation reagent (biotin-spacer 
arm N-hydroxysuccinimide ester in methyl formamide) per mg of protein added. The 
mixture was incubated 1 h at room temperature on a rotary wheel and then passed 
over an equilibrated (PBS, pH 7.5) G25-Sephatex column (10 ml bed volume). 
Fractions (0.5 ml) were collected and analysed by SDS-PAGE (10 p1/fraction). 
Fractions containing biotinylated IgG (two bands of 55 and 25 kD) were pooled and 
the concentration estimated from SDS-PAGE gels by comparing with standard 
amounts of BSA electrophoresed alongside the fractions. Biotinylated antibodies 
were usually stored at 4°C. 
SDS-polyacrylamide electrophoresis (PAGE) 
A Mini-Protean II gel apparatus (BioRad) was used to analyse proteins under 
denaturing conditions. Separating and stacking gel solutions were prepared as 
follows: 
Separating gel (12% w/v): Stacking gel (4% w/v): 
water: 	 3.35 ml 	6.1 ml 
1.5 M Tris-HCl, pH 8.8: 	2.5 ml 2.5 ml 0.5 M Tris-HCL, pH 6.8 
10%SDS: 	 100 p.1 	100 p.1 
acry l amide/bisacry lamidea : 4.0 ml 13 ml 
10 % w/v ammonium 	50 p.1 	50 p.1 
persulphate: 
Total volume: 	 10 ml (= 2 gels) 
a of a 30% w/v acrylamide, 0.8% bisacrylamide solution 
Prior to pouring the gels TEMED (10 p.1) was added in each case. Before 
electrophoresis of the samples, 4x sample buffer (0.15 M Tris pH 6.8, 1.4 M 3-
mercaptoethanol, 4% SDS, 20% glycerol, 5mM EDTA, 0.01% bromophenol blue) 
was added (final concentration lx; total volume 10-15 p.1) and the mixture boiled for 
5 mm. After loading the samples electrophoresis was performed in running buffer (25 
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mM Tris, 192 mM glycine, 0.1 % SDS; pH 8.8) at 0.4 mA and 250-300 V for -25 
mm. 
IV.B.2) 	Phage amplification, purification and analysis 
Large-scale preparation ofphage particles 
Overnight cultures (LB-medium containing tetracycline, 20 mg/ml; 1 litre) that had 
been inoculated with single colonies of phage-infected K9lKan E.coli cells were 
cleared by two centrifugation steps at 5000 rpm (Sorvall GS3 rotor) and 8000 rpm 
(Sorvall GSA rotor) for 10 mm. The phage particles were precipitated by adding 
PEG/NaC1 solution (0.15 volumes) to the cleared supernatant, mixing thoroughly by 
inversion and incubating for 16 h at 4°C. Phage were collected by centrifugation for 
30 min at 8000 rpm (Sorvall GSA rotor) and the solution decanted carefully. Pellets 
were resuspended in TBS (total of 30 ml per I original culture) and cleared by 
centrifugation at 15 000 rpm (Sorvall SS34 rotor). The dissolved phage were 
precipitated a second time by again adding NaC 1/PEG solution (0.15 volume) and 
incubation for at least 1 h at 4°C. Phage were collected by centrifugation at 10 000 
rpm (Sorvall SS34), pellets again dissolved in TBS (10 ml) and the solution cleared 
by centrifugation as above. 5.64 g of CsCl were weight in a new tube, the phage 
solution added and mixed. The total net weight was then adjusted to 18.2 g with TBS 
which provided about 14 ml of phage/CsCI solution with a density of 1.30 g/ml. The 
solution was centrifuged in 14 ml tubes at 37 000 rpm (Sorvall, TST 41.14 rotor), 
10°C for 60 h. After carefully removing the opaque band in the middle of the gradient 
(usually around 1 cm wide) and avoiding taking flocculent material from beneath the 
phage band, the phage solution was transferred to tubes for the TST60.4 rotor 
(Sorvall; 4.4 ml), topped up with TBS, mixed, and the phage pelleted by 
centrifugation at 45 000 rpm for 4 h at 10°C. This centrifugation step removes most 
of the remaining CsCl and can be repeated if very clean phage are required as, for 
example, for immunisation of animals. After the last centrifugation step the pellet 
was dissolved in TBS (3 ml per I original culture) containing 0.02% NaN 3 . The 
virion concentration of the solution was measured at 320 and 269 nm at a 1/100 
dilution in water and the concentration calculated using the formula A 769-A 370 x 6 x 
1016/92 kb. A typical concentration obtained by the purification method described 
here was about 10' virions/ml. 
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Titration ofphage as plaque forming units (p.fu.) 
For titering of plaque forming units, phage were diluted serially (usually to 10 -8 for 
an amplified and purified phage solution) in TBS containing gelatine (1 gIl) and 
aliquots of this dilution (100 tl) added to a suspension of K91Kan cells (400 p.1) 
grown to 0D 600 0.2 (1/10 dilution) in TB-medium from a 1/100 inoculation with an 
overnight culture. Melted soft agar (3 ml) was then poured into the tubes containing 
the phage dilution/host cell suspension, gently mixed and poured on L-agar plates 
containing kanamycin (100 mg/ml). The plates were incubated overnight at 37 0C and 
plaques counted the next day. 
Titration ofphage as transforming units ('t. u.) 
For titering of transforming units, phage were diluted serially as described above, 
aliquots (10 p.1) gently mixed with K91Kan cells (10 p.1) from a TB-culture grown as 
described above and then left for 10 min at room temperature to allow the phage to 
infect the E. coli cells. LB-medium (1 ml) containing tetracycline (0.2 p.g/ml) was 
added to the cell suspension and incubated 30-40 min at 37°C on a rotary wheel to 
allow expression of antibiotic resistance genes. Aliquots (200 p.1) were plated on 
agar plates containing tetracycline (40 p.g/ml) and kanamycin (100 p.g/ml) and 
incubated overnight at 37 0C. Colonies were counted the next day. 
Preparation of single-stranded phage DNA for sequence analysis 
Single-stranded phage DNA was prepared from 1.5 ml overnight cultures inoculated 
with single colonies of K9 1 Kan cells infected with phage derived from titering t.u.. 
Cells were removed by centrifugation at 11000 rpm for 5 mm (Heraeus Biofuge 15R, 
also all following centrifugations) and the clear supernatants poured into fresh tubes 
containing PEGINaC1 solution (0.15 volumes). Tubes were inverted 100 times and 
put on ice for 4h for precipitation of phage particles. Phage were collected by 
centrifugation at 11000 rpm, 10°C for 15 min and the PEGINaC1 solution carefully 
removed by aspiration. Pellets were redissolved in TBS (250 p1) and extracted once 
with phenol (200 p.1) and once with chloroformliso-amylalcohol (24:1; 200 p.1). DNA 
was precipitated by adding 1/10 volume sodium acetate (3 M, pH 5.2) and 2.5 
volumes ethanol to the aqueous phase. After vortexing the tubes were stored 
overnight at -20°C. DNA was collected by centrifugation at 11000 rpm, 4°C for 30 
min and the pellets washed with cold 70% ethanol. Pellets were dried in a desiccator 
and dissolved in water (20 p.1). Aliquots (8 p.1) were used directly for sequencing 
reactions. 
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Sequence analysis ofphage DNA 
Sequencing reactions were performed essentially after the dideoxy-mediated chain 
termination method (Sanger et al., 1977). 
Annealing mix: 
8 p1 single-stranded template DNA in water 
1 iil 1 M Tris/50 mM MgC1 2 
1 p.1 primer (OD 0.23, 5'AGT TTT GTC GTC TTT CC 3', complementary to fd-
phage genome downstream of the multiple cloning site) 
The annealing mixture was heated to 80 0C for 5 mm, briefly centrifuged and left to 
cool at room temperature. Aliquots (2 p.1) were then distributed to four wells of a 
microtiter plate for each sample analysed. To each well containing nucleotide mixes 
(order G, A, T, C; 2 p.1) reaction mix (2 p.1) was added: 
Nucleotide mixes (volumes in p.!): 
G A T C 
0.5mMdGTP 12.5 250 250 250 
0.5mM dTTP 250 250 12.5 250 
0.5mM dCTP 250 250 250 12.5 
10mM ddGTP 8 - - - 
10mM ddATP - 0.5 - - 
10mM ddTTP - - 25 - 
10mM ddCTP - - - 4 
TE 500 250 500 500 
Reaction mix (volumes are Der temDlate analysed): 
8 p.1 10mM Tris pH 8.0 
0.1p.l 1MDTT 
0.5 p.1 [CC- 35 S]dATP (10 p.Ci/p.l) 
1.5 U E. coli DNA polymerase I Kienow fragment (5 U/p.!) 
The reagents were gently mixed by tapping the plate and incubated at room 
temperature for 25 mm. Chase mix was added (0.25 mM dGTP, dATP, dTTP and 
dCTP in TE; 2 p.1) and incubation continued for a further 20 mm. The reaction was 
stopped by adding gel loading buffer [(0.1% (w/v) xylene cyanol, 0.1% (w/v) 
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bromophenol blue, 10 mM EDTA in formamide; 2 tl)]. For electrophoresis aliquots 
(2 iii) of each reaction were heated to 80 0C for 5 min and immediately loaded onto a 
6% denaturing polyacrylamid gel and the DNA fragments separated at 60 W in lx 
TBE on a S2 gel apparatus (BRL) for about 3-4 h. Gels were dried for 2 h on a gel 
dryer and autoradiographed overnight at -70 0C. 
Urea-polvaclamide gel solution (for 50 ml): 
7.5 ml acrylamide (40% w/v acrylamide/2.105 % w/v bisacrylamide) 
5.0 ml lOx TBE (90 mM Tris, 90 mM boric acid, 2 mM di-sodium EDTA) 
23 g urea 
250 tI ammonium persulfate (10% w/v) 
10 .tl TEMED 
Immuno dot blots with anti-fdphage rabbit serum 
Various dilutions of fusion phage particles (10 5 to 1010  particles in 50 p1 PBS) were 
blotted in four sets on nitrocellulose membrane (Costar) by using a Schleicher & 
Schuell dot blot apparatus. The membrane was blocked in blocking buffer (PBS 
containing 5 % w/v milk powder) for 90 mm, the membrane cut into strips each 
carrying one full set of phage dilutions and each strip incubated with different 
dilutions of anti-fd phage rabbit serum (1/100, 1/200, 11500 and 1/1000 in PBS 
containing 1% w/v milk powder) at room temperature for 2h. The membrane strips 
were washed twice for 10 min with PBS and incubated with alkaline phosphatase 
conjugated anti-rabbit IgG (diluted 115000 in PBS containing 1% w/v milk powder) 
for 2h at room temperature. After washing again as above the blot was developed 
using BCIP (50 mg/ml in water) and NBT (50 mg/ml in 70% v/v DMF). 
The detection threshold of phage particles with anti-phage serum was 108  particles. 
For use in indirect phage-sandwich ELISAs IgG molecules were purified from the 
anti-fd phage rabbit serum as described and used at 0.5 p.g/ml. 
IV.B.3) 	Biopanning procedures 
Amplification of the random hexapeptide phage-display library 
The phage library was received from Prof. G. Smith as an aliquot of an amplified 
library (Scott and Smith, 1990). To obtain sufficient material for biopanning 
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experiments the library was amplified further as follows: Two TB-cultures (50 ml) 
were inoculated with K9lKan cells of an overnight culture (0.5 ml) and grown to a 
density of 0D600 0.2 (1/10 dilution). Shaking was slowed down for 5 mm, the culture 
infected with the library (1012  physical particles; 4 p.1) and slow shaking continued for 
15 mm. Each pre-culture was poured into a fresh flask containing LB-medium (500 
ml) supplemented with tetracycline (0.2 p.g/ml) and incubated on the shaker for 35 
mm. The tetracycline concentration was adjusted by adding 0.5 ml (20 mg/ml stock 
solution) to each flask and incubation continued overnight. The following day 
aliquots of the culture were titred as t.u. (10- 5 dilutions) and the total number of 
infected cells for each culture determined. Phage particles contained in the overnight 
culture representing the amplified library were prepared as described for the large-
scale preparation of phage particles. 
Biopanning with polyclonal serum IgG and petri dishes as solid support 
3.5 cm petri dishes (Falcon) were coated overnight at 4°C with streptavidin (10 p.g in 
imi 0.1 M NaHC031  pH 8.6) and then blocked with blocking solution (0.1 M 
NaHCO3.; 5mg/ml BSA; 0.1 p.g/ml streptavidin) for 1 h at 4°C. Dishes were washed 
6 times with washing buffer (TBS/0.05% Tween 20) and then filled with washing 
buffer (400 p.1) containing BSA (1 mg/ml). For rounds 1 and 2 the streptavidin-
coated dishes were saturated with substrate by adding biotinylated, purified IgG 
molecules (30 p.1 containing around 10 p.g) to the solution and incubating 2 h at 4°C 
("Phage+LigateStreptavidin method"). After coating the plate remaining streptavidin 
binding sites were blocked by adding biotin (10 mM; 4 p.1) and further incubation for 
1 h. After washing the dishes as above, plates were filled with washing buffer (400 p. 
1) containing biotin (10 mM; 4 p.1) and the amplified phage library (5 p.!, 4 x 1010  TU; 
round 1 only) or amplified eluate (100 41 round 2 only; 1.5 x 1010  TU), respectively. 
Phage were incubated 4 h at 4°C with gentle agitation on a Bellydancer. After 
discarding the solution, dishes were washed 8 times with washing buffer at room 
temperature and bound phage eluted by adding elution buffer (400 p.1; 0.1 N HCl 
adjusted to pH 2.2 with glycine) and gently rocking for 10 min at room temperature. 
For round 3 ("PL+S method") 100 p.1 of amplified eluate from round 2 was incubated 
with 6-12 p.1 biotinylated substrate (around 2-4 p.g) in an Eppendorf tube overnight at 
4°C on a rotary wheel and then together with washing buffer (400 p.1 total volume) 
transferred to freshly streptavidin-coated and blocked dishes. After incubation for 10 
113 
IV. Materials and Methods 
min at room temperature dishes were washed and phage eluted as described above 
for rounds 1 and 2. 
Phage eluates were neutralised with Tris-HC1 (1 M, pH 9.5; 75 p.1). For amplification 
of phage contained in the first eluate (475 j.tl) the whole eluate was used and 
therefore was reduced to 100 p.1 by centrifugation in a Microsept spin filter with 160 
kD cut-off size (Sorvall SS34 rotor; 5000 rpm). For subsequent rounds only 100 p.! 
(21%) of the eluate was taken as input for the amplification. 
Biopanning with polyclonal serum IgG using paramagnetic Dynabeads® as solid 
support 
Streptavidin-coated magnetic beads (Dynal, M-280) were used as solid support to 
affinity select phage specific for polyclonal antibodies. The quantity of beads used 
here, had a surface area approximately that of 3.5 cm petri dishe, with a maximal 
binding capacity of 3 Vg biotinylated IgG molecules (according to the manufacturer's 
instructions). 
After washing the beads twice with PBS containing BSA (0.1% wlv), using a 
magnetic concentrator (Dynal, MPC-E), the equivalent of 30 p.! original bead 
suspension was coated with biotinylated substrate (5 p.g purified IgG) according to 
the manufacturer's instructions for 30 min at room temperature. The substrate-coated 
beads were blocked by adding biotin (10 mM; 0.5 p.!) to the coating solution and 
continuing incubation at room temperature for 1 h. Beads were washed 4-5 times as 
above. Input phage for the biopanning were either the phage library (5 p.1 round 1; 
3.6 x 1010  TU) or amplified eluates (100 p.1 round 2 and following). The total volume 
of the beads and phage suspension was adjusted with PBS containing BSA (0.1% 
w/v; final volume 250 p.1) and incubated for 4 h at 4°C. Beads were then washed 6 
times with PBS containing Tween 20 (0.05% v/v) and the bound phage eluted with 
elution buffer (50 p.1) for 10-15 min at room temperature. Eluates were neutralised 
with Tris-HC1 (1 M, adjusted to pH 2.2 with glycine; 10 p.!) and phage amplified and 
titered. Due to the smaller volumes of the eluates using this method there was no 
need to concentrate the first eluate prior to amplification. 
Biopanning with monoclonal antibodies using microwells as solid support 
Wells of a 96-well ELISA plate were coated with purified monoclonal antibody (1 p. 
g/ml in 0.2 M ammonium bicarbonate buffer, pH 9.6; 200 p.!) overnight at 4 0C and 
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then blocked for 2 h with TBS containing Tween 20 (0.05% v/v) and BSA (1%). 
After washing with TBS containing Tween 20 (0.05% v/v) and BSA (0.1%), the 
phage (5 jtl containing 10 t.u. phage library for round 1; 50 .tl amplified eluate for 
following rounds) in TBS containing BSA (0.1% w/v; 50 .il total volume) were 
incubated in the wells for 4 h at 4°C. Wells were washed 10 times with the same 
buffer as before and the bound phage eluted with elution buffer (50 d) for 10 min at 
room temperature. The eluates were neutralised with 1 M Tris-HC1, p1-I 9.5 (10 tl) 
and phage amplified and titered. 
Amplification and titration ofphage contained in eluates of biopanning experiments 
(output phage) 
Whole or concentrated eluates (100 i.l) were gently mixed with K91 Kan cells (100 ji 
1) from a TB-culture grown to 0D 600 0.2 (1/10 dilution) and incubated for 10 min at 
room temperature. The suspension of infected E.coli cells was then added to LB-
medium (20 ml) containing tetracycline (0.2 p.g/ml) in an Erlenmeyer flask and 
incubated on a shaker at 37 0C for 30 mm. Afterwards, an aliquot (lOp.l) was 
removed from the culture for titration of output phage and tetracycline added (20 tl 
of a 20 mg/ml stock solution). Incubation was continued overnight. Phage titres of 
the aliquot taken from the culture were determined as t.u. as described above and the 
total number of phage contained in the 20 ml culture before amplification calculated. 
Amplified phage were prepared from the overnight culture by two precipitations with 
NaCl/PEG solution as described above for the large-scale purification and dissolved 
in TBS (200 tl) containing NaN3 (0.02% v/v). 
IV.B.4) 	Analysis of individual phage 
Phage binding assay on solid phase (input-output relationship) 
U-shaped wells of polystyrene strip plates were coated with MAb (1 1g/ml in 0.2 M 
ammonium bicarbonate buffer, pH 9.6; 200 .tl) overnight at room temperature, 
washed three times with TBS and blocked for 2 h at room temperature by adding 
TBS containing BSA (1 Omg/ml; 200 p1). After three further washes the wells were 
filled with various concentrations of purified phage particles (10 to 1010  p.f.u.; 200 
p1) diluted in TBS containing BSA (0.2 mg/ml) and NaN 3 (0.02% v/v) and incubated 
for 1 h at 4 °C. Each phage concentration was assayed in triplicate. After one hour the 
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phage solutions were removed from the wells and plates were then washed 10 times 
with the buffer used above and bound phage eluted with elution buffer (200 jl). The 
amount of phage recovered from each well was determined by titration as p.f.u. and 
plotted against the amount of input phage per well. 
Phage binding assay over time (time course experiments) 
For these experiments five identical sets of plates were prepared with coating 
conditions as above and the input phage concentrations kept constant (10 8 p.f.u./well; 
200 t1). Each plate represented a point on a time course with incubation times of 10, 
31,100, 316 and 1000 mm (corresponding to half log intervals). After each 
incubation period the relevant plate was washed as described above, the bound phage 
eluted and the titer of the eluate determined as p.f.u. The amount of phage recovered 
from each well was plotted against the time of incubation. 
Determination of relative dissociation constants (KDre9 for the interaction of phage 
with monoclonal antibodies in solution 
This procedure was adapted from Friguet et al. (1985). Step I involved incubation of 
a constant concentration of purified phage particles with variable amounts of MAb 
18/7 until equilibrium was reached: MAb 18/7 at various concentrations (0.32 to 30 
nM in TBS and one blank sample containing buffer only; measurements for each 
MAb concentration were made in triplicates) was mixed with a constant amount of 
phage [108  p.f.u./ml, in TBS containing BSA (0.2 mg/ml) and NaN 3 (0.02% v/v)] 
and incubated for 18 hr at 4°C in a water bath. Step II was to determine the number 
of unbound phage remaining in the solution after 18 h. For this, an aliquot (1 OOp.l) of 
each mixture was transferred to the wells of a U-shaped well polystyrene strip plate 
that had been coated with MAb as described above. After 1 hr at 4 °C the wells were 
washed 10 times with TB S, supplemented with BSA (0.2 mg/ml). Bound phage were 
eluted with elution buffer (200tl) and quantitated by titration of p.f.u. 
For the determination of the K DreI values two methods were used: 
1.) The mean of the values of one set of triplicates from one or several experiments 
representing the number of phage remaining in solution at equilibrium for a certain 
MAb concentration was determined and the percentage of free phage remaining in 
solution calculated with the number obtained for the well in the absence of MAb (set 
at 100%). Percentages were then plotted against the concentration of MAb (added in 
step 1) and a curve fitted to these points using the least square curve fitting option 
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contained in the Sigma Plot Graph plotting program (see Fig. 11.5). The concentration 
of MAb at which 50% of the total amount of phage remain unbound at equilibrium 
equals the KD'  value (the theoretical background is described in Results section 
II.A.3)). 
2.) The number of free phage remaining in solution at various MAb concentrations 
allows calculation of the concentration of all other reactants in the equilibrium given 
that the input titers and the input concentrations were known. With these figures a 
plot can be generated according to the Scatchard equation with the slope of the plot 
yielding the K01.eI  value (the theoretical background is described in Results section 
iI.A. 3)). 
Indirect phage -sandwich enzyme-linked immunosorbent assay (ELISA) using anti-fd 
phage antibodies 
Wells of ELISA microplates were coated overnight at room temperature with 
purified polyclonal serum IgG [100 ng in ammonium bicarbonate buffer (0.2 M, pH 
9.6; 100 tl)]. The coating solution was removed, the wells washed once with 
washing buffer (TBS, 0.05% v/v Tween 20) and blocked for 90 min at room 
temperature with blocking buffer (TBS, 5% w/v dry milk powder; 200 p.!). The wells 
were washed three times with washing buffer and the phage solution added to the 
wells (10" p.f.u. in TBS, 1% w/v milk powder; 100 p.!). The phage were either 
purified by centrifugation in CsC1 gradient or where large numbers of phage were 
screened, crudly purified by one PEG precipitation and dissolved in 1/10 of the 
original culture volume. The phage solutions were incubated in the wells at 4°C 
overnight. Next day the wells were washed three times as above at 4 0C and then 
incubated with rabbit anti-fd phage antibodies (purified IgG, 0.5 p.g/rnl in blocking 
buffer; 100 p.!) for 2 h at 4°C. Wells were washed again as above and incubated with 
alkaline phosphatase-conjugated goat anti-rabbit IgG antibodies (diluted 115000 in 
blocking buffer; 100 j.il). The wells were washed again as before, slammed on a pile 
of paper towels to remove traces of liquid and substrate added (pNPP 1 mg/rnl in 
diethanolarnine, 10 mM, pH 9.6; 100 p.!). The assays were developed at room 
temperature for 1 h. The reaction was stopped by adding EDTA (0.1 M; 100 p.1) and 
the optical densities determined by reading on a Dynatech® plate reader at 405 nm. 
Blank wells for calibration contained substrate and stop solution only. All ELISA 
assays were carried out in duplicate. 
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Competition experiments by indirect phage-sandwich ELISA using synthetic peptides 
The binding of phage particles to wells coated with purified polyclonal serum IgG 
was competed by addition of synthetic peptides with various amino acid sequences. 
The assay was performed as described above except that the phage solution 
additionally contained synthetic peptides at variable (10-7  to  10-3  M) or constant 
concentrations (10 -3 M). Peptides were freeze dried after analysis and then dissolved 
in water to make up defined stock solutions. Since P2 was extremely hygroscopic the 
precise peptide concentration was determined after dissolving the peptide in water by 
amino acid analysis of a hydrolysed peptide aliquot, kindly performed by M. Daniels 
and Prof. R.P. Ambler, ICMB, University of Edinburgh. 
IV.B.5) 	Immunisation of rabbits with phage particles 
Fuse5 based fusion phage purified by CsC1 gradient centrifugation (Smith and Scott, 
1993) and dissolved were used directly as immunogens. Two rabbits per immunogen 
were injected three times in four week intervals in the legs and ears with diluted 
phage solution (100 p1, 1.7 x 10 12 particles in PBS). Serum from the third test 
bleeding (two weeks after third injection) was tested for reactivity with fd phage 
particles by performing immuno dot blots with various dilutions of phage particles 
(IV.B.2, p.112). IgG molecules were purified as described in IV.B.1. The 
immunisations were carried out by Glynis Leadbetter of the Department of Medical 
Microbiology, University of Edinburgh. 
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Identification of polyclonal serum specificities with phage-display 
libraries 
Volker Germaschewski and Kenneth Murray 
Institute of Cell and Molecular Biology, University of Edinburgh, King's Buildings, 
Mayfield Road, Edinburgh EH9 3JR, UK 
I Virol. Methods (1996), in press 
Abstract: 
A random hexapeptide fusion-phage library was screened to isolate phage that bound 
antibodies in a serum induced by hepatitis B virus surface antigen (lE-IBsAg). Analysis 
of the isolated phage and comparison with their displayed peptide sequences with the 
primary sequence of HBsAg revealed areas where 3 and 4 amino acid matches 
accumulated. Differential binding studies of individual phage clones with immune 
and pre-immune sera identified phage carrying sequences that matched with region 
117-122 of HBsAg which may represent a linear epitope or part of a larger antigenic 
determinant. Synthetic hexapeptides representing this region competed for binding 
with the matching phage clones. 
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Screening a Monoclonal Antibody With a 
Fusion-Phage Display Library Shows a Discontinuity 
in a Linear Epitope Within PreSi of Hepatitis B Virus 
Volker Germaschewski and Kenneth Murray 
Institute of Cell and Molecular Biology, University of Edinburgh, Edinburgh, Scotland, UK 
The epitope recognized by the monoclonal anti-
body MA18/7, specific for the PreSi-domain of 
the hepatitis B virus surface antigen, has been 
defined precisely by means of a library of fusion-
phage carrying random hexapeptides on the tip 
of filamentous phage fd particles. Phage, iso-
lated after only one round of affinity selection, 
displayed hexapeptides showing strong conser-
vation of the PreSi primary sequence in the re-
gion 19-23 with three noncontiguous residues, 
DP (20 and 21) and F (23) appearing in phage that 
bound the antibody. The importance of these 
core residues was supported by comparing the 
antibody binding of individual phage in solution, 
which provided relative dissociation constants 
for these interactions. Replacement of F (23) by Y 
was the only substitution observed in the three 
core residues, and resulted in somewhat weaker 
binding. Synthetic tetra- and hexapeptides con-
taining these key residues inhibited the reaction 
between the phage and the antibody. 
© 1995 Wiley-Liss, Inc. 
KEY WORDS: random-peptide library, fd 
phage, biopanning, HBsAg 
INTRODUCTION 
The region of an antigen which binds to a specific 
antibody, usually termed an epitope, may be defined by 
a short sequence of amino acid residues (linear 
epitopes), or the site may be more complex and involve 
the juxtaposition of residues that are well separated 
from each other within the linear sequence (conforma-
tional epitopes). Definition of the amino acid residues 
that constitute an epitope is of fundamental importance 
to immunological studies and to the design and devel-
opment of vaccines and the evaluation of their effective-
ness. Where the amino acid sequence of an antigenic 
protein is known, synthetic oligopeptides representing 
parts of this sequence have frequently proved to be 
valuable reagents for the location of regions that consti-
tute or contain epitopes for a particular antibody or 
antiserum. Such studies have helped to locate linear 
0 1995 WILEY-LISS, INC. 
and conformational epitopes in the antigens of hepati-
tis B virus (HBV) [Gerin et al., 19831. 
The surface antigen (HBsAg) of HBV may contain 
three polypeptides termed S (small), M (middle), and L 
(large), which result from the variable use of three start 
codons within the open reading frame of the surface 
antigen gene. The L polypeptide begins with the PreSi 
region (108 amino acids), followed by the PreS2 domain 
(55 residues) and the amino acid sequence of S (226 
residues). The M polypeptide comprises the PreS2 se-
quence as its N-terminal region, followed by the S se-
quence. S is the most abundant product and occurs in 
glycosylated and nonglycosylated forms. M and L also 
occur in differentially glycosylated forms. In addition to 
its presence in the viral envelope, HBsAg is found in 
large quantities in the serum of infected individuals as 
both spherical and filamentous particles, and propor-
tions of the L, M, and S polypeptides in these three 
forms differ appreciably. Both polyclonal and mono-
clonal antibodies have been identified against immuno-
logical determinants in the domains PreSi, PreS2, and 
S of HBsAg, and studies with synthetic peptides have 
identified several distinct determinants including com-
ponents of conformational epitopes in S (summarized 
by Ashton-Rickardt and Murray [1989]; see also Germ 
et al. [19831). Heermann et al. [1984] found that the 
monoclonal antibody (MAb) MA 18/7 specifically recog-
nizes the PreSi domain, and therefore interacts only 
with the L polypeptide. They also showed that the only 
observed amino acid change between different HBV 
serotypes, glycine to arginine at position 24 of PreSi, 
was tolerated without reducing antibody binding. 
Coursaget et al. [1991] mapped the epitope recognized 
by this MAb to residues 18-25 (QLDPAFRA). Somin-
skaya et al. [1992] then used progressive deletions 
around this sequence to show that the central tetrapep-
tide DPAF constituted the epitope recognized by 
MA18/7. 
Accepted for publication August 23, 1994. 
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In the work described here, fd-fusion phage that bind 
specifically to MAb MA18/7 were isolated from a ran-
dom hexapeptide phage-display library [Scott and 
Smith, 1990]. This essentially unbiased approach has 
proved to be very powerful for determining native 
epitopes recognized by MAbs [Scott and Smith, 1990; 
Cwirla et al., 1990; Felici et al., 1991; Stephen and 
Lane, 19921, but may also identify new, apparently un-
related sequences, or mimotopes, which can open new 
vistas in terms of targets (such as components of confor-
mational epitopes) for existing antibodies [Scott and 
Smith, 1990; Christian et al., 19921. The results show 
that the phage-display method can provide a very sim-
ple route to high-resolution mapping, which yields in-
formation about the contribution of individual amino 
acids to the binding of the antibody which could not be 
obtained as readily with most methods based upon syn-
thetic peptides or deletion analysis. In this specific case 
the phage isolated from the library carry sequences 
that lie within the region DPAF (PreSi aa 20-23), iden-
tified by Sominskaya et al. [19921, but not all of these 
amino acids are necessary for binding MA18/7. Fur-
thermore, we have shown that the system can be used 
quite simply in a quantitative mode to measure relative 
affinities of a MAb for different peptide sequences. The 
identity of the epitope was confirmed by quantitative 
studies, showing that binding of the cloned fusion 
phage to the MAb was inhibited by synthetic peptides 
carrying the core epitope sequence. 
MATERIALS AND METHODS 
Monoclonal Antibody and Fusion 
Phage-Display Library 
The MAb MA18/7 was a gift from Dr. K.H. Heer-
mann and Prof. W. Gerlich, University of GOttingen, 
Germany. 
The phage-display library was amplified from a pri-
mary library, consisting of approximately 2 x 10 8  inde-
pendent transformants, and was generously given to 
us by Prof. G.P. Smith, University of Missouri, Colum-
bia, MO. 
Biopanning Procedure 
Wells of an ELISA plate (Corning) were coated with 
MAb MA 18/7(1 p.g/ml in 0.2 M ammonium bicarbonate 
buffer, pH 9.6; 200 p.!) overnight at 4°C, and then 
blocked for 2 hr with TBS (0.05 M tris-HC1, pH 7.5, 0.15 
M NaC1) containing Tween-20 (0.05%) and bovine se-
rum albumin (BSA; 1%). After washing with TBS con-
taining Tween-20 (0.05%) and BSA (0.1%), the phage 
library (5 p.!; 10' ° transforming units (t.u.) or 50 p.l of 
amplified eluate for rounds 2-4) in TBS containing 
BSA (0.1%; 50 p.1 total volume) was incubated in the 
wells for 4 hr at 4°C. The wells were washed 10 times 
with the same buffer as before, and the bound phage 
were eluted with elution buffer (0.1 N HC1, adjusted to 
pH 2.2 with glycine; 50 p.!) for 10 min at room tempera-
ture. The eluates were neutralized with 1 M tris-HC1,  
pH 9.5 (10 p.l), and amplified by gently mixing the 
eluate (60 p.l) with a suspension of K91Kan cells (60 pA) 
at 0D600  (optical density) 0.2 (1/10 dilution), and leav-
ing it for 10 min at room temperature. The cells were 
suspended in 20 ml LB (Luria-Bertoni) medium con-
taining tetracycline (0.2 mg/ml) and incubated at 37°C 
for 45 mm. Tetracycline (20 mg/ml; 20 pA) was then 
added, and an aliquot (10 pA) removed for titration as 
t.u. [Smith and Scott, 1993b]. Incubation was continued 
overnight. Phage particles were purified the following 
day as described by Smith and Scott [1993b]. 
Titration of Phage as Plaque-Forming 
Units (p.f.u.) 
For the titration of plaque-forming units (p.f.u.), 
phage were diluted serially (usually to 10-8  for an am-
plified phage solution) in TBS containing gelatin (1 g/l) 
and aliquots of this dilution (100 pA) added to a suspen-
sion of K91Kan cells (400 p.!) at 0D 600 0.2 (1/10 dilu-
tion). Melted soft agar (3 ml) was then poured into the 
tubes containing the phage dilution/host cell suspen-
sion, and poured onto agar plates containing kanamy -
cm (100 mg/ml). The plates were incubated overnight 
at 37°C, and plaques were counted the next day. 
Sequence Analysis of Phage DNA 
fd-DNA (single-stranded) was prepared from 1.5 ml 
overnight cultures of K91Kan cells infected with indi-
vidual colonies essentially as described by Sambrook et 
al. [1989]. 
Half of the DNA was used for sequencing with the 
dideoxy-mediated chain termination method [Sanger 
et al., 19771, using Klenow DNA-polymerase (NBL 
Gene Sciences Ltd., Cramlington, UK) and the primer 
(5'AGT TTT GTC GTC TTT CC 3'; synthesized by 
Oswel DNA Service, Dept. of Chemistry, University of 
Edinburgh). 
Binding Assay in Solution Between Individual 
Phage and MAb MA18/7 
This procedure was adapted from Friguet et al. 
[1985]. Each assay was carried out in triplicate. Each 
phage used in the assay was purified from the superna-
tant of a 500 ml overnight culture of infected K91Kan 
cells [Smith and Scott, 1993b]. Purified phage (2 x 10 9 
p.f.u./ml; 200 pA) were then incubated with various con-
centrations of MAb MA 18/7 (final concentrations rang-
ing from iO-iO M) in TBS containing BSA (0.2 
mg/ml) overnight at 6°C (total volume, 400 RI). The 
concentration of free phage remaining in solution at 
equilibrium was determined for each sample contain-
ing different concentrations of MA 18/7, by transferring 
the phage[MAb mixture (100 pA containing approxi-
mately 10 8 p.f.u.) to microtiter wells (Costar strip 
plates, high capacity) coated with MA18/7 (as described 
above). After incubation for 1 hr at 6°C, the wells were 
washed extensively and the phage particles eluted as 
described above, and titered as p.f.u. 
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Fig. 1. Hexapeptide sequences displayed on phage isolated from 
selection rounds 1, 2, and 4. The experiment with MA18/7 and the 
random phage library is described in Materials and Methods. The bold 
box represents the residues of PreSi defined as the binding site for 
MA18/7 by Coursaget et al. [19911. The amino acids within the thin  
boxes are the conserved residues with respect to residues in the PreSi 
sequence; the hexapeptides labelled as "no matches" are from round 1, 
and display no obvious consensus with the PreSi region examined 
here. 
Competition Experiments With 
Synthetic Peptides 
Phage particle concentration was adjusted to a titer 
of 4 x 109 p.f.u./mi in TBS containing BSA (0.2 mg/ml). 
Aliquots of the phage solution (50 i1) were mixed with 
serial dilutions (50 [iI) of the synthetic peptides (final 
concentration ranging from 10_6_10_11 M for P1, and 
from 10-~-10-9 M for P2 and P3, diluted in TBS con-
taining BSA (0.2 mg/ml)) and transferred to microtiter 
wells coated with MA18/7 as described above. After 
incubation for 90 min at 6°C, the wells were emptied 
and washed and the phage eluted as described above. 
Phage titers were determined as p.f.u., as described 
above. 
The peptides were synthesized in the Department of 
Chëmitry of the University-of-Edinburgh (forwhch 
we thank Prof. R. Ramage), and had the following  
amino acid sequences: P1) LDPAFR, P2) DPGF, and 
P3) ALLTRILG. Due to its very hygroscopic nature, the 
concentration of P2 was determined after dissolving it 
in TBS by amino acid analysis of the hydrolyzed pep-
tide, as kindly carried out by M. Daniel and Prof. R.P. 
Ambler, ICMB, University of Edinburgh. 
RESULTS 
Biopanmng the Fusion-Phage Library With the 
MAb MA18/7 
About a dozen phage-transformed E. coli colonies iso-
lated from the eluates from each of four successive 
rounds of affinity selection and amplification (biopan-
ning) were analyzed by sequencing the insert in gene 
ifi of the phage genome. Figure 1 shows that after only 
one round of biopanning, almost 50% of the phage ana-
lyzed ariedpeptidescorresponding with-three or four 
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TABLE I. Characteristics of the Four Phage Chosen for the Affinity Assay in Solution 
Sequence of Conserved KD .et 
hexapeptide residues at 6°C 
Phage no. 	inserta out of 6 Comment (nM) 
E2-12 ALDPAY 4 F (23) subst. by Y 0.8 
E2-14 	SLDPGF 4 Core motif + L (19) 0.3 
E4-2 PDPGFN 3 Core motif only 0.2 
E4-4 	QLDPGF 5 Frequent substitution of G 0.2 
for A (22) 
'The bold type identifies residues that occur in the PreSi sequence. 
residues of the sequence LDPAF of PreSi (aa 19-23) 
with the dipeptide DP present in all of the matching 
sequences. In fact, DP was conserved throughout all the 
phage analyzed from rounds 2 and 4. The phenylala-
nine (F) at residue 23 was also strongly conserved with 
a conservative substitution by tyrosine (Y) in two cases. 
Alanine (A) at residue 22 was only present in 45% of the 
phage examined, but was otherwise replaced by amino 
acids with small side chains such as glycine (G), valine 
(V), and serine (S). 
Figure 1 depicts the alignment of the hexapeptide 
sequences displayed by individual phage with the 
amino acid sequence of PreSi in the region identified as 
the epitope for MA1817 by Coursaget et al. [19911 (bold 
box). The matching residues in the various phage lie 
within this sequence, but there was no conservation of 
the alanine at residue 25, and residues 18 and 24 (Q and 
R, respectively) were present in only two or one of the 
phage, respectively. 
Affinity Assays in Solution 
The relative dissociation constants (KDreI) for four of 
the isolated phage (Table I) were measured to compare 
the binding affinity of phage with different residues in 
the hexapeptide from those in the native PreSi se-
quence. 
The KDreI values were determined from curve-fitting 
plots of the proportion of unbound phage at various 
antibody concentrations (Fig. 2) which gave the values 
shown in Table I, column 5. All were in the nM range 
for the temperature chosen for the experiment (6°C). 
The differences between the four phage analyzed are 
small. E4-4 had the largest number of amino acids 
(five), corresponding to the PreSi primary sequence, 
and had one of the lowest KD­ 1  values. Phage E2-14, 
E4-2, and E4-4 all had similar KDreI values, but phage 
E2-12, which represents the two phage where residue 
23 (F) is not conserved, had the highest KDre, i.e., the 
lowest affinity. These values emphasize the relative 
unimportance of residues 18(Q) and 19 (L) for the bind-
ing of the antibody. 
Competition Experiments With Synthetic 
Peptides and Phage Specific for MA 18/7 
The hexapeptide P1 covered six conserved amino ac-
ids at the center of the epitope (LDPAFR). Parts of this 
sequence occurred among all the phage analyzed (Fig. 
1). P2 was a tetrapeptide that had only the three con-
served amino acids D, P, and F from the PreSi se- 
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Fig. 2. The graphs show the percentage of free phage remaining in 
solution after incubation with various concentrations of MA18/7 in 
solution at 6°C, as described in Materials and Methods. The percent-
age of free phage remaining in solution at equilibrium is plotted 
against the concentration of the MAb in solution (aM; no MAb 
added = 100% free phage); the curves were then fitted to the points 
using the hyperbolic least square curve-fitting option (Marquardt-
Levenberg algorithm [Marquardt, 19631) of SigmaPlot (Jandel, 
Erkrath, Germany), and the KDrOI values were derived as the parame-
ter of this process. The plots shown represent data of two experiments 
performed for each of the four individual phage from Table I. 
quence, with the A at position 22 replaced by G. P3 was 
an octapeptide of unrelated sequence. 
These peptides were used as competitors for binding 
to MAb MA 18/7, with cloned phage isolated after the 
biopanning procedure. Phage E4-4 was incubated with 
various amounts of the synthetic peptides in microtiter 
wells coated with the MAb (see Materials and Meth-
ods). Figure 3 shows the effects of increasing concentra-
tions of competing peptide on the binding of this phage 
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Fig. 3. The graph shows the competition between a standard con-
centration of phage and various concentrations of peptides P1, P2, and 
P3 for binding to the MAb MA18/7, as described in Materials and 
Methods. The percentage of phage eluted from the wells is plotted 
against the concentration of peptides added as competitors (no peptide 
added = 100% phage eluted). p.f.u., plaque forming unit. 
At concentrations above 10-8  M, peptide P1 strongly 
inhibited the binding of the phage to the antibody and 
completely abolished it at 1 M (Fig. 3). Similar results 
were obtained with other phage displaying fewer amino 
acids of the PreSi sequence (data not shown). The tet-
rapeptide P2, representing the core motif DPGF of the 
PreSi epitope, was less effective in competing for bind-
ing, and concentrations above 1 1iM were needed 
to reduce phage-binding substantially, but at 0.1 mM, 
phage-binding was reduced to less than 10%. The octa-
peptide P3, used as a negative control, showed no such 
inhibitory effects even at the highest concentration. 
DISCUSSION 
The purpose of this study was to define precisely the 
amino acids within the PreSi sequence of HBV which 
are essential for binding the monoclonal antibody 
MA18/7. A fusion-phage library consisting of hexapep-
tides displayed on the tip of filamentous phage particles 
was used to provide an unbiased and unconstrained 
survey of the residues involved in binding the MAb. 
The results were compared with those from the study 
by Coursaget et al. [1991], with overlapping hexapep-
tides spanning amino acids 12-53 (i.e., 1-42 of PreSi as 
used here), which located the epitope within residues 
18-25 (QLDPAFRA) of PreSi, and with those from 
Sominskaya et al. [1992], who used progressive dele-
tions in the coding sequence for PreSi to express a 
series of PreSi peptides with deletions flanking the 
epitope, which was thus located within residues 20-23 
(DPAF). 
In the experiments described here, phage were iso-
lated after only one round of affinity selection, which 
showed three highly conserved residues corresponding 
with the PreSi sequence which are critical for efficient 
binding to the antibody. This minimal core motif of 
residues 20 (D), 21 (P), and 23 (F or Y) was conserved in 
all -phage examined, and these residues - are therefore 
Germaschewski and Murray 
believed to make direct contact with the antibody. 
Neighboring amino acids showed little or no conserva-
tion, and therefore probably have little influence on 
antibody binding. While 20 (D) and 21 (P) were invari-
ant, a conservative substitution was observed for the 
other key residue 23 (Y for F). Residue 22 (A), between 
the core residues 21 and 23, allowed a wider range of 
substitution by other amino acids with small neutral 
side chains, and may therefore serve to maintain the 
correct spacing for the key residues in the presented 
peptide, while not necessarily interacting directly with 
the MAb. 
This high-resolution mapping of residues directly in-
volved in binding could not be achieved by using over-
lapping peptides of the same length [Coursaget et al., 
19911, or by more complex studies using deletions in the 
coding sequence cloned into the RNA bacteriophage fr 
expression vectors [Sominskaya et al., 19921. While 
complex omission- and alanine-substitution analysis of 
the critical residues recognized by another MAb gave 
comparable resolution [Appel et al., 19901, the result 
described now was obtained readily from the conserva-
tion of amino acids observed within a relatively small 
number of phage analyzed. 
The relative dissociation constants for four of the 
cloned phage that bound the antibody (Fig. 2 and Table 
I, column 5) gave quantitative support to the definition 
of the amino acids that constitute the epitope. Substitu-
tion of the phenylalanine residue (23) by tyrosine low-
ered the strength of binding slightly, and phage E4-2, 
which carries only the core motif D, P, and F at residues 
20, 21, and 23, respectively, had essentially the same 
KDrI as phage E4-4, which has two additional residues 
in common with the sequence that occurs in PreSi. The 
contribution of residues Q (18) and L (19) therefore can 
be, at best, only very small. The dissociation constants 
in Table I were obtained from measurements of the 
titer of phage eluted from antibody bound to a solid 
phase after equilibration with various concentrations 
of the antibody in solution, as described in Materials 
and Methods. 
The competition studies with synthetic peptides (Fig. 
3) showed that a hexapeptide (P1) with all six amino 
acids corresponding to the PreSi epitope is an effective 
competitor against phage E4-4, which has the most con-
served amino acids (five, QLDP and F). The IC 50 of the 
interaction of this peptide with the MAb is about an 
order of magnitude less than the K 0re for phage E4-4. 
The shorter peptide carrying the three highly con-
served residues (P2) also competed effectively with 
phage E4-4 for the MAb, but at a substantially higher 
concentration (IC 50 , about 10 riM), whereas an octapep-
tide of unrelated sequence showed no inhibition, even 
at 0.1 mM. Stereochemical factors of one form or an-
other may well contribute to the relatively high concen-
trations of the peptides required to compete effectively 
with the fusion phage for the antibody binding sites; 
this has also been observed by others [Smith et al., 
1993a; Yayon et al., 19931. The phage filaments have a 
number (probably three or five) copies of the hexapep- 
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tide at their tip which may all bind with antibody mol-
ecules in close proximity to each other on the solid 
phase, and so give an enhanced binding affinity for the 
phage in relation to that of the free peptide. The free 
peptides may also occupy a larger population of confor-
mations than their counterparts in the fusion phage, 
giving a lower effective concentration of a favorable 
conformation for interaction with the antibody. The 
need for a higher concentration was enhanced further 
when the tetrapeptide, P2, was used in the experiments 
described here, and might be a further reflection of the 
role of undefined stereochemical factors. But it could 
also reflect, in part, weak contributions of the addi-
tional residues of the larger peptide, or perhaps, more 
Probably, destabilizing effects of charged residues at 
the two termini of the smaller peptide in close proxim-
ity to the binding site [Smith et al., 1993a]. Despite 
these effects it could be demonstrated that a peptide 
containing as few as three critical amino acids is suffi-
cient for specific interaction with the MAb. 
The results described here define the residues within 
the PreSi sequence which are conserved within all the 
fusion phage analyzed which bind to the monoclonal 
antibody MA18/7, and in contrast to other work [Cour-
saget et al., 1991; Sominskaya et al., 1992] are able to 
distinguish between residues within a core motif essen-
tial for binding. The conclusion is that even in this case 
where the residues previously identified would proba-
bly be considered as a "linear epitope," the critical resi-
dues for binding are not contiguous in the primary se-
quence. 
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ABSTRACT 
Studies of interactions between filamentous fusion 
phage particles and protein or nucleic acid molecules 
have gained increasing importance with recent suc-
cesses of screening techniques based upon random 
phage display libraries (biopanning). Since a number 
of different phage are usually obtained by biopanning, 
it is useful to compare quantitatively the binding 
affinities of individual phage for the substrate used for 
selection. A procedure is described for determination 
of relative dissociation constants (K,4ReI) between 
filamentous phage carrying peptide fusions to the coat 
protein gplll and substrates in solution. This novel 
method is based on the measurement of phage titres. 
Phage selected from a random fusion phage library for 
binding to a monoclonal antibody or a viral structural 
protein exhibited Kd Rei  values in the nanomolar and 
micromolar ranges for their respective substrates, 
thus validating the method over a wide range of 
binding affinities. 
INTRODUCTION 
Libraries of phage displaying random peptide sequences are 
being used increasingly to identify sequences that interact 
specifically with a particular protein or nucleic acid. In some 
instances the substrate used for screening the library has been a 
monoclonal antibody and the system has been used for epitope 
mapping (1). The method can give very high resolution, defining 
the specific amino acids involved in binding the antibody (2). 
However, the power of the random approach lies in the discovery 
of amino acid sequences that bind to proteins or specific nucleic 
acid sequences about which little or nothing is known of potential 
binding sites (3-8). In such cases, ligands isolated from the 
library frequently show little or no primary sequence motifs of 
any known proteins. These so-called mimotope sequences 
presumably resemble the structure of a potential binding site and 
therefore bind the protein (9). 
To identify mimotopes as specific ligands and subsequently 
compare them with other sequences in terms of affinity for the  
substrate used in screening it is necessary to examine the 
interaction quantitatively as well as qualitatively. The method 
described here provides direct comparison of the binding affinity 
of different phage for a substrate in solution without the need to 
synthesize peptides. That the assay is performed in solution is 
crucial, since the conformation of a protein can change on binding 
to a solid phase, with a resulting change of binding affinity (10). 
We have used two groups of phage that were isolated from a 
random phage display library by screening with: (i) a monoclonal 
antibody specific for the PreS 1 domain of the surface antigen of 
hepatitis B virus (HBV); (ii) a structural protein from the 
nucleocapsid of HBV, to determine the relative dissociation 
constants (Kd' 1) for the interactions between the phage particles 
and their target proteins in solution. All phage were previously 
identified as specific ligands for the proteins used for screening 
the library and the selection procedures have been described 
elsewhere (2,8). The essential features of the method are that the 
substrate is incubated with the phage in solution until equilibrium 
is reached and the amount of unbound phage remaining in 
solution is then determined by adsorption on a solid phase coated 
with the substrate. The adsorbed phage are then eluted from the 
solid phase and titred, representing a value proportional to the free 
phage in the solution of the reactants at equilibrium. The titration 
of infective units (plaque forming units, p.f.u.) thereby offers a 
sensitivity that could not be achieved with most other techniques, 
as, in principle, one free phage particle can be detected. Scatchard 
plots of such results from a series of reactions at a range of protein 
concentrations deliver KdRel values. 
MATERIALS AND METHODS 
Phage particles and proteins 
Phage particles 131-134  are specific for the HBV core antigen 
particle (HBcAg) and were isolated from a random hexapeptide 
phage display library (11) by three rounds of biopanning against 
HBcAg adsorbed on nitrocellulose discs (8). HBcAg was 
expressed in Escherichia coli (12). Phage particles E2-16, E2-17, 
E4-2 and E4-4 are specific for the monoclonal antibody MA 18/7, 
directed against the PreS 1 protein domain of HBV surface 
antigen (13), and originated from rounds two and four of a 
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Phage particles were purified from the supernatant of 500 ml 
overnight cultures of infected E.coli K91Kan cells by polyethy-
lene glycol precipitation and CsCl gradient centrifugation, as 
described by Smith and Scott (14). 
Determination of phage titre as plaque forming units 
(p.f.u.) 
Phage solutions were diluted serially in TBS (0.05 M Tris-HCI, 
pH 7.5, 0.15 M NaC1) containing gelatin (1 gIl) and aliquots of 
these dilutions (100 1.11) were added to a suspension of K9 1 Kan 
cells (400 j.tl) at 0D600 0.2 (1/10 dilution). Melted soft agar (3 
ml) was then poured into the tubes containing the suspension of 
phage and host cells and the mixture poured on agar plates 
containing kanamycin (100 t1). The plates were incubated 
overnight at 37°C and plaques counted the following day. 
Phage binding assay on solid phase 
U-shaped wells of 'high capacity' polystyrene strip plates 
(#2585; Costar) were coated with protein [20 tg/ml HBcAg in 
25 mM potassium phosphate, pH 7.5, 150 mM NaCl (PBS) or 
1 tg/ml MA 18/7 in 0.2 M ammonium bicarbonate buffer, pH 
9.6; volume 200 111] overnight at room temperature, washed 
three times with TBS and blocked for 2 h fl at room temperature 
by adding TBS containing bovine serum albumin (BSA) (200 
tl, 10 mg/ml). After three further washes with TB S. wells were 
filled with various concentrations of purified phage particles 
diluted in TBS buffer containing 0.2 mg/ml BSA, 0.02% NaN3 
(107_101 p.f.u./200 Ill) and incubated for 1 hat 6°C. After 1 h 
the phage solutions were removed from the wells and the plates 
were then washed 10 times with TBS containing 0.2 mg/ml 
BSA and bound phage eluted by incubation with elution buffer 
(200 tl, 0.1 M HC1, titrated to pH 2.2 by addition of solid 
glycine) for 10 mm. Eluates were neutralized with 40 l.tl 1 M 
Tris-HC1, pH 9.5, and the phage titres determined. Triplicate 
measurements were made at each phage concentration. 
For time course experiments five identical sets of plates were 
prepared with coating conditions as above and the input phage 
concentrations were kept constant (200 .tl, 108  p.f.u./well). 
Each plate represented a point on a time course with incubation 
times of 10, 31, 100, 316 and 1000 mm (corresponding to 
half-log intervals). After each incubation period the relevant 
plate was treated as described above and the bound phage 
eluted and titred. 
Phage binding assay in solution 
This procedure was adapted from Friguet et al. (15). First, the 
proteins (HBcAg or MAb) were incubated in solution with the 
purified phage particles until equilibrium was reached (18 h). 
In the case of binding of phage B I to HBcAg this was attained 
as follows. The antigen at various concentrations (0.32-10 
IIM) was mixed with a constant amount of phage (10 9 p.f.u./ml) 
-- in.TBScontaining 0.2 mg/mi BSA,-0.02% NaN3. After 18h at 
6°C, an aliquot (100 j.tl) of each mixture was transferred to the 
• PhageE4-4 
o PhageBi 
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Figure 1. Linear relationship between input and output p.f.u. from wells coated 
with HBcAg or monoclonal antibody. Varying input concentrations of either 
phage B 1 (0) or phage E44 (•) were incubated for I hon polystyrene wells 
coated with either HBcAg or MA I 8/7 respectively and the number of bound 
phage (output) determined by titrating eluted p.f.u. Assays were performed in 
triplicate and error bars represent the deviation from the mean. 
wells of a U-shaped, polystyrene, radioimmunoassay strip plate 
that had been coated with HBcAg as described above. After 1 h 
at 6°C the wells were washed 10 times with TBS supplemented 
with 0.2 mg/ml BSA. Bound phage were then eluted, neutralized 
and titred as described above; all assays were performed in 
triplicate. In the case of binding phage B2 and B3 to HBcAg, the 
antigen concentration was varied from 1.58 to 50 tM and for 
phage 94 the antigen concentrations were varied from 0.63 to 20 
l.iM. The binding assay between monoclonal antibody MA 18/7 
and phage was performed in the same way, except that the 
antibody concentration was varied from 0.32 to 30 nM and the 
solid phase was coated with MA 18/7 as described. 
RESULTS 
The method for determination of relative dissociation constants 
between fusion phage and substrate molecules in solution is 
based upon that used for the measurement of affinity constants 
in solution between antigens and antibodies (15). A constant 
concentration of fusion phage was incubated with varying 
concentrations of substrate until equilibrium was reached. The 
number of free phage can be quantitated by incubating the 
mixture in microtitre plates coated with antigen or antibody, 
washing the wells, eluting the phage bound to the wells with 
glycmne-HCI buffer, pH 2.2, and quantitating the phage in the 
eluate by titration of p.f.u.. To show that the phage concentration 
in the eluate reflected the free phage concentration in the 
reaction mixture, varying concentrations of phage (input) were 
incubated in microtitre wells coated with antigen or antibody for 
1 h, the wells were washed and bound phage eluted (output) and 
titred. The output p.f.u. was directly proportional to input p.f.u. 
over a two log range for fusion phage B 1 and E44 (Fig. 1), 
which differ greatly in their binding affinities (Table 1). The 
-
standard error involved in measuring phage titre varied between 
S and lO%. -- - - - 
biopanning procedure using the same random hexapeptide 
phage display library and MA 18/7-coated wells of an ELISA 
plate (2). 
Large scale preparation of phage particles 
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Figure 2. 'lime course of phage binding to substrate-coated solid phase. Fusion 
phage (108  pf.u.) E4-4 (•) or BI (0) were incubated on polystyrene wells 
coated with either MA I 817 or HBcAg respectively for different periods of time 
and bound phage determined by titrating eluted p.f.u. Points represent the 
average of three assays and error bars the deviation from the mean. 
Table 1. Relative dissociation constants and characteristics of phage analysed 
Phage 	gpIII fusiona Specificity 	KdReI b 	KdRel 
BI 	LLGR1K HBcAg 	0.15±0.01fsM 	0.17±0.01tM 
B2 YLLRFR HBcAg 1.4 ± 0.1 sM 1.5 ± 0,1 jiM 
B3 	LLGRLK HBcAg 	1.1 ±0.1 PM 	1.1 ±0.1 jiM 
B4 LLGRFK 1-lBcAg 0.56 ± 0.02 jiM 	0.64 ± 0.03 jiM 
E4-2 	PDPGFN MA 18/7 	0.17 ± 0.02 jiM 	0.2 nM 
E44 	QLDPGF MA 18/7 0.25 ± 0.02 nM 	0.2 nM 
E2-16 	LDPJFR MAI8/7 	0.10 ± 0.01 nM 	ndd 
E2-17 	DPAFND MA 18/7 0.22 ± 0.01 nM 	ndd 
altalic indicates matching amino acids with the sequence of the PreS I antigen. 
bRelatjve dissociation constants calculated by linear regression of Scatchard 
plots (Fig. 3). 
cRelative dissociation constants calculated by curve fitting to a hyperbolic func-
tion (2,8). 
dNot determined. 
Figure 2 shows a time course experiment in which a constant 
concentration of fusion phage (108  p.f.u.) was incubated with 
substrate-coated wells for different time periods. A plateau was 
reached after 5 h, with --14% of phage E44 bound to MA1817-
coated wells and —4% of phage B 1 captured by HBcAg-coated 
wells. These results presumably reflect the differing strengths of 
binding in the two cases. 
The linear relationship between input phage titre and output of 
phage eluted from ligand-coated wells allows the determination 
of free phage concentration at equilibrium, provided that the total 
phage concentration is known. Indeed, if the total phage 
concentration (p r) is incubated with the binding substrate at any 
given concentration, the free phage concentration (p), is related 
to the p.f.u. measured in the eluate by the following equation: 
P'Pt = p.f.u./p.f.u. 0 	 (1) 
where p.f.u.0 is the titre measured for the (eluted) phage in the 
absence of antigen. This will only be true if the equilibrium in the 
liquid phase is undisturbed during exposure of the mixture to the 
coated wells. It is unlikely that this will result in significant 
perturbation of the equilibrium in solution, since the number of 
phage binding to the solid phase under the experimental 
conditions used (i.e. quantity and accessibility of the protein 
substrate coated on the wells and time of incubation of the 
mixtures in the wells) represents <5% of the total free phage 
concentration (Figs 1 and 2). To verify this, fusion phage B 1 and 
E4-4 were incubated at various concentrations (in triplicate) for 
1 h with substrate-coated wells (HBcAg and MA! 8/7 respective-
ly) and the contents of each well were then transferred to another 
coated well and again incubated for the same time. The bound 
phage in the two sets of wells were quantitated as described 
previously and found to be identical, within 95% standard error 
limits. This linear relationship between input and output p.f.u. 
from HBcAg-coated wells was also demonstrated for fusion 
phage B2, B3 and B4 (data not shown). 
Since Equation 1 was shown to be valid and if one phage 
particle binds one antigen particle or antibody molecule, the 
concentrations of bound phage (x) and of free antigen or antibody 
(a) at equilibrium can be calculated from the mass conservation 
equations: 
X=Pt—P 	 (2) 
a=a0 —x 	 (3) 
where a0 is the total concentration of antigen and Pt  and p 
represent the total and free phage concentrations respectively. At 
equilibrium, x, a and pt are related to the dissociation constant Kd 
by the Scatchard equation (16): 
x/a = [Pt - x]/Kd 	 (4) 
Equation 4 can be rearranged to give: 
x/pt a = ( l/Kd) - (x/Kd Pt) 	 (5) 
The gradient of a plot of x/Pta  against x/pt is therefore equal to 
—l/Kd. Figure 3 shows Scatchard plots for phage B 1-4 binding to 
truncated HBcAg (Fig. 3A) and phage E2-16, E2-17, E4-2 and 
E4-4 binding to MA 18/7 (Fig. 3B). KdRd values were calculated 
from linear regressions of the plots and show the order of affinity 
of the hexapeptides displayed on the phage for the ligands against 
which they were selected (Table 1). 
Once the linearity of the input to output ratio (Fig. 1) has been 
confirmed, up to five dissociation constants may be conveniently 
determined over a 2 day period, including data analysis. For ease 
of handling of larger numbers of plates, an image analyser may 
be used for counting plaques. 
DISCUSSION 
The method described here for measuring relative dissociation 
constants between fusion phage and ligands in solution should be 
generally applicable and enables direct comparison of the binding 
abilities of individual phage clones. However, dissociation 
constants obtained in this way should be regarded as relative 
values, since the presence of up to five copies of the gpffl fusion 
protein of the filamentous phage complicates matters. This could 
enable a single phage particle to simultaneously bind one molecule 
or particle on the solid phase and another molecule in solution or 
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a single phage particle could bind to the ligand (particulary in the 
case of the HBcAg particle) via multiple interactions, thus 
enhancing the affinity. Further, since HBcAg and MA 18/7 were 
present in large excess over the fusion phage, a single phage could 
bind more than one protein molecule or particle unless steric 
hindrance played a role. 
However, these factors should remain constant when comparing 
individual fusion phage clones selected for a given substrate or a 
given phage clone for different ligands and the method described 
for measuring Kd' 1  is valid because two essential criteria have 
been fulfilled. First, and most importantly, input and output phage 
titres are linearly related (Fig. 1), although the high affinity of 
phage E44 for the MAb apparently leads to saturation with inputs 
higher than 108.5  p.f.u. This linear relationship between input and 
output phage concentrations has been observed in all cases that 
have been studied, which include examples that differ by four 
orders of magnitude in their apparent Kd values. Secondly, in both 
cases <5% of free phage were bound to the wells during the 1 h 
incubation period used in the experiment (Fig. 2). Thus with both 
high and moderate affinity interactions it is unlikely that the 
equilibrium between the reactants in solution is significantly 
disturbed during this phase of the assay. 
Compared with the high affinity interactions of phage E2-16, 
E217E4 -2 and-E4-4 -with -the-monoclonal.antibody, the relative - - 
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Figure 3. Scatchard plots for fusion phage bound to HBcAg (A) or monoclonal 
antibody MA 18/7 (B). x is the concentration of bound phage, Pt  is the total 
phage concentration and a is the free substrate concentration. Measurements 
were as described in the Materials and Method. Points represent the average of 
three results. 
with HBcAg represent moderate binding affinities (Table 1). This 
validates the method over a wide range (four orders of magnitude) 
of binding constants for reactions between phage and proteins. The 
KdRdl values (Table 1), calculated by linear regression of the 
Scatchard plots (Fig. 3), are very similar to those obtained by a 
curve fitting calculation using the same data (2,8). The slight 
differences are probably attributable to the additional constraint 
introduced into the curve fitting that p = Pt at zero antigen or 
antibody concentration. 
Surface plasmon resonance has been used to evaluate the binding 
of fusion phage clones to a monoclonal antibody (17), but it did not 
appear possible to determine the rates of association or dissocia-
tion. Measurement of phage titre offers greater sensitivity com-
pared with refractive index changes at the surface of the sensor 
chip. For example, phage concentrations greater than 1011  p.f.u./ml 
were required to observe a signal above background in the surface 
plasmon resonance experiments, whereas here concentrations of 
10 p.f.u./ml were employed and, in principle, this could be much 
lower. Additionally the determination of phage titres involves 
minimum expense. 
The procedure described here for calculating relative dissocia-
tion constants between fusion phage and substrates in solution 
should find wide application in the growing field of selection of 
peptide ligands to complex macromolecules and assemblies by the 
use of phage display libraries (3,8,18). After the selection process 
has been completed and amplified phage clones sequenced, it is 
necessary to confirm that the selected phage bind to their substrate 
in solution and to compare relative binding affinities between the 
various phage clones. The procedure described here achieves both 
these objectives. Further, the choice of synthetic peptides for 
competition studies is facilitated by comparing binding affinities 
for the same ligand of fusion phage with varying amino acids in 
their displayed peptide sequences. Although examples do exist 
where the gpIII protein context contribute significantly to the 
binding affinity of the fusion phage for the substrate (19), it is 
expected that the relative order of binding of a set of fusion phage 
will be similar to that of the free peptides. In addition, for the 
examples discussed here the free peptides were synthesized and 
found to bind the selected substrates (2,8). The method may also 
find use in studying structure—function relationships where whole 
protein domains, such as human growth hormone (20), zinc finger 
domains (7,21) or antibodies (22), have been expressed on 
filamentous phage. Therefore, it should be possible to rank affinity 
variants in the phage-associated form without the need to purify 
free domains. 
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